価格表
在庫・価格 ： 2025年04月30日 14時10分 現在
| 商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
|---|---|---|---|---|---|---|
|
Albumin, Mouse Urine, ELISA Kit, Albuwell M データシート |
1011 |
EXOエクソセル EXOCELL Division of Ethos Biosciences, Inc. |
1 kit | ¥245,000 |
無 (未発注) |
追加 |
在庫・価格 ： 2025年04月30日 14時10分 現在
使用文献
| No. | 文献情報 | 備考 | 参照 |
|---|---|---|---|
| 1 |
Tammela T et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 Jul;454(7204):656-60 Tammela T et al 2008/01/01 |
 |
|
| 2 |
Beckerman P et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat. Med. 2017 Apr;23(4):429-438 Beckerman P et al 2017/01/01 |
|
|
| 3 |
Okamoto K et al. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat. Genet. 2011 May;43(5):459-63 Okamoto K et al 2011/01/01 |
|
|
| 4 |
Belcik JT et al. Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer. J. Am. Coll. Cardiol. 2012 Aug;60(7):618-25 Belcik JT et al 2012/01/01 |
|
|
| 5 |
Sun XN et al. T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma. Circ. Res. 2017 May;120(10):1584-1597 Sun XN et al 2017/01/01 |
|
|
| 6 |
Dharaneeswaran H et al. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. Circ. Res. 2014 Jul;115(2):238-251 Dharaneeswaran H et al 2014/01/01 |
|
|
| 7 |
Zhang MZ et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 2012 Dec;122(12):4519-32 Zhang MZ et al 2012/01/01 |
|
|
| 8 |
Sachs N et al. Blood pressure influences end-stage renal disease of Cd151 knockout mice. J. Clin. Invest. 2012 Jan;122(1):348-58 Sachs N et al 2012/01/01 |
|
|
| 9 |
Jeansson M et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 2011 Jun;121(6):2278-89 Jeansson M et al 2011/01/01 |
|
|
| 10 |
Moreth K et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J. Clin. Invest. 2010 Dec;120(12):4251-72 Moreth K et al 2010/01/01 |
|
|
| 11 |
Kume S et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 2010 Apr;120(4):1043-55 Kume S et al 2010/01/01 |
|
|
| 12 |
Tanaka M et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J. Clin. Invest. 2010 Mar;120(3):768-77 Tanaka M et al 2010/01/01 |
|
|
| 13 |
Timmins JM et al. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J. Clin. Invest. 2009 Oct;119(10):2925-41 Timmins JM et al 2009/01/01 |
|
|
| 14 |
Crowley SD et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J. Clin. Invest. 2009 Apr;119(4):943-53 Crowley SD et al 2009/01/01 |
|
|
| 15 |
Yanagita M et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Invest. 2002 Jul;110(2):239-46 Yanagita M et al 2002/01/01 |
|
|
| 16 |
Saji Y et al. Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J. Hepatol. 2004 Oct;41(4):545-50 Saji Y et al 2004/01/01 |
|
|
| 17 |
Peng H et al. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun 2017 11;8(1):1493 Peng H et al 2017/01/01 |
|
|
| 18 |
Andres-Hernando A et al. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice. Nat Commun 2017 02;8:14181 Andres-Hernando A et al 2017/01/01 |
|
|
| 19 |
Song A et al. Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. Nat Commun 2017 02;8:14108 Song A et al 2017/01/01 |
|
|
| 20 |
Bai X et al. The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension. Nat Commun 2013;4:2910 Bai X et al 2013/01/01 |
|
|
| 21 |
Carota IA et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury. J. Exp. Med. 2019 04;216(4):936-949 Carota IA et al 2019/01/01 |
|
|
| 22 |
Li F et al. Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia. Proc. Natl. Acad. Sci. U.S.A. 2016 11;113(47):13450-13455 Li F et al 2016/01/01 |
|
|
| 23 |
Wang CH et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc. Natl. Acad. Sci. U.S.A. 2011 Feb;108(5):2070-5 Wang CH et al 2011/01/01 |
|
|
| 24 |
Kakoki M et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(22):10190-5 Kakoki M et al 2010/01/01 |
|
|
| 25 |
Kakoki M et al. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc. Natl. Acad. Sci. U.S.A. 2004 Sep;101(36):13302-5 Kakoki M et al 2004/01/01 |
|
|
| 26 |
Ziyadeh FN et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl. Acad. Sci Ziyadeh FN et al 2000/01/01 |
|
|
| 27 |
Lindblom P et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 2003 Aug;17(15):1835-40 Lindblom P et al 2003/01/01 |
|
|
| 28 |
Eriguchi M et al. The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2018 10;29(10):2546-2561 Eriguchi M et al 2018/01/01 |
|
|
| 29 |
Zimmerman SE et al. Nephronectin Regulates Mesangial Cell Adhesion and Behavior in Glomeruli. J. Am. Soc. Nephrol. 2018 04;29(4):1128-1140 Zimmerman SE et al 2018/01/01 |
|
|
| 30 |
Zhang MZ et al. Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model. J. Am. Soc. Nephrol. 2017 Nov;28(11):3300-3311 Zhang MZ et al 2017/01/01 |
|
|
| 31 |
Lichtnekert J et al. Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage. J. Am. Soc. Nephrol. 2016 Dec;27(12):3611-3627 Lichtnekert J et al 2016/01/01 |
|
|
| 32 |
Ayanga BA et al. Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 09;27(9):2733-47 Ayanga BA et al 2016/01/01 |
|
|
| 33 |
Takaori K et al. Severity and Frequency of Proximal Tubule Injury Determines Renal Prognosis. J. Am. Soc. Nephrol. 2016 08;27(8):2393-406 Takaori K et al 2016/01/01 |
|
|
| 34 |
Zhou X et al. Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. J. Am. Soc. Nephrol. 2016 06;27(6):1765-76 Zhou X et al 2016/01/01 |
|
|
| 35 |
Gagliardini E et al. B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 Apr;27(4):999-1005 Gagliardini E et al 2016/01/01 |
|
|
| 36 |
Erpenbeck L et al. ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy. J. Am. Soc. Nephrol. 2016 Jan;27(1):120-31 Erpenbeck L et al 2016/01/01 |
|
|
| 37 |
Fukuda R et al. Podocyte p53 Limits the Severity of Experimental Alport Syndrome. J. Am. Soc. Nephrol. 2016 Jan;27(1):144-57 Fukuda R et al 2016/01/01 |
|
|
| 38 |
Li SY et al. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2015 Dec;26(12):3072-84 Li SY et al 2015/01/01 |
|
|
| 39 |
Lazzeri E et al. Human Urine-Derived Renal Progenitors for Personalized Modeling of Genetic Kidney Disorders. J. Am. Soc. Nephrol. 2015 Aug;26(8):1961-74 Lazzeri E et al 2015/01/01 |
|
|
| 40 |
Xavier S et al. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J. Am. Soc. Nephrol. 2015 Apr;26(4):817-29 Xavier S et al 2015/01/01 |
|
|
| 41 |
Kawakami T et al. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS. J. Am. Soc. Nephrol. 2015 May;26(5):1040-52 Kawakami T et al 2015/01/01 |
|
|
| 42 |
Morito N et al. Overexpression of Mafb in podocytes protects against diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Nov;25(11):2546-57 Morito N et al 2014/01/01 |
|
|
| 43 |
Locatelli M et al. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J. Am. Soc. Nephrol. 2014 Aug;25(8):1786-98 Locatelli M et al 2014/01/01 |
|
|
| 44 |
Tak E et al. CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Mar;25(3):547-63 Tak E et al 2014/01/01 |
|
|
| 45 |
Peired A et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J. Am. Soc. Nephrol. 2013 Nov;24(11):1756-68 Peired A et al 2013/01/01 |
|
|
| 46 |
Kidokoro K et al. Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy. J. Am. Soc. Nephrol. 2013 Jun;24(7):1139-50 Kidokoro K et al 2013/01/01 |
|
|
| 47 |
Rutkowski JM et al. Adiponectin promotes functional recovery after podocyte ablation. J. Am. Soc. Nephrol. 2013 Feb;24(2):268-82 Rutkowski JM et al 2013/01/01 |
|
|
| 48 |
Ogawa Y et al. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J. Am. Soc. Nephrol. 2012 Jul;23(7):1198-209 Ogawa Y et al 2012/01/01 |
|
|
| 49 |
Yi X et al. Reduced expression of lipoic acid synthase accelerates diabetic nephropathy. J. Am. Soc. Nephrol. 2012 Jan;23(1):103-11 Yi X et al 2012/01/01 |
|
|
| 50 |
Iyoda M et al. Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2009 Jan;20(1):68-77 Iyoda M et al 2009/01/01 |
|
|
| 51 |
Suzuki H et al. Toll-like receptor 9 affects severity of IgA nephropathy. J. Am. Soc. Nephrol. 2008 Dec;19(12):2384-95 Suzuki H et al 2008/01/01 |
|
|
| 52 |
Yuzawa Y et al. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J. Am. Soc. Nephrol. 2008 Sep;19(9):1701-11 Yuzawa Y et al 2008/01/01 |
|
|
| 53 |
Wilkinson L et al. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development. J. Am. Soc. Nephrol. 2007 Jun;18(6):1697-708 Wilkinson L et al 2007/01/01 |
|
|
| 54 |
Meier M et al. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J. Am. Soc. Nephrol. 2007 Apr;18(4):1190-8 Meier M et al 2007/01/01 |
|
|
| 55 |
Nakagawa T et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 2007 Feb;18(2):539-50 Nakagawa T et al 2007/01/01 |
|
|
| 56 |
Peltier J et al. Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice. J. Am. Soc. Nephrol. 2006 Dec;17(12):3415-23 Peltier J et al 2006/01/01 |
|
|
| 57 |
Wang L et al. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. J. Am. Soc. Nephrol. 2005 Dec;16(12):3611-22 Wang L et al 2005/01/01 |
|
|
| 58 |
Suzuki H et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J. Am. Soc. Nephrol. 2005 May;16(5):1289-99 Suzuki H et al 2005/01/01 |
|
|
| 59 |
Takahashi N et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J. Am. Soc. Nephrol. 2005 Jan;16(1):125-32 Takahashi N et al 2005/01/01 |
|
|
| 60 |
Suganami T et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J. Am. Soc. Nephrol. 2001 Dec;12(12):2652-63 Suganami T et al 2001/01/01 |
|
|
| 61 |
Kasahara M et al. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J. Am. Soc. Nephrol. 2000 Sep;11(9):1691-701 Kasahara M et al 2000/01/01 |
|
|
| 62 |
Denhez B et al. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy. Diabetes 2019 05;68(5):1026-1039 Denhez B et al 2019/01/01 |
|
|
| 63 |
Kruger C et al. Proximal Tubular Cell-Specific Ablation of Carnitine Acetyltransferase Causes Tubular Disease and Secondary Glomerulosclerosis. Diabetes 2019 04;68(4):819-831 Kruger C et al 2019/01/01 |
|
|
| 64 |
Cassis P et al. ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental Diabetes. Diabetes 2018 10;67(10):2069-2083 Cassis P et al 2018/01/01 |
|
|
| 65 |
Li Z et al. Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes. Diabetes 2018 09;67(9):1847-1857 Li Z et al 2018/01/01 |
|
|
| 66 |
Sun SF et al. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in <i>db/db</i> Mice by Targeting miR-29b. Diabetes 2018 04;67(4):731-744 Sun SF et al 2018/01/01 |
|
|
| 67 |
Dogn辿 S et al. Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes. Diabetes 2016 09;65(9):2742-53 Dogn辿 S et al 2016/01/01 |
|
|
| 68 |
Kaida Y et al. DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy. Diabetes 2013 Sep;62(9):3241-50 Kaida Y et al 2013/01/01 |
|
|
| 69 |
Menne J et al. Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. Diabetes 2013 Apr;62(4):1167-74 Menne J et al 2013/01/01 |
|
|
| 70 |
Zhang MZ et al. Intrarenal dopamine inhibits progression of diabetic nephropathy. Diabetes 2012 Oct;61(10):2575-84 Zhang MZ et al 2012/01/01 |
|
|
| 71 |
Cha DR et al. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes 2007 Aug;56(8):2036-45 Cha DR et al 2007/01/01 |
|
|
| 72 |
Ohshiro Y et al. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 2006 Nov;55(11):3112-20 Ohshiro Y et al 2006/01/01 |
|
|
| 73 |
Shibuya K et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 2005 Mar;54(3):838-45 Shibuya K et al 2005/01/01 |
|
|
| 74 |
Zhang H et al. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice. Kidney Int. 2017 10;92(4):909-921 Zhang H et al 2017/01/01 |
|
|
| 75 |
Bae EH et al. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney Int. 2017 06;91(6):1347-1361 Bae EH et al 2017/01/01 |
|
|
| 76 |
Klemis V et al. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney Int. 2017 06;91(6):1374-1385 Klemis V et al 2017/01/01 |
|
|
| 77 |
Wnuk M et al. Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney. Kidney Int. 2017 04;91(4):868-879 Wnuk M et al 2017/01/01 |
|
|
| 78 |
Giani JF et al. Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity. Kidney Int. 2017 04;91(4):856-867 Giani JF et al 2017/01/01 |
|
|
| 79 |
He X et al. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney Int. 2017 03;91(3):642-657 He X et al 2017/01/01 |
|
|
| 80 |
Baumann B et al. Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney Int. 2016 10;90(4):797-808 Baumann B et al 2016/01/01 |
|
|
| 81 |
Souza AC et al. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int. 2016 Apr;89(4):809-22 Souza AC et al 2016/01/01 |
|
|
| 82 |
Zhang A et al. Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int. 2011 Jul;80(1):51-60 Zhang A et al 2011/01/01 |
|
|
| 83 |
Tanaka Y et al. Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int. 2011 Apr;79(8):871-82 Tanaka Y et al 2011/01/01 |
|
|
| 84 |
Ren S et al. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int. 2009 Oct;76(8):857-67 Ren S et al 2009/01/01 |
|
|
| 85 |
Bodin S et al. Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int. 2009 Aug;76(4):395-403 Bodin S et al 2009/01/01 |
|
|
| 86 |
Kuwabara T et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009 Feb;75(3):285-94 Kuwabara T et al 2009/01/01 |
|
|
| 87 |
Chen S et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int. 2008 Aug;74(3):289-99 Chen S et al 2008/01/01 |
|
|
| 88 |
Yokoi H et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 2008 Feb;73(4):446-55 Yokoi H et al 2008/01/01 |
|
|
| 89 |
Tapia R et al. Semaphorin3a disrupts podocyte foot processes causing acute proteinuria. Kidney Int. 2008 Mar;73(6):733-40 Tapia R et al 2008/01/01 |
|
|
| 90 |
Suzuki H et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 2007 Aug;72(3):319-27 Suzuki H et al 2007/01/01 |
|
|
| 91 |
Brodeur AC et al. Type I collagen glomerulopathy: postnatal collagen deposition follows glomerular maturation. Kidney Int. 2007 May;71(10):985-93 Brodeur AC et al 2007/01/01 |
|
|
| 92 |
Brezniceanu ML et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 2007 May;71(9):912-23 Brezniceanu ML et al 2007/01/01 |
|
|
| 93 |
Jiang T et al. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int. 2005 Dec;68(6):2608-20 Jiang T et al 2005/01/01 |
|
|
| 94 |
Mishra R et al. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int. 2005 Jan;67(1):82-93 Mishra R et al 2005/01/01 |
|
|
| 95 |
Fan Q et al. Gene expression profile in diabetic KK/Ta mice. Kidney Int. 2003 Dec;64(6):1978-85 Fan Q et al 2003/01/01 |
|
|
| 96 |
Hishikawa A et al. Decreased KAT5 Expression Impairs DNA Repair and Induces Altered DNA Methylation in Kidney Podocytes. Cell Rep 2019 Jan;26(5):1318-1332.e4 Hishikawa A et al 2019/01/01 |
|
|
| 97 |
Fan X et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2012 Jul;2(1):52-61 Fan X et al 2012/01/01 |
|
|
| 98 |
Li G et al. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J. Cell Biol. 2010 Dec;191(6):1113-25 Li G et al 2010/01/01 |
|
|
| 99 |
Sachs N et al. Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 2006 Oct;175(1):33-9 Sachs N et al 2006/01/01 |
|
|
| 100 |
Wang JH et al. Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice. Arthritis Rheum. 2013 Oct;65(10):2703-12 Wang JH et al 2013/01/01 |
|
|
| 101 |
Hsu HC et al. Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum. 2011 Jul;63(7):2038-48 Hsu HC et al 2011/01/01 |
|
|
| 102 |
Wang JH et al. Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice. Arthritis Rheum. 2011 Apr;63(4):1054-64 Wang JH et al 2011/01/01 |
|
|
| 103 |
Hsu HC et al. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum. 2006 Jan;54(1):343-55 Hsu HC et al 2006/01/01 |
|
|
| 104 |
Clark KL et al. Epidermal injury promotes nephritis flare in lupus-prone mice. J. Autoimmun. 2015 Dec;65:38-48 Clark KL et al 2015/01/01 |
|
|
| 105 |
Segerer S et al. Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am. J. Kidney Dis. 2002 Apr;39(4):876-88 Segerer S et al 2002/01/01 |
|
|
| 106 |
Nastase MV et al. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 2018 08;68-69:293-317 Nastase MV et al 2018/01/01 |
|
|
| 107 |
Kahlenberg JM et al. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheumatol 2014 Jan;66(1):152-62 Kahlenberg JM et al 2014/01/01 |
|
|
| 108 |
Li F et al. Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice. Hypertension 2018 05;71(5):894-903 Li F et al 2018/01/01 |
|
|
| 109 |
He B et al. TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia. Hypertension 2018 04;71(4) He B et al 2018/01/01 |
|
|
| 110 |
Liu Z et al. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation. Hypertension 2017 10;70(4):822-830 Liu Z et al 2017/01/01 |
|
|
| 111 |
Norlander AE et al. Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension. Hypertension 2016 07;68(1):167-74 Norlander AE et al 2016/01/01 |
|
|
| 112 |
Hyndman KA et al. Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure. Hypertension 2013 07;62(1):91-8 Hyndman KA et al 2013/01/01 |
|
|
| 113 |
Lai EY et al. Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass. Hypertension 2010 Apr;55(4):983-9 Lai EY et al 2010/01/01 |
|
|
| 114 |
Jia Z et al. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 2010 Feb;55(2):539-46 Jia Z et al 2010/01/01 |
|
|
| 115 |
Facemire CS et al. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. Hypertension 2010 Feb;55(2):531-8 Facemire CS et al 2010/01/01 |
|
|
| 116 |
Crowley SD et al. A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension. Hypertension 2010 Jan;55(1):99-108 Crowley SD et al 2010/01/01 |
|
|
| 117 |
Suzuki H et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension 2009 Nov;54(5):1129-35 Suzuki H et al 2009/01/01 |
|
|
| 118 |
Wang Y et al. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension 2008 Aug;52(2):264-70 Wang Y et al 2008/01/01 |
|
|
| 119 |
Bowers MC et al. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension 2005 Jul;46(1):51-7 Bowers MC et al 2005/01/01 |
|
|
| 120 |
Supowit SC et al. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension 2005 Jan;45(1):109-14 Supowit SC et al 2005/01/01 |
|
|
| 121 |
Russo L et al. Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene. Mol Metab 2018 03;9:98-113 Russo L et al 2018/01/01 |
|
|
| 122 |
Chen HY et al. MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol. Ther. 2014 Apr;22(4):842-53 Chen HY et al 2014/01/01 |
|
|
| 123 |
Ohashi K et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vasc. Biol. 2007 Sep;27(9):1910-7 Ohashi K et al 2007/01/01 |
|
|
| 124 |
Holterman CE et al. Podocyte NADPH Oxidase 5 Promotes Renal Inflammation Regulated by the Toll-Like Receptor Pathway. Antioxid. Redox Signal. 2019 05;30(15):1817-1830 Holterman CE et al 2019/01/01 |
|
|
| 125 |
Yuan H et al. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy. Antioxid. Redox Signal. 2016 Mar;24(7):361-75 Yuan H et al 2016/01/01 |
|
|
| 126 |
Lee WJ et al. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy. Antioxid. Redox Signal. 2016 Feb;24(4):217-231 Lee WJ et al 2016/01/01 |
|
|
| 127 |
Han JH et al. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE <sup>-/-</sup> mice fed a western diet. Diabetologia 2017 02;60(2):364-376 Han JH et al 2017/01/01 |
|
|
| 128 |
Kuwabara T et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 2012 Aug;55(8):2256-66 Kuwabara T et al 2012/01/01 |
|
|
| 129 |
Ka SM et al. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia 2012 Feb;55(2):509-19 Ka SM et al 2012/01/01 |
|
|
| 130 |
Zhou T et al. Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 2012 Jan;55(1):255-66 Zhou T et al 2012/01/01 |
|
|
| 131 |
Liu F et al. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia 2011 Oct;54(10):2713-23 Liu F et al 2011/01/01 |
|
|
| 132 |
Makino H et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia 2006 Oct;49(10):2514-24 Makino H et al 2006/01/01 |
|
|
| 133 |
Ishii H et al. Recombinant annexin-2 inhibits the progress of diabetic nephropathy in a diabetic mouse model via recovery of hypercoagulability. Thromb. Haemost. 2007 Jan;97(1):124-8 Ishii H et al 2007/01/01 |
|
|
| 134 |
Ka SM et al. A low toxicity synthetic cinnamaldehyde derivative ameliorates renal inflammation in mice by inhibiting NLRP3 inflammasome and its related signaling pathways. Free Radic. Biol. Med. 2016 Feb;91:10-24 Ka SM et al 2016/01/01 |
|
|
| 135 |
Hisamichi M et al. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension. FASEB J. 2017 01;31(1):72-84 Hisamichi M et al 2017/01/01 |
|
|
| 136 |
Xu Y et al. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J. 2010 Feb;24(2):609-16 Xu Y et al 2010/01/01 |
|
|
| 137 |
Arakawa K et al. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br. J. Pharmacol. 2001 Jan;132(2):578-86 Arakawa K et al 2001/01/01 |
|
|
| 138 |
Yates LL et al. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation. Hum. Mol. Genet. 2010 Dec;19(23):4663-76 Yates LL et al 2010/01/01 |
|
|
| 139 |
Wang B et al. Overexpressed cyclophilin B suppresses aldosterone-induced proximal tubular cell injury both in vitro and in vivo. Oncotarget 2016 10;7(43):69309-69320 Wang B et al 2016/01/01 |
|
|
| 140 |
Zhao M et al. PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria. Oncotarget 2016 Mar;7(11):12150-62 Zhao M et al 2016/01/01 |
|
|
| 141 |
Meng XM et al. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin. Oncotarget 2015 Nov;6(35):36984-97 Meng XM et al 2015/01/01 |
|
|
| 142 |
Zhang Q et al. Activation of the Nrf2-ARE Pathway Ameliorates Hyperglycemia-Mediated Mitochondrial Dysfunction in Podocytes Partly Through Sirt1. Cell. Physiol. Biochem. 2018;48(1):1-15 Zhang Q et al 2018/01/01 |
|
|
| 143 |
Bonnemaison ML et al. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice. Clin. Sci. 2019 01;133(2):167-180 Bonnemaison ML et al 2019/01/01 |
|
|
| 144 |
Wei X et al. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension. Clin. Sci. 2017 Apr;131(7):567-581 Wei X et al 2017/01/01 |
|
|
| 145 |
Kim EN et al. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging (Albany NY) 2018 01;10(1):83-99 Kim EN et al 2018/01/01 |
|
|
| 146 |
Zhao L et al. High-salt diet induces outward remodelling of efferent arterioles in mice with reduced renal mass. Acta Physiol (Oxf) 2017 03;219(3):652-659 Zhao L et al 2017/01/01 |
|
|
| 147 |
Nagasu H et al. Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice. Lab. Invest. 2016 Jan;96(1):25-36 Nagasu H et al 2016/01/01 |
|
|
| 148 |
Burnworth B et al. SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab. Invest. 2012 Apr;92(4):499-510 Burnworth B et al 2012/01/01 |
|
|
| 149 |
Du SW et al. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells. J. Immunol. 2018 12;201(11):3258-3268 Du SW et al 2018/01/01 |
|
|
| 150 |
Wolf SJ et al. TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling. J. Immunol. 2018 07;201(2):393-405 Wolf SJ et al 2018/01/01 |
|
|
| 151 |
Fujita Y et al. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J. Immunol. 2014 Feb;192(3):979-84 Fujita Y et al 2014/01/01 |
|
|
| 152 |
Ding Y et al. IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells. J. Immunol. 2013 Aug;191(4):1614-24 Ding Y et al 2013/01/01 |
|
|
| 153 |
Anders HJ et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J. Immunol. 2003 Jun;170(11):5658-66 Anders HJ et al 2003/01/01 |
|
|
| 154 |
Kawahata K et al. Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self. J. Immunol. 1999 Jun;162(11):6482-91 Kawahata K et al 1999/01/01 |
|
|
| 155 |
Grove KJ et al. Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J. Lipid Res. 2014 07;55(7):1375-85 Grove KJ et al 2014/01/01 |
|
|
| 156 |
Buga GM et al. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J. Lipid Res. 2008 Jan;49(1):192-205 Buga GM et al 2008/01/01 |
|
|
| 157 |
Lin Y et al. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. J. Endocrinol. 2011 May;209(2):185-91 Lin Y et al 2011/01/01 |
|
|
| 158 |
Carlson RP et al. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases. Ann. N. Y. Acad. Sci. 1993 Jun;685:86-113 Carlson RP et al 1993/01/01 |
|
|
| 159 |
He T et al. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway. J. Mol. Med. 2016 12;94(12):1359-1371 He T et al 2016/01/01 |
|
|
| 160 |
Tak E et al. Protective role for netrin-1 during diabetic nephropathy. J. Mol. Med. 2013 Sep;91(9):1071-80 Tak E et al 2013/01/01 |
|
|
| 161 |
Stelloh C et al. Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res 2012 Feb;159(2):80-9 Stelloh C et al 2012/01/01 |
|
|
| 162 |
Yu J et al. MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy. Oxid Med Cell Longev 2016;2016:7496930 Yu J et al 2016/01/01 |
|
|
| 163 |
Laping NJ et al. Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells. Biochem. Pharmacol. 2000 Apr;59(7):847-53 Laping NJ et al 2000/01/01 |
|
|
| 164 |
Mozaffari MS et al. Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage. J. Nutr. Biochem. 2012 Aug;23(8):977-85 Mozaffari MS et al 2012/01/01 |
|
|
| 165 |
Soni H et al. γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling. J. Cell. Mol. Med. 2019 01;23(1):260-270 Soni H et al 2019/01/01 |
|
|
| 166 |
Mortuza R et al. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1. J. Cell. Mol. Med. 2015 Aug;19(8):1857-67 Mortuza R et al 2015/01/01 |
|
|
| 167 |
Huang C et al. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrol. Dial. Transplant. 2014 Feb;29(2):313-24 Huang C et al 2014/01/01 |
|
|
| 168 |
Seok SJ et al. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol. Dial. Transplant. 2013 Jul;28(7):1700-10 Seok SJ et al 2013/01/01 |
|
|
| 169 |
Nakata J et al. Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs. Nephrol. Dial. Transplant. 2013 Feb;28(2):320-6 Nakata J et al 2013/01/01 |
|
|
| 170 |
Takamiya Y et al. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice. Nephrol. Dial. Transplant. 2012 Sep; Takamiya Y et al 2012/01/01 |
|
|
| 171 |
Park JK et al. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Nephrol. Dial. Transplant. 2008 Jun;23(6):1844-53 Park JK et al 2008/01/01 |
|
|
| 172 |
Lee S et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol. Dial. Transplant. 2007 Feb;22(2):396-408 Lee S et al 2007/01/01 |
|
|
| 173 |
Schadde E et al. Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol. Dial. Transplant. 2000 Jul;15(7):1046-53 Schadde E et al 2000/01/01 |
|
|
| 174 |
Arimura E et al. Deteriorated glucose metabolism with a high-protein, low-carbohydrate diet in db mice, an animal model of type 2 diabetes, might be caused by insufficient insulin secretion. Eur J Nutr 2017 Feb;56(1):237-246 Arimura E et al 2017/01/01 |
|
|
| 175 |
Arimura E et al. Low-protein diet improves blood and urinary glucose levels and renal manifestations of diabetes in C57BLKS-db/db mice. Eur J Nutr 2013 Mar;52(2):813-24 Arimura E et al 2013/01/01 |
|
|
| 176 |
Chao CY et al. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 2010 Mar;54(3):388-95 Chao CY et al 2010/01/01 |
|
|
| 177 |
Lin CC et al. Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice. Mol Nutr Food Res 2008 Nov;52(11):1358-64 Lin CC et al 2008/01/01 |
|
|
| 178 |
Van Krieken R et al. Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice. Endocrinology 2018 03;159(3):1479-1495 Van Krieken R et al 2018/01/01 |
|
|
| 179 |
Luo J et al. FSP-1 Impairs the Function of Endothelium Leading to Failure of Arteriovenous Grafts in Diabetic Mice. Endocrinology 2015 Jun;156(6):2200-10 Luo J et al 2015/01/01 |
|
|
| 180 |
Lin Y et al. Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology 2013 Oct;154(10):3855-63 Lin Y et al 2013/01/01 |
|
|
| 181 |
Wang Y et al. Role of substance P in renal injury during DOCA-salt hypertension. Endocrinology 2012 Dec;153(12):5972-9 Wang Y et al 2012/01/01 |
|
|
| 182 |
Kawamura M et al. Undernutrition in utero augments systolic blood pressure and cardiac remodeling in adult mouse offspring: possible involvement of local cardiac angiotensin system in developmental origins of cardiovascular disease. Endocrinology 2007 Mar Kawamura M et al 2007/01/01 |
|
|
| 183 |
Saritas T et al. Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis. Sci Rep 2019 03;9(1):4596 Saritas T et al 2019/01/01 |
|
|
| 184 |
Oe Y et al. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep 2019 Feb;9(1):2986 Oe Y et al 2019/01/01 |
|
|
| 185 |
Ono H et al. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy. Sci Rep 2018 Jul;8(1):10548 Ono H et al 2018/01/01 |
|
|
| 186 |
Zambrano S et al. FYVE domain-containing protein ZFYVE28 regulates EGFR-signaling in podocytes but is not critical for the function of filtration barrier in mice. Sci Rep 2018 Mar;8(1):4712 Zambrano S et al 2018/01/01 |
|
|
| 187 |
Oe Y et al. Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase. Sci Rep 2018 01;8(1):102 Oe Y et al 2018/01/01 |
|
|
| 188 |
Marks ES et al. Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria. Sci Rep 2017 10;7(1):12821 Marks ES et al 2017/01/01 |
|
|
| 189 |
Walton SL et al. Prenatal hypoxia leads to hypertension, renal renin-angiotensin system activation and exacerbates salt-induced pathology in a sex-specific manner. Sci Rep 2017 Aug;7(1):8241 Walton SL et al 2017/01/01 |
|
|
| 190 |
Kato Y et al. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci Rep 2017 Apr;7:46624 Kato Y et al 2017/01/01 |
|
|
| 191 |
Rao J et al. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells. Sci Rep 2017 01;7:39727 Rao J et al 2017/01/01 |
|
|
| 192 |
Futatsugi K et al. Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules. Sci Rep 2016 Nov;6:36533 Futatsugi K et al 2016/01/01 |
|
|
| 193 |
Wang X et al. Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions. Sci Rep 2016 08;6:31506 Wang X et al 2016/01/01 |
|
|
| 194 |
Araki M et al. Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis. Sci Rep 2016 Aug;6:31216 Araki M et al 2016/01/01 |
|
|
| 195 |
Morigi M et al. A previously unrecognized role of C3a in proteinuric progressive nephropathy. Sci Rep 2016 06;6:28445 Morigi M et al 2016/01/01 |
|
|
| 196 |
Glastras SJ et al. Maternal Obesity Promotes Diabetic Nephropathy in Rodent Offspring. Sci Rep 2016 06;6:27769 Glastras SJ et al 2016/01/01 |
|
|
| 197 |
Ohno S et al. Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure. Sci Rep 2016 Jun;6:27192 Ohno S et al 2016/01/01 |
|
|
| 198 |
Rosenquist TA et al. Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse. Drug Metab. Dispos. 2010 May;38(5):761-8 Rosenquist TA et al 2010/01/01 |
|
|
| 199 |
Yi X et al. Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice. Atherosclerosis 2012 Jul;223(1):137-43 Yi X et al 2012/01/01 |
|
|
| 200 |
Guo J et al. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome. Hum. Gene Ther. 2019 07;30(7):865-881 Guo J et al 2019/01/01 |
|
|
| 201 |
Teixeira SR et al. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J. Nutr. 2003 Mar;133(3):673-8 Teixeira SR et al 2003/01/01 |
|
|
| 202 |
Tamaki M et al. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element. Am. J. Physiol. Endocrinol. Metab. 2019 03;316(3):E418-E431 Tamaki M et al 2019/01/01 |
|
|
| 203 |
Thomas AA et al. ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications. Am. J. Physiol. Endocrinol. Metab. 2018 03;314(3):E191-E200 Thomas AA et al 2018/01/01 |
|
|
| 204 |
Wu D et al. A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2016 Feb;310(3):E225-37 Wu D et al 2016/01/01 |
|
|
| 205 |
Li C et al. High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. Am. J. Physiol. Endocrinol. Metab. 2015 Nov;309(9):E802-10 Li C et al 2015/01/01 |
|
|
| 206 |
Chen G et al. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am. J. Physiol. Endocrinol. Metab. 2012 Sep;303(5):E563-75 Chen G et al 2012/01/01 |
|
|
| 207 |
Zhang D et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2011 Feb;300(2):E287-95 Zhang D et al 2011/01/01 |
|
|
| 208 |
An X et al. Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression. Front Physiol 2018;9:1195 An X et al 2018/01/01 |
|
|
| 209 |
Song K et al. Loss of mucin-type <i>O</i>-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney. J. Biol. Chem. 2017 10;292(40):16491-16497 Song K et al 2017/01/01 |
|
|
| 210 |
Verma R et al. Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J. Biol. Chem. 2003 Jun;278(23):20716-23 Verma R et al 2003/01/01 |
|
|
| 211 |
Rhaleb NE et al. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice. J. Hypertens. 2011 Feb;29(2):330-8 Rhaleb NE et al 2011/01/01 |
|
|
| 212 |
Inada A et al. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell. Physiol. 2008 May;215(2):383-91 Inada A et al 2008/01/01 |
|
|
| 213 |
Bagavant H et al. Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease. Am. J. Pathol. 2011 Aug;179(2):651-60 Bagavant H et al 2011/01/01 |
|
|
| 214 |
Alikhan MA et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am. J. Pathol. 2011 Sep;179(3):1243-56 Alikhan MA et al 2011/01/01 |
|
|
| 215 |
Thompson J et al. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am. J. Pathol. 2011 Sep;179(3):1179-87 Thompson J et al 2011/01/01 |
|
|
| 216 |
Zhu C et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ. Am. J. Pathol. 2011 May;178(5):2020-31 Zhu C et al 2011/01/01 |
|
|
| 217 |
Veron D et al. Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome. Am. J. Pathol. 2010 Nov;177(5):2225-33 Veron D et al 2010/01/01 |
|
|
| 218 |
Abrass CK et al. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am. J. Pathol. 2010 Feb;176(2):839-49 Abrass CK et al 2010/01/01 |
|
|
| 219 |
Tanaka T et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am. J. Pathol. 2009 Apr;174(4):1203-11 Tanaka T et al 2009/01/01 |
|
|
| 220 |
Wong DW et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 2007 Aug;171(2):438-51 Wong DW et al 2007/01/01 |
|
|
| 221 |
Harvey SJ et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am. J. Pathol. 2007 Jul;171(1):139-52 Harvey SJ et al 2007/01/01 |
|
|
| 222 |
Xu C et al. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis. Clin. Immunol. 2018 12;197:179-185 Xu C et al 2018/01/01 |
|
|
| 223 |
Inage M et al. Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin. Int. J. Biol. Sci. 2009;5(4):304-10 Inage M et al 2009/01/01 |
|
|
| 224 |
Chen Y et al. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation 2005 May;79(10):1378-85 Chen Y et al 2005/01/01 |
|
|
| 225 |
Schaper M et al. Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis. Infect. Immun. 2003 Jul;71(7):4087-92 Schaper M et al 2003/01/01 |
|
|
| 226 |
Hisamichi M et al. Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury. Hypertens. Res. 2018 Jan;41(1):8-17 Hisamichi M et al 2018/01/01 |
|
|
| 227 |
Wang Y et al. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension. Mol. Med. 2011;17(11-12):1204-12 Wang Y et al 2011/01/01 |
|
|
| 228 |
Yang Y et al. Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice. AAPS J 2017 11;19(6):1791-1803 Yang Y et al 2017/01/01 |
|
|
| 229 |
Lee DL et al. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2006 Mar;290(3):H935-40 Lee DL et al 2006/01/01 |
|
|
| 230 |
Ito Y et al. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Exp. Gerontol. 2005 Apr;40(4):315-23 Ito Y et al 2005/01/01 |
|
|
| 231 |
Ichihara A et al. Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice. J Am Soc Hypertens ;2(5):332-40 Ichihara A et al |
|
|
| 232 |
Ren X et al. Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-<i>β</i> Signal Pathway. Mediators Inflamm. 2016;2016:5147571 Ren X et al 2016/01/01 |
|
|
| 233 |
Bowman-Colin C et al. The Role of Endocrine System in the Inflammatory Process. Mediators Inflamm. 2016;2016:6081752 Bowman-Colin C et al 2016/01/01 |
|
|
| 234 |
Guo H et al. Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury. Mediators Inflamm. 2016;2016:4387031 Guo H et al 2016/01/01 |
|
|
| 235 |
Zhang X et al. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice. Int J Mol Sci 2016 Aug;17(8) Zhang X et al 2016/01/01 |
|
|
| 236 |
Lin CY et al. Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice. J. Agric. Food Chem. 2011 May;59(9):5117-24 Lin CY et al 2011/01/01 |
|
|
| 237 |
Chen KH et al. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 2011 Mar;190(1):45-53 Chen KH et al 2011/01/01 |
|
|
| 238 |
Wang L et al. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press. Res. 2008;31(2):111-21 Wang L et al 2008/01/01 |
|
|
| 239 |
Manhiani MM et al. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension. Kidney Blood Press. Res. 2007;30(4):195-202 Manhiani MM et al 2007/01/01 |
|
|
| 240 |
Okada H et al. Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes. J Diabetes Investig 2015 Jan;6(1):35-43 Okada H et al 2015/01/01 |
|
|
| 241 |
Engler FA et al. Investigation of the influence of nephropathy on monoclonal antibody disposition: a pharmacokinetic study in a mouse model of diabetic nephropathy. Pharm. Res. 2014 May;31(5):1185-93 Engler FA et al 2014/01/01 |
|
|
| 242 |
Crowley SD et al. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010 Apr;298(4):R1089-97 Crowley SD et al 2010/01/01 |
|
|
| 243 |
Escano CS et al. Renal dopaminergic defect in C57Bl/6J mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Dec;297(6):R1660-9 Escano CS et al 2009/01/01 |
|
|
| 244 |
do Carmo JM et al. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Sep;297(3):R803-12 do Carmo JM et al 2009/01/01 |
|
|
| 245 |
Levine DZ et al. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Apr;290(4):R975-81 Levine DZ et al 2006/01/01 |
|
|
| 246 |
Sakata N et al. Effect of rat-to-mouse bioartificial pancreas xenotransplantation on diabetic renal damage and survival. Pancreas 2006 Apr;32(3):249-57 Sakata N et al 2006/01/01 |
|
|
| 247 |
Wang Z et al. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice. Inflammation 2014 Dec;37(6):2020-9 Wang Z et al 2014/01/01 |
|
|
| 248 |
Song R et al. Prorenin receptor is critical for nephron progenitors. Dev. Biol. 2016 Jan;409(2):382-91 Song R et al 2016/01/01 |
|
|
| 249 |
Zha D et al. Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1. Life Sci. 2019 Mar;221:109-120 Zha D et al 2019/01/01 |
|
|
| 250 |
Kajiyama T et al. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy. Clin. Dev. Immunol. 2011;2011:819646 Kajiyama T et al 2011/01/01 |
|
|
| 251 |
Declèves AÉ et al. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets. Exp. Physiol. 2016 Jan;101(1):193-206 Declèves AÉ et al 2016/01/01 |
|
|
| 252 |
Wang ZH et al. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur. J. Pharmacol. 2010 Feb;628(1-3):255-60 Wang ZH et al 2010/01/01 |
|
|
| 253 |
Katoh M et al. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur. J. Pharmacol. 2000 Jun;398(3):381-7 Katoh M et al 2000/01/01 |
|
|
| 254 |
Sims-Lucas S et al. Augmented and accelerated nephrogenesis in TGF-beta2 heterozygous mutant mice. Pediatr. Res. 2008 Jun;63(6):607-12 Sims-Lucas S et al 2008/01/01 |
|
|
| 255 |
Zhang S et al. Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1-Induced Preeclampsia Phenotype in Mice. G3 (Bethesda) 2018 10;8(10):3377-3382 Zhang S et al 2018/01/01 |
|
|
| 256 |
Verschuren L et al. A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone. BMC Med Genomics 2014 Jun;7:35 Verschuren L et al 2014/01/01 |
|
|
| 257 |
Lee DL et al. Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension. PPAR Res 2011;2011:502631 Lee DL et al 2011/01/01 |
|
|
| 258 |
Dylewski J et al. Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo. PLoS ONE 2019;14(2):e0209732 Dylewski J et al 2019/01/01 |
|
|
| 259 |
Dieter BP et al. Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease. PLoS ONE 2019;14(2):e0211555 Dieter BP et al 2019/01/01 |
|
|
| 260 |
Zheng X et al. Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy. PLoS ONE 2017;12(9):e0185250 Zheng X et al 2017/01/01 |
|
|
| 261 |
Schoemaker MH et al. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. PLoS ONE 2017;12(7):e0180648 Schoemaker MH et al 2017/01/01 |
|
|
| 262 |
Glastras SJ et al. The renal consequences of maternal obesity in offspring are overwhelmed by postnatal high fat diet. PLoS ONE 2017;12(2):e0172644 Glastras SJ et al 2017/01/01 |
|
|
| 263 |
Toffoli B et al. Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. PLoS ONE 2017;12(2):e0171474 Toffoli B et al 2017/01/01 |
|
|
| 264 |
Xu L et al. Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy. PLoS ONE 2016;11(10):e0163208 Xu L et al 2016/01/01 |
|
|
| 265 |
Glastras SJ et al. Mouse Models of Diabetes, Obesity and Related Kidney Disease. PLoS ONE 2016;11(8):e0162131 Glastras SJ et al 2016/01/01 |
|
|
| 266 |
Song K et al. Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury. PLoS ONE 2016;11(7):e0159872 Song K et al 2016/01/01 |
|
|
| 267 |
Kim DH et al. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. PLoS ONE 2016;11(4):e0153965 Kim DH et al 2016/01/01 |
|
|
| 268 |
Ossoli A et al. Lipoprotein X Causes Renal Disease in LCAT Deficiency. PLoS ONE 2016;11(2):e0150083 Ossoli A et al 2016/01/01 |
|
|
| 269 |
Gangadharan Komala M et al. Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin. PLoS ONE 2015;10(10):e0141143 Gangadharan Komala M et al 2015/01/01 |
|
|
| 270 |
Gangadharan Komala M et al. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS ONE 2014;9(11):e108994 Gangadharan Komala M et al 2014/01/01 |
|
|
| 271 |
Jia Z et al. COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes. PLoS ONE 2014;9(7):e93182 Jia Z et al 2014/01/01 |
|
|
| 272 |
Komers R et al. Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment. PLoS ONE 2014;9(5):e96987 Komers R et al 2014/01/01 |
|
|
| 273 |
Aizawa M et al. Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy. PLoS ONE 2014;9(4):e95365 Aizawa M et al 2014/01/01 |
|
|
| 274 |
Hua KF et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway. PLoS ONE 2013;8(10):e77794 Hua KF et al 2013/01/01 |
|
|
| 275 |
James LR et al. Connective tissue growth factor (CTGF) expression modulates response to high glucose. PLoS ONE 2013;8(8):e70441 James LR et al 2013/01/01 |
|
|
| 276 |
Radonjic M et al. Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PLoS ONE 2013;8(2):e56122 Radonjic M et al 2013/01/01 |
|
|
| 277 |
Mortuza R et al. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE 2013;8(1):e54514 Mortuza R et al 2013/01/01 |
|
|
| 278 |
Jaffa MA et al. Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes. PLoS ONE 2012;7(9):e44714 Jaffa MA et al 2012/01/01 |
|
|
| 279 |
Steenhard BM et al. Transgenic expression of human LAMA5 suppresses murine Lama5 mRNA and laminin α5 protein deposition. PLoS ONE 2011;6(9):e23926 Steenhard BM et al 2011/01/01 |
|
|
| 280 |
Li FH et al. The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-κB signaling pathway. Biomed. Pharmacother. 2018 Nov;107:1377-1384 Li FH et al 2018/01/01 |
|
|
| 281 |
Amann K et al. Lack of nidogen-2 increases blood pressure, glomerular and tubulointerstitial damage in DOCA-salt hypertension. Eur. J. Clin. Invest. 2009 Feb;39(2):116-25 Amann K et al 2009/01/01 |
|
|
| 282 |
Xiao T et al. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Mol. Cell. Biochem. 2014 Sep;394(1-2):145-54 Xiao T et al 2014/01/01 |
|
|
| 283 |
Warner LM et al. Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse. Inflamm. Res. 1995 Aug;44 Suppl 2:S205-6 Warner LM et al 1995/01/01 |
|
|
| 284 |
Chen G et al. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):63-71 Chen G et al 2011/01/01 |
|
|
| 285 |
Okamura K et al. Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver. Histochem. Cell Biol. 2006 Mar;125(3):247-57 Okamura K et al 2006/01/01 |
|
|
| 286 |
Nitta K et al. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. Biomed Res Int 2016;2016:9172157 Nitta K et al 2016/01/01 |
|
|
| 287 |
Imaruoka K et al. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide. Biochem. Biophys. Res. Commun. 2019 03;510(4):587-593 Imaruoka K et al 2019/01/01 |
|
|
| 288 |
Tanaka Y et al. Overexpression of acetyl CoA carboxylase β exacerbates podocyte injury in the kidney of streptozotocin-induced diabetic mice. Biochem. Biophys. Res. Commun. 2018 01;495(1):1115-1121 Tanaka Y et al 2018/01/01 |
|
|
| 289 |
Aoyama M et al. Fructose induces tubulointerstitial injury in the kidney of mice. Biochem. Biophys. Res. Commun. 2012 Mar;419(2):244-9 Aoyama M et al 2012/01/01 |
|
|
| 290 |
Kaplan J et al. Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model. Lupus 2008 Sep;17(9):822-31 Kaplan J et al 2008/01/01 |
|
|
| 291 |
Mirzoyan K et al. Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease. J. Physiol. Biochem. 2016 Dec;72(4):803-812 Mirzoyan K et al 2016/01/01 |
|
|
| 292 |
Tamura Y et al. Ezetimibe ameliorates early diabetic nephropathy in db/db mice. J. Atheroscler. Thromb. 2012;19(7):608-18 Tamura Y et al 2012/01/01 |
|
|
| 293 |
Baban B et al. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: role of indoleamine 2,3-dioxygenase and programmed death-1. Exp. Mol. Pathol. 2013 Apr;94(2):343-51 Baban B et al 2013/01/01 |
|
|
| 294 |
Zhang X et al. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling. Biol Trace Elem Res 2016 Oct;173(2):372-83 Zhang X et al 2016/01/01 |
|
|
| 295 |
Gao Q et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med. 2010 Jan;76(1):27-33 Gao Q et al 2010/01/01 |
|
|
| 296 |
Tamura Y et al. Differential effect of statins on diabetic nephropathy in db/db mice. Int. J. Mol. Med. 2011 Nov;28(5):683-7 Tamura Y et al 2011/01/01 |
|
|
| 297 |
Iwai M et al. Investigation of parenchymal cell differentiation in organotypic slice culture of mouse fetal liver under administration of sodium butyrate. Cell Biol. Toxicol. 2002;18(3):147-56 Iwai M et al 2002/01/01 |
|
|
| 298 |
Park JH et al. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin. Arch. Pharm. Res. 2017 Mar;40(3):391-402 Park JH et al 2017/01/01 |
|
|
| 299 |
Choi D et al. Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus. Arch. Pharm. Res. 2011 Aug;34(8):1301-10 Choi D et al 2011/01/01 |
|
|
| 300 |
Milagres T et al. Rehydration with fructose worsens dehydration-induced renal damage. BMC Nephrol 2018 Jul;19(1):180 Milagres T et al 2018/01/01 |
|
|
| 301 |
Mountz JD et al. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol. 2005 Feb;61(2):128-38 Mountz JD et al 2005/01/01 |
|
|
| 302 |
Xiao Z et al. Glomerular podocytes express type 1 adenylate cyclase: inactivation results in susceptibility to proteinuria. Nephron Exp. Nephrol. 2011;118(3):e39-48 Xiao Z et al 2011/01/01 |
|
|
| 303 |
Sakamaki Y et al. Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis. Nephron Exp. Nephrol. 2010;115(2):e22-32 Sakamaki Y et al 2010/01/01 |
|
|
| 304 |
Tsujimura T et al. Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats. Nephron Exp. Nephrol. 2008;110(4):e99-108 Tsujimura T et al 2008/01/01 |
|
|
| 305 |
Jo YI et al. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Nephron Exp. Nephrol. 2007;107(3):e87-94 Jo YI et al 2007/01/01 |
|
|
| 306 |
Collins SJ et al. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice. Nephron Exp. Nephrol. 2006;104(1):e23-34 Collins SJ et al 2006/01/01 |
|
|
| 307 |
Monkawa T et al. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis. Nephron Exp. Nephrol. 2006;102(1):e8-18 Monkawa T et al 2006/01/01 |
|
|
| 308 |
Cheng H et al. Expression of mediators of renal injury in the remnant kidney of ROP mice is attenuated by cyclooxygenase-2 inhibition. Nephron Exp. Nephrol. 2005;101(3):e75-85 Cheng H et al 2005/01/01 |
|
|
| 309 |
Hisamichi M et al. Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury. Biomarkers 2017 Feb;22(1):5-13 Hisamichi M et al 2017/01/01 |
|
|
| 310 |
Steenhard BM et al. Kidney development and gene expression in the HIF2alpha knockout mouse. Dev. Dyn. 2007 Apr;236(4):1115-25 Steenhard BM et al 2007/01/01 |
|
|
| 311 |
Zhang J et al. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. J Nat Med 2016 Oct;70(4):740-8 Zhang J et al 2016/01/01 |
|
|
| 312 |
Zoja C et al. Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy. Nephron 2016;132(1):59-69 Zoja C et al 2016/01/01 |
|
|
| 313 |
Xi W et al. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy. Cell Biol. Int. 2018 Nov;42(11):1523-1532 Xi W et al 2018/01/01 |
|
|
| 314 |
Yamashita M et al. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice. Clin. Exp. Nephrol. 2017 Feb;21(1):16-26 Yamashita M et al 2017/01/01 |
|
|
| 315 |
Zhang X et al. Effect of zinc deficiency on mouse renal interstitial fibrosis in diabetic nephropathy. Mol Med Rep 2016 Dec;14(6):5245-5252 Zhang X et al 2016/01/01 |
|
|
| 316 |
Ichikawa D et al. Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion. Nephrology (Carlton) 2018 Apr;23(4):308-316 Ichikawa D et al 2018/01/01 |
|
|
| 317 |
Gangadharan Komala M et al. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes. Nephrology (Carlton) 2016 May;21(5):423-31 Gangadharan Komala M et al 2016/01/01 |
|
|
| 318 |
Lim SW et al. Ginseng treatment attenuates autophagic cell death in chronic cyclosporine nephropathy. Nephrology (Carlton) 2014 Aug;19(8):490-9 Lim SW et al 2014/01/01 |
|
|
| 319 |
Ali Q et al. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury. J Renin Angiotensin Aldosterone Syst 2016 Jul;17(3) Ali Q et al 2016/01/01 |
|
|
| 320 |
Colombaro V et al. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover. Acta Histochem. 2015 Jan;117(1):83-91 Colombaro V et al 2015/01/01 |
|
|
| 321 |
Lu X et al. Danshen (Radix Salviae Miltiorrhizae) reverses renal injury induced by myocardial infarction. J Tradit Chin Med 2015 Jun;35(3):306-11 Lu X et al 2015/01/01 |
|
|
| 322 |
Cheng L et al. Everolimus vs. rapamycin for treating diabetic nephropathy in diabetic mouse model. J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):457 Cheng L et al 2011/01/01 |
|
|
| 323 |
Wei P et al. Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail 2009;31(6):503-13 Wei P et al 2009/01/01 |
|
|
| 324 |
Zhu X et al. Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice. Med. Sci. Monit. 2016 Oct;22:3902-3909 Zhu X et al 2016/01/01 |
|
|
| 325 |
Takiyama Y et al. Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8. EBioMedicine 2018 Oct;36:329-346 Takiyama Y et al 2018/01/01 |
|
|
| 326 |
Sun WY et al. Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury. JCI Insight 2018 09;3(17) Sun WY et al 2018/01/01 |
|
|
| 327 |
Zhao M et al. Angiotensin II Stimulates the NLRP3 Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction. Kidney Dis (Basel) 2018 Jun;4(2):83-94 Zhao M et al 2018/01/01 |
|
|
| 328 |
Trostel J et al. Different effects of global osteopontin and macrophage osteopontin in glomerular injury. Am. J. Physiol. Renal Physiol. 2018 10;315(4):F759-F768 Trostel J et al 2018/01/01 |
|
|
| 329 |
Sharp CN et al. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease. Am. J. Physiol. Renal Physiol. 2018 07;315(1):F161-F172 Sharp CN et al 2018/01/01 |
|
|
| 330 |
Sharma I et al. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 01;314(1):F107-F121 Sharma I et al 2018/01/01 |
|
|
| 331 |
Bai M et al. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury. Am. J. Physiol. Renal Physiol. 2017 04;312(4):F556-F564 Bai M et al 2017/01/01 |
|
|
| 332 |
Roncal-Jimenez CA et al. Aging-associated renal disease in mice is fructokinase dependent. Am. J. Physiol. Renal Physiol. 2016 10;311(4):F722-F730 Roncal-Jimenez CA et al 2016/01/01 |
|
|
| 333 |
Herrera M et al. Inhibition of T-cell activation by CTLA4-Fc is sufficient to ameliorate proteinuric kidney disease. Am. J. Physiol. Renal Physiol. 2016 Jul;:ajprenal.00179.2016 Herrera M et al 2016/01/01 |
|
|
| 334 |
Lemos DR et al. Maintenance of vascular integrity by pericytes is essential for normal kidney function. Am. J. Physiol. Renal Physiol. 2016 12;311(6):F1230-F1242 Lemos DR et al 2016/01/01 |
|
|
| 335 |
Zeng F et al. Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion. Am. J. Physiol. Renal Physiol. 2016 10;311(4):F695-F707 Zeng F et al 2016/01/01 |
|
|
| 336 |
Kitsunai H et al. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. Physiol Rep 2016 Mar;4(6) Kitsunai H et al 2016/01/01 |
|
|
| 337 |
Zhu J et al. Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production. Am. J. Physiol. Renal Physiol. 2016 05;310(9):F895-908 Zhu J et al 2016/01/01 |
|
|
| 338 |
Sas KM et al. Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease. J Proteomics Bioinform 2015 Oct;Suppl 14 Sas KM et al 2015/01/01 |
|
|
| 339 |
Ramkumar N et al. Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension. Physiol Rep 2016 Jan;4(1) Ramkumar N et al 2016/01/01 |
|
|
| 340 |
Munusamy S et al. Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. Am. J. Physiol. Renal Physiol. 2015 Oct;309(8):F731-43 Munusamy S et al 2015/01/01 |
|
|
| 341 |
Eadon MT et al. A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice. Antivir. Chem. Chemother. 2015 Apr;24(2):72-6 Eadon MT et al 2015/01/01 |
|
|
| 342 |
Zhuang Y et al. Albumin impairs renal tubular tight junctions via targeting the NLRP3 inflammasome. Am. J. Physiol. Renal Physiol. 2015 May;308(9):F1012-9 Zhuang Y et al 2015/01/01 |
|
|
| 343 |
Wang Y et al. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension. Exp. Biol. Med. (Maywood) 2015 Sep;240(9 Wang Y et al 2015/01/01 |
|
|
| 344 |
Ichikawa D et al. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury. Am. J. Physiol. Renal Physiol. 2015 Jan;308(2):F114-21 Ichikawa D et al 2015/01/01 |
|
|
| 345 |
Ichikawa D et al. Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation. Am. J. Physiol. Renal Physiol. 2014 Mar;306(6):F655-63 Ichikawa D et al 2014/01/01 |
|
|
| 346 |
Vallon V et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am. J. Physiol. Renal Physiol. 2014 Jan;306(2):F194-204 Vallon V et al 2014/01/01 |
|
|
| 347 |
Liu Y et al. Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice. Am. J. Physiol. Renal Physiol. 2013 Dec;305(11):F1555-62 Liu Y et al 2013/01/01 |
|
|
| 348 |
Liu S et al. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. Am. J. Physiol. Renal Physiol. 2013 Dec;305(11):F1533-41 Liu S et al 2013/01/01 |
|
|
| 349 |
Li J et al. Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. Am. J. Physiol. Renal Physiol. 2013 Apr;304(7):F1000-8 Li J et al 2013/01/01 |
|
|
| 350 |
Day RT et al. Apelin retards the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2013 Mar;304(6):F788-800 Day RT et al 2013/01/01 |
|
|
| 351 |
Basu R et al. Loss of TIMP3 selectively exacerbates diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2012 Nov;303(9):F1341-52 Basu R et al 2012/01/01 |
|
|
| 352 |
Ji X et al. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Am. J. Physiol. Renal Physiol. 2012 Oct;303(8):F1207-15 Ji X et al 2012/01/01 |
|
|
| 353 |
Rabadi MM et al. HMGB1 in renal ischemic injury. Am. J. Physiol. Renal Physiol. 2012 Sep;303(6):F873-85 Rabadi MM et al 2012/01/01 |
|
|
| 354 |
Nagao T et al. Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra 2012 Jan;2(1):87-103 Nagao T et al 2012/01/01 |
|
|
| 355 |
Walker KA et al. High nephron endowment protects against salt-induced hypertension. Am. J. Physiol. Renal Physiol. 2012 Jul;303(2):F253-8 Walker KA et al 2012/01/01 |
|
|
| 356 |
Lai EY et al. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am. J. Physiol. Renal Physiol. 2012 Jul;303(1):F64-74 Lai EY et al 2012/01/01 |
|
|
| 357 |
Nagasu H et al. Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice. Am. J. Physiol. Renal Physiol. 2012 Jun;302(11):F1402-8 Nagasu H et al 2012/01/01 |
|
|
| 358 |
Tanabe K et al. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Am. J. Physiol. Renal Physiol. 2012 May;302(9):F1151-60 Tanabe K et al 2012/01/01 |
|
|
| 359 |
Yang S et al. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am. J. Physiol. Renal Physiol. 2012 Mar;302(6):F742-9 Yang S et al 2012/01/01 |
|
|
| 360 |
Zhang MZ et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Am. J. Physiol. Renal Physiol. 2012 Feb;302(4):F433-8 Zhang MZ et al 2012/01/01 |
|
|
| 361 |
McKittrick IB et al. Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am. J. Physiol. Renal Physiol. 2011 Dec;301(6):F1326-33 McKittrick IB et al 2011/01/01 |
|
|
| 362 |
Awad AS et al. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am. J. Physiol. Renal Physiol. 2011 Dec;301(6):F1358-66 Awad AS et al 2011/01/01 |
|
|
| 363 |
Sanchez AP et al. Role of the USF1 transcription factor in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 2011 Aug;301(2):F271-9 Sanchez AP et al 2011/01/01 |
|
|
| 364 |
Rosenquist TA. Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse. Am. J. Physiol. Renal Physiol. 2011 Jun;300(6):F1360-7 Rosenquist TA 2011/01/01 |
|
|
| 365 |
Bivona BJ et al. Glomerular filtration rate determinations in conscious type II diabetic mice. Am. J. Physiol. Renal Physiol. 2011 Mar;300(3):F618-25 Bivona BJ et al 2011/01/01 |
|
|
| 366 |
Li F et al. Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J. Thromb. Haemost. 2010 Oct;8(10):2122-32 Li F et al 2010/01/01 |
|
|
| 367 |
Wang Y et al. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am. J. Physiol. Renal Physiol. 2009 Dec;297(6):F1550-9 Wang Y et al 2009/01/01 |
|
|
| 368 |
Manhiani M et al. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am. J. Physiol. Renal Physiol. 2009 Sep;297(3):F740-8 Manhiani M et al 2009/01/01 |
|
|
| 369 |
Nakhoul FM et al. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am. J. Physiol. Renal Physiol. 2009 Apr;296(4):F830-8 Nakhoul FM et al 2009/01/01 |
|
|
| 370 |
Kim SY et al. Role of kidney ADP-ribosyl cyclase in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F291-7 Kim SY et al 2009/01/01 |
|
|
| 371 |
Deji N et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009 Jan;296(1):F118-26 Deji N et al 2009/01/01 |
|
|
| 372 |
Park S et al. Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am. J. Physiol. Renal Physiol. 2008 Nov;295(5):F1504-11 Park S et al 2008/01/01 |
|
|
| 373 |
Francois H et al. A role for the thromboxane receptor in L-NAME hypertension. Am. J. Physiol. Renal Physiol. 2008 Oct;295(4):F1096-102 Francois H et al 2008/01/01 |
|
|
| 374 |
Crowley SD et al. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F515-24 Crowley SD et al 2008/01/01 |
|
|
| 375 |
Tan Y et al. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2007 Oct;293(4):F1026-35 Tan Y et al 2007/01/01 |
|
|
| 376 |
Ju叩rez P et al. Soluble betaglycan reduces renal damage progression in db/db mice. Am. J. Physiol. Renal Physiol. 2007 Jan;292(1):F321-9 Ju叩rez P et al 2007/01/01 |
|
|
| 377 |
Mishra R et al. Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney. Am. J. Physiol. Renal Physiol. 2004 May;286(5):F913-21 Mishra R et al 2004/01/01 |
|
|
| 378 |
Hashimoto N et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am. J. Physiol. Renal Physiol. 2004 Mar;286(3):F516-25 Hashimoto N et al 2004/01/01 |
|
|
| 379 |
Mori T et al. Parenchymal cells proliferate and differentiate in an organotypic slice culture of the neonatal liver. Anat. Embryol. 1999 Apr;199(4):319-27 Mori T et al 1999/01/01 |
|
|
| 380 |
Kidokoro K et al. Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging. Circulation 2019 07;140(4):303-315 Kidokoro K et al 2019/01/01 |
|
|
| 381 |
Galvan DL et al. Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice. J. Clin. Invest. 2019 05;129(7):2807-2823 Galvan DL et al 2019/01/01 |
|
|
| 382 |
Wen Y et al. KLF4 in Macrophages Attenuates TNF<i>α</i>-Mediated Kidney Injury and Fibrosis. J. Am. Soc. Nephrol. 2019 10;30(10):1925-1938 Wen Y et al 2019/01/01 |
|
|
| 383 |
Zhang MZ et al. The Role of the EGF Receptor in Sex Differences in Kidney Injury. J. Am. Soc. Nephrol. 2019 09;30(9):1659-1673 Zhang MZ et al 2019/01/01 |
|
|
| 384 |
Lu X et al. Opposing actions of renal tubular- and myeloid-derived porcupine in obstruction-induced kidney fibrosis. Kidney Int. 2019 12;96(6):1308-1319 Lu X et al 2019/01/01 |
|
|
| 385 |
Das R et al. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis. Kidney Int. 2019 10;96(4):927-941 Das R et al 2019/01/01 |
|
|
| 386 |
Cassis P et al. Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy. Kidney Int. 2019 10;96(4):906-917 Cassis P et al 2019/01/01 |
|
|
| 387 |
Arif E et al. Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019 09;96(3):656-673 Arif E et al 2019/01/01 |
|
|
| 388 |
Tang J et al. Urinary Renin in Patients and Mice With Diabetic Kidney Disease. Hypertension 2019 07;74(1):83-94 Tang J et al 2019/01/01 |
|
|
| 389 |
Krishnan SM et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc. Res. 2019 03;115(4):776-787 Krishnan SM et al 2019/01/01 |
|
|
| 390 |
Xu BH et al. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metab. Clin. Exp. 2020 02;103:154013 Xu BH et al 2020/01/01 |
|
|
| 391 |
Billi AC et al. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. JCI Insight 2019 Apr;4(8) Billi AC et al 2019/01/01 |
|
|
| 392 |
Lang Y et al. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes. Cell Death Dis 2019 05;10(6):401 Lang Y et al 2019/01/01 |
|
|
| 393 |
Mehta N et al. Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease. Antioxid. Redox Signal. 2019 Sep;31(8):551-571 Mehta N et al 2019/01/01 |
|
|
| 394 |
Felizardo RJF et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. FASEB J. 2019 11;33(11):11894-11908 Felizardo RJF et al 2019/01/01 |
|
|
| 395 |
Ichikawa H et al. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway. J Am Heart Assoc 2019 04;8(8):e012195 Ichikawa H et al 2019/01/01 |
|
|
| 396 |
Elmarakby AA et al. A dual role of 12/15-lipoxygenase in LPS-induced acute renal inflammation and injury. Biochim Biophys Acta Mol Cell Biol Lipids 2019 11;1864(11):1669-1680 Elmarakby AA et al 2019/01/01 |
|
|
| 397 |
Li C et al. (Pro)renin receptor contributes to renal mitochondria dysfunction, apoptosis and fibrosis in diabetic mice. Sci Rep 2019 08;9(1):11667 Li C et al 2019/01/01 |
|
|
| 398 |
Vinel C et al. Apelin affects the mouse aging urinary peptidome with minimal effects on kidney. Sci Rep 2019 07;9(1):10647 Vinel C et al 2019/01/01 |
|
|
| 399 |
Schwarz A et al. Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement. Sci Rep 2019 06;9(1):8888 Schwarz A et al 2019/01/01 |
|
|
| 400 |
Erlandsson L et al. Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model. Sci Rep 2019 06;9(1):8561 Erlandsson L et al 2019/01/01 |
|
|
| 401 |
Takagaki Y et al. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice. Sci Rep 2019 May;9(1):7519 Takagaki Y et al 2019/01/01 |
|
|
| 402 |
Sabapathy V et al. Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy. Front Pharmacol 2019;10:572 Sabapathy V et al 2019/01/01 |
|
|
| 403 |
Hye Khan MA et al. Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice. Front Pharmacol 2019;10:512 Hye Khan MA et al 2019/01/01 |
|
|
| 404 |
Tsuchida Y et al. Lipoprotein modulation of proteinuric renal injury. Lab. Invest. 2019 07;99(8):1107-1116 Tsuchida Y et al 2019/01/01 |
|
|
| 405 |
Arbeeny CM et al. CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy. J. Pharmacol. Exp. Ther. 2019 06;369(3):503-510 Arbeeny CM et al 2019/01/01 |
|
|
| 406 |
Suzuki T et al. Immune-associated renal disease found in caspase 3-deficient mice. Cell Tissue Res. 2020 Feb;379(2):323-335 Suzuki T et al 2020/01/01 |
|
|
| 407 |
Kosaki K et al. Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice. Hypertens. Res. 2019 10;42(10):1518-1527 Kosaki K et al 2019/01/01 |
|
|
| 408 |
Yoshida N et al. T cell-specific STAT3 deficiency abrogates lupus nephritis. Lupus 2019 Oct;28(12):1468-1472 Yoshida N et al 2019/01/01 |
|
|
| 409 |
Gooding J et al. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy. BMC Nephrol 2019 04;20(1):141 Gooding J et al 2019/01/01 |
|
|
| 410 |
Wetzel MD et al. l-Homoarginine supplementation prevents diabetic kidney damage. Physiol Rep 2019 09;7(18):e14235 Wetzel MD et al 2019/01/01 |
|
|
| 411 |
Sato Y et al. Increase of core temperature affected the progression of kidney injury by repeated heat stress exposure. Am. J. Physiol. Renal Physiol. 2019 11;317(5):F1111-F1121 Sato Y et al 2019/01/01 |
|
|
| 412 |
Jain A et al. In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes. J Diabetes Metab Disord 2019 Jun;18(1):133-143 Jain A et al 2019/01/01 |
|
|
| 413 |
Song P et al. Knockout of Na<sup>+</sup>-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration. Am. J. Physiol. Renal Physiol. 2019 07;317(1):F207-F217 Song P et al 2019/01/01 |
|
|
| 414 |
Nilsson D et al. Foxc2 is essential for podocyte function. Physiol Rep 2019 May;7(9):e14083 Nilsson D et al 2019/01/01 |
|
|
| 415 |
Zhong B et al. Ablation of TRPV1 Elevates Nocturnal Blood Pressure in Western Diet-fed Mice. Curr Hypertens Rev 2019;15(2):144-153 Zhong B et al 2019/01/01 |
|
|
| 416 |
Qi W et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 2017 Jun;23(6):753-762 Qi W et al 2017/01/01 |
|
|
| 417 |
Hackl MJ et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat. Med. 2013 Dec;19(12):1661-6 Hackl MJ et al 2013/01/01 |
|
|
| 418 |
Zhou CC et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008 Aug;14(8):855-62 Zhou CC et al 2008/01/01 |
|
|
| 419 |
Wu H et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med 2016 Mar;8(331):331ra40 Wu H et al 2016/01/01 |
|
|
| 420 |
Seshan SV et al. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood 2009 Aug;114(8):1675-83 Seshan SV et al 2009/01/01 |
|
|
| 421 |
Qing X et al. iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling. J. Clin. Invest. 2018 Apr;128(4):1397-1412 Qing X et al 2018/01/01 |
|
|
| 422 |
Majumder S et al. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease. J. Clin. Invest. 2018 Jan;128(1):483-499 Majumder S et al 2018/01/01 |
|
|
| 423 |
Wang J et al. Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. J. Clin. Invest. 2016 06;126(6):2077-92 Wang J et al 2016/01/01 |
|
|
| 424 |
Wu J et al. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. J. Clin. Invest. 2015 Nov;125(11):4091-106 Wu J et al 2015/01/01 |
|
|
| 425 |
Fan X et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J. Clin. Invest. 2014 Nov;124(11):4941-52 Fan X et al 2014/01/01 |
|
|
| 426 |
Daehn I et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 2014 Apr;124(4):1608-21 Daehn I et al 2014/01/01 |
|
|
| 427 |
Dugan LL et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J. Clin. Invest. 2013 Nov;123(11):4888-99 Dugan LL et al 2013/01/01 |
|
|
| 428 |
Knight JS et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 2013 Jul;123(7):2981-93 Knight JS et al 2013/01/01 |
|
|
| 429 |
George B et al. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J. Clin. Invest. 2012 Feb;122(2):674-92 George B et al 2012/01/01 |
|
|
| 430 |
Inoki K et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 2011 Jun;121(6):2181-96 Inoki K et al 2011/01/01 |
|
|
| 431 |
Sharma K et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008 May;118(5):1645-56 Sharma K et al 2008/01/01 |
|
|
| 432 |
Reiser J et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 2004 May;113(10):1390-7 Reiser J et al 2004/01/01 |
|
|
| 433 |
Ashraf S et al. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun 2018 05;9(1):1960 Ashraf S et al 2018/01/01 |
|
|
| 434 |
Zeng B et al. ORAI channels are critical for receptor-mediated endocytosis of albumin. Nat Commun 2017 12;8(1):1920 Zeng B et al 2017/01/01 |
|
|
| 435 |
Becker-Herman S et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J. Exp. Med. 2011 Sep;208(10):2033-42 Becker-Herman S et al 2011/01/01 |
|
|
| 436 |
Balbas MD et al. MAGI-2 scaffold protein is critical for kidney barrier function. Proc. Natl. Acad. Sci. U.S.A. 2014 Oct;111(41):14876-81 Balbas MD et al 2014/01/01 |
|
|
| 437 |
Fox R et al. Mitochondrial DNA polymerase editing mutation, PolgD257A, reduces the diabetic phenotype of Akita male mice by suppressing appetite. Proc. Natl. Acad. Sci. U.S.A. 2011 May;108(21):8779-84 Fox R et al 2011/01/01 |
|
|
| 438 |
Wang XX et al. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J. Am. Soc. Nephrol. 2018 01;29(1):118-137 Wang XX et al 2018/01/01 |
|
|
| 439 |
Nlandu-Khodo S et al. Blocking TGF-<i>β</i> and <i>β</i>-Catenin Epithelial Crosstalk Exacerbates CKD. J. Am. Soc. Nephrol. 2017 Dec;28(12):3490-3503 Nlandu-Khodo S et al 2017/01/01 |
|
|
| 440 |
Velez JCQ et al. Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury. J. Am. Soc. Nephrol. 2017 Jul;28(7):2119-2132 Velez JCQ et al 2017/01/01 |
|
|
| 441 |
Mori KP et al. Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy. J. Am. Soc. Nephrol. 2017 Jan;28(1):278-289 Mori KP et al 2017/01/01 |
|
|
| 442 |
Yao Y et al. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function. J. Am. Soc. Nephrol. 2016 Dec;27(12):3653-3665 Yao Y et al 2016/01/01 |
|
|
| 443 |
Puelles VG et al. Validation of a Three-Dimensional Method for Counting and Sizing Podocytes in Whole Glomeruli. J. Am. Soc. Nephrol. 2016 Oct;27(10):3093-3104 Puelles VG et al 2016/01/01 |
|
|
| 444 |
New LA et al. Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture. J. Am. Soc. Nephrol. 2016 08;27(8):2422-35 New LA et al 2016/01/01 |
|
|
| 445 |
Wang XX et al. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J. Am. Soc. Nephrol. 2016 05;27(5):1362-78 Wang XX et al 2016/01/01 |
|
|
| 446 |
You YH et al. Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2016 Feb;27(2):466-81 You YH et al 2016/01/01 |
|
|
| 447 |
Sato Y et al. Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J. Am. Soc. Nephrol. 2015 Aug;26(8):1806-15 Sato Y et al 2015/01/01 |
|
|
| 448 |
Chen J et al. EGF receptor deletion in podocytes attenuates diabetic nephropathy. J. Am. Soc. Nephrol. 2015 May;26(5):1115-25 Chen J et al 2015/01/01 |
|
|
| 449 |
Lal MA et al. Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration. J. Am. Soc. Nephrol. 2015 Mar;26(3):647-62 Lal MA et al 2015/01/01 |
|
|
| 450 |
Zhou X et al. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation. J. Am. Soc. Nephrol. 2015 Jan;26(1):121-32 Zhou X et al 2015/01/01 |
|
|
| 451 |
Lanaspa MA et al. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Nov;25(11):2526-38 Lanaspa MA et al 2014/01/01 |
|
|
| 452 |
Cathelin D et al. Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. J. Am. Soc. Nephrol. 2014 Aug;25(8):1662-8 Cathelin D et al 2014/01/01 |
|
|
| 453 |
Borsting E et al. Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. J. Am. Soc. Nephrol. 2014 Sep;25(9):2067-78 Borsting E et al 2014/01/01 |
|
|
| 454 |
Marrone AK et al. MicroRNA-17~92 is required for nephrogenesis and renal function. J. Am. Soc. Nephrol. 2014 Jul;25(7):1440-52 Marrone AK et al 2014/01/01 |
|
|
| 455 |
Chen J et al. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J. Am. Soc. Nephrol. 2013 Feb;24(2):198-207 Chen J et al 2013/01/01 |
|
|
| 456 |
Li F et al. eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J. Am. Soc. Nephrol. 2012 Apr;23(4):652-60 Li F et al 2012/01/01 |
|
|
| 457 |
Chen J et al. EGFR signaling promotes TGFβ-dependent renal fibrosis. J. Am. Soc. Nephrol. 2012 Feb;23(2):215-24 Chen J et al 2012/01/01 |
|
|
| 458 |
Papeta N et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J. Am. Soc. Nephrol. 2011 Nov;22(11):1991-6 Papeta N et al 2011/01/01 |
|
|
| 459 |
Decl竪ves AE et al. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011 Oct;22(10):1846-55 Decl竪ves AE et al 2011/01/01 |
|
|
| 460 |
Cheng H et al. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. J. Am. Soc. Nephrol. 2011 Jul;22(7):1240-51 Cheng H et al 2011/01/01 |
|
|
| 461 |
Dai Y et al. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J. Am. Soc. Nephrol. 2011 May;22(5):890-901 Dai Y et al 2011/01/01 |
|
|
| 462 |
Kimura T et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 2011 May;22(5):902-13 Kimura T et al 2011/01/01 |
|
|
| 463 |
Wang Y et al. Peptide nanofibers preconditioned with stem cell secretome are renoprotective. J. Am. Soc. Nephrol. 2011 Apr;22(4):704-17 Wang Y et al 2011/01/01 |
|
|
| 464 |
Eckel J et al. TRPC6 enhances angiotensin II-induced albuminuria. J. Am. Soc. Nephrol. 2011 Mar;22(3):526-35 Eckel J et al 2011/01/01 |
|
|
| 465 |
Stitt-Cavanagh EM et al. A maladaptive role for EP4 receptors in podocytes. J. Am. Soc. Nephrol. 2010 Oct;21(10):1678-90 Stitt-Cavanagh EM et al 2010/01/01 |
|
|
| 466 |
Hudkins KL et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J. Am. Soc. Nephrol. 2010 Sep;21(9):1533-42 Hudkins KL et al 2010/01/01 |
|
|
| 467 |
Brezniceanu ML et al. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J. Am. Soc. Nephrol. 2010 Jun;21(6):943-54 Brezniceanu ML et al 2010/01/01 |
|
|
| 468 |
Xavier S et al. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J. Am. Soc. Nephrol. 2009 Oct;20(10):2127-37 Xavier S et al 2009/01/01 |
|
|
| 469 |
Cheng H et al. Distinct roles for basal and induced COX-2 in podocyte injury. J. Am. Soc. Nephrol. 2009 Sep;20(9):1953-62 Cheng H et al 2009/01/01 |
|
|
| 470 |
Fujita H et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J. Am. Soc. Nephrol. 2009 Jun;20(6):1303-13 Fujita H et al 2009/01/01 |
|
|
| 471 |
Ronconi E et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 2009 Feb;20(2):322-32 Ronconi E et al 2009/01/01 |
|
|
| 472 |
Lorenzen J et al. The role of osteopontin in the development of albuminuria. J. Am. Soc. Nephrol. 2008 May;19(5):884-90 Lorenzen J et al 2008/01/01 |
|
|
| 473 |
Guo S et al. Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J. Am. Soc. Nephrol. 2008 Jun;19(6):1168-76 Guo S et al 2008/01/01 |
|
|
| 474 |
Faulhaber-Walter R et al. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J. Am. Soc. Nephrol. 2008 Apr;19(4):722-30 Faulhaber-Walter R et al 2008/01/01 |
|
|
| 475 |
Guo J et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J. Am. Soc. Nephrol. 2008 May;19(5):961-72 Guo J et al 2008/01/01 |
|
|
| 476 |
Liu F et al. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J. Am. Soc. Nephrol. 2008 Feb;19(2):269-80 Liu F et al 2008/01/01 |
|
|
| 477 |
Awad AS et al. Activation of adenosine 2A receptors preserves structure and function of podocytes. J. Am. Soc. Nephrol. 2008 Jan;19(1):59-68 Awad AS et al 2008/01/01 |
|
|
| 478 |
Menne J et al. The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury. J. Am. Soc. Nephrol. 2007 Jul;18(7):2046-53 Menne J et al 2007/01/01 |
|
|
| 479 |
Hiramatsu N et al. Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J. Am. Soc. Nephrol. 2007 Feb;18(2):515-27 Hiramatsu N et al 2007/01/01 |
|
|
| 480 |
Cheng H et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J. Am. Soc. Nephrol. 2007 Feb;18(2):551-9 Cheng H et al 2007/01/01 |
|
|
| 481 |
Tchekneva EE et al. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. J. Am. Soc. Nephrol. 2007 Jan;18(1):103-12 Tchekneva EE et al 2007/01/01 |
|
|
| 482 |
Ye M et al. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 2006 Nov;17(11):3067-75 Ye M et al 2006/01/01 |
|
|
| 483 |
Sung SH et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 2006 Nov;17(11):3093-104 Sung SH et al 2006/01/01 |
|
|
| 484 |
Zhao HJ et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J. Am. Soc. Nephrol. 2006 Oct;17(10):2664-9 Zhao HJ et al 2006/01/01 |
|
|
| 485 |
Jiang T et al. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease. J. Am. Soc. Nephrol. 2005 Aug;16(8):2385-94 Jiang T et al 2005/01/01 |
|
|
| 486 |
Lang A et al. Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J. Am. Soc. Nephrol. 2005 Feb;16(2):383-91 Lang A et al 2005/01/01 |
|
|
| 487 |
Michaud JL et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J. Am. Soc. Nephrol. 2003 May;14(5):1200-11 Michaud JL et al 2003/01/01 |
|
|
| 488 |
Taneda S et al. Amelioration of diabetic nephropathy in SPARC-null mice. J. Am. Soc. Nephrol. 2003 Apr;14(4):968-80 Taneda S et al 2003/01/01 |
|
|
| 489 |
Anders HJ et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J. Am. Soc. Nephrol. 2001 May;12(5):919-31 Anders HJ et al 2001/01/01 |
|
|
| 490 |
Pan Y et al. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function. Diabetes 2018 04;67(4):717-730 Pan Y et al 2018/01/01 |
|
|
| 491 |
Lo CS et al. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice. Diabetes 2017 07;66(7):1964-1978 Lo CS et al 2017/01/01 |
|
|
| 492 |
Qi H et al. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility. Diabetes 2017 03;66(3):763-778 Qi H et al 2017/01/01 |
|
|
| 493 |
Wang X et al. Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy. Diabetes 2017 02;66(2):494-504 Wang X et al 2017/01/01 |
|
|
| 494 |
Lizotte F et al. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes. Diabetes 2016 Dec;65(12):3705-3717 Lizotte F et al 2016/01/01 |
|
|
| 495 |
Keshari KR et al. Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance. Diabetes 2015 Feb;64(2):344-52 Keshari KR et al 2015/01/01 |
|
|
| 496 |
Abdo S et al. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes 2014 Oct;63(10):3483-96 Abdo S et al 2014/01/01 |
|
|
| 497 |
Zhang MZ et al. Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy. Diabetes 2014 Jun;63(6):2063-72 Zhang MZ et al 2014/01/01 |
|
|
| 498 |
Taniguchi K et al. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes 2013 Nov;62(11):3874-86 Taniguchi K et al 2013/01/01 |
|
|
| 499 |
Huang C et al. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice. Diabetes 2013 Aug;62(8):2923-34 Huang C et al 2013/01/01 |
|
|
| 500 |
Deshpande SD et al. Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 2013 Sep;62(9):3151-62 Deshpande SD et al 2013/01/01 |
|
|
| 501 |
Mima A et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes. Diabetes 2012 Nov;61(11):2967-79 Mima A et al 2012/01/01 |
|
|
| 502 |
Chang SY et al. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012 Oct;61(10):2565-74 Chang SY et al 2012/01/01 |
|
|
| 503 |
Lo CS et al. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 2012 Oct;61(10):2597-608 Lo CS et al 2012/01/01 |
|
|
| 504 |
Fragiadaki M et al. Hyperglycemia causes renal cell damage via CCN2-induced activation of the TrkA receptor: implications for diabetic nephropathy. Diabetes 2012 Sep;61(9):2280-8 Fragiadaki M et al 2012/01/01 |
|
|
| 505 |
Morris SM et al. Arginase-2 mediates diabetic renal injury. Diabetes 2011 Nov;60(11):3015-22 Morris SM et al 2011/01/01 |
|
|
| 506 |
Naito M et al. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 2011 Sep;60(9):2265-73 Naito M et al 2011/01/01 |
|
|
| 507 |
Wang XX et al. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 2010 Nov;59(11):2916-27 Wang XX et al 2010/01/01 |
|
|
| 508 |
Li J et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 2010 Oct;59(10):2612-24 Li J et al 2010/01/01 |
|
|
| 509 |
Reiniger N et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010 Aug;59(8):2043-54 Reiniger N et al 2010/01/01 |
|
|
| 510 |
Oudit GY et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 2010 Feb;59(2):529-38 Oudit GY et al 2010/01/01 |
|
|
| 511 |
Roxburgh SA et al. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 2009 Jul;58(7):1641-50 Roxburgh SA et al 2009/01/01 |
|
|
| 512 |
Eid AA et al. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009 May;58(5):1201-11 Eid AA et al 2009/01/01 |
|
|
| 513 |
Friedman DJ et al. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes 2009 Apr;58(4):999-1006 Friedman DJ et al 2009/01/01 |
|
|
| 514 |
Brezniceanu ML et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008 Feb;57(2):451-9 Brezniceanu ML et al 2008/01/01 |
|
|
| 515 |
Jiang T et al. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 2007 Oct;56(10):2485-93 Jiang T et al 2007/01/01 |
|
|
| 516 |
Friedman DJ et al. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 2007 Sep;56(9):2371-9 Friedman DJ et al 2007/01/01 |
|
|
| 517 |
Szab坦 C et al. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 2006 Nov;55(11):3004-12 Szab坦 C et al 2006/01/01 |
|
|
| 518 |
Makino H et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006 Oct;55(10):2747-56 Makino H et al 2006/01/01 |
|
|
| 519 |
Proctor G et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006 Sep;55(9):2502-9 Proctor G et al 2006/01/01 |
|
|
| 520 |
Susztak K et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 Jan;55(1):225-33 Susztak K et al 2006/01/01 |
|
|
| 521 |
Xu S et al. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006 Jan;55(1):110-9 Xu S et al 2006/01/01 |
|
|
| 522 |
Qi Z et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005 Sep;54(9):2628-37 Qi Z et al 2005/01/01 |
|
|
| 523 |
Wang Z et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005 Aug;54(8):2328-35 Wang Z et al 2005/01/01 |
|
|
| 524 |
Susztak K et al. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 2004 Mar;53(3):784-94 Susztak K et al 2004/01/01 |
|
|
| 525 |
Oku A et al. T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 1999 Sep;48(9):1794-800 Oku A et al 1999/01/01 |
|
|
| 526 |
Chen X et al. Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney Int. 2019 04;95(4):880-895 Chen X et al 2019/01/01 |
|
|
| 527 |
Kitagawa A et al. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kidney Int. 2019 03;95(3):680-692 Kitagawa A et al 2019/01/01 |
|
|
| 528 |
Arkatkar T et al. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression. Kidney Int. 2018 10;94(4):728-740 Arkatkar T et al 2018/01/01 |
|
|
| 529 |
Anusornvongchai T et al. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response. Kidney Int. 2018 09;94(3):536-550 Anusornvongchai T et al 2018/01/01 |
|
|
| 530 |
Grove KJ et al. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney. Kidney Int. 2018 08;94(2):292-302 Grove KJ et al 2018/01/01 |
|
|
| 531 |
Wong DWL et al. Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuria. Kidney Int. 2018 06;93(6):1367-1383 Wong DWL et al 2018/01/01 |
|
|
| 532 |
Lim BJ et al. Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury. Kidney Int. 2017 12;92(6):1395-1403 Lim BJ et al 2017/01/01 |
|
|
| 533 |
You H et al. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. Kidney Int. 2017 03;91(3):671-682 You H et al 2017/01/01 |
|
|
| 534 |
Zhang MZ et al. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 2017 02;91(2):375-386 Zhang MZ et al 2017/01/01 |
|
|
| 535 |
De Marinis Y et al. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. Kidney Int. 2016 Feb;89(2):342-53 De Marinis Y et al 2016/01/01 |
|
|
| 536 |
Katagiri D et al. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int. 2016 Feb;89(2):374-85 Katagiri D et al 2016/01/01 |
|
|
| 537 |
Hayashi K et al. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria. Kidney Int. 2015 Oct;88(4):745-53 Hayashi K et al 2015/01/01 |
|
|
| 538 |
Awad AS et al. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. Kidney Int. 2015 Oct;88(4):722-33 Awad AS et al 2015/01/01 |
|
|
| 539 |
Cheng H et al. Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int. 2015 Jul;88(1):85-94 Cheng H et al 2015/01/01 |
|
|
| 540 |
Spinale JM et al. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 2015 Mar;87(3):564-74 Spinale JM et al 2015/01/01 |
|
|
| 541 |
Xu J et al. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy. Kidney Int. 2015 Mar;87(3):543-56 Xu J et al 2015/01/01 |
|
|
| 542 |
Li SY et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int. 2014 Aug;86(2):358-69 Li SY et al 2014/01/01 |
|
|
| 543 |
George B et al. Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis. Kidney Int. 2014 Jun;85(6):1382-1394 George B et al 2014/01/01 |
|
|
| 544 |
Decl竪ves AE et al. Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury. Kidney Int. 2014 Mar;85(3):611-23 Decl竪ves AE et al 2014/01/01 |
|
|
| 545 |
Tao J et al. A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis. Kidney Int. 2014 Apr;85(4):972-80 Tao J et al 2014/01/01 |
|
|
| 546 |
Sugar T et al. Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo. Kidney Int. 2014 Feb;85(2):307-18 Sugar T et al 2014/01/01 |
|
|
| 547 |
Miyazawa T et al. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. Kidney Int. 2013 Dec;84(6):1176-88 Miyazawa T et al 2013/01/01 |
|
|
| 548 |
You H et al. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism. Kidney Int. 2013 Dec;84(6):1189-97 You H et al 2013/01/01 |
|
|
| 549 |
Cheng H et al. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int. 2012 Dec;82(11):1176-83 Cheng H et al 2012/01/01 |
|
|
| 550 |
Finer G et al. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int. 2012 Sep;82(5):525-36 Finer G et al 2012/01/01 |
|
|
| 551 |
Wang W et al. Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia. Kidney Int. 2012 May;81(10):1002-1014 Wang W et al 2012/01/01 |
|
|
| 552 |
Asai O et al. Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int. 2012 Mar;81(6):539-47 Asai O et al 2012/01/01 |
|
|
| 553 |
Guo S et al. Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis. Kidney Int. 2011 Nov;80(9):946-958 Guo S et al 2011/01/01 |
|
|
| 554 |
Qing X et al. Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int. 2011 Feb;79(3):331-9 Qing X et al 2011/01/01 |
|
|
| 555 |
Leelahavanichkul A et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010 Dec;78(11):1136-53 Leelahavanichkul A et al 2010/01/01 |
|
|
| 556 |
Chua S et al. A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8. Kidney Int. 2010 Sep;78(5):453-62 Chua S et al 2010/01/01 |
|
|
| 557 |
Hayashi K et al. Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int. 2010 Jul;78(1):69-78 Hayashi K et al 2010/01/01 |
|
|
| 558 |
Veron D et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 2010 Jun;77(11):989-99 Veron D et al 2010/01/01 |
|
|
| 559 |
Godin N et al. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int. 2010 Jun;77(12):1086-97 Godin N et al 2010/01/01 |
|
|
| 560 |
Chan KT et al. Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int. 2009 Feb;75(4):366-72 Chan KT et al 2009/01/01 |
|
|
| 561 |
Liu F et al. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int. 2009 Jan;75(2):156-66 Liu F et al 2009/01/01 |
|
|
| 562 |
Salzler HR et al. Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. Kidney Int. 2007 Nov;72(10):1226-32 Salzler HR et al 2007/01/01 |
|
|
| 563 |
Soler MJ et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007 Sep;72(5):614-23 Soler MJ et al 2007/01/01 |
|
|
| 564 |
Andrade D et al. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease. Arthritis Rheum. 2011 Andrade D et al 2011/01/01 |
|
|
| 565 |
Villarino A et al. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. Elife 2016 03;5 Villarino A et al 2016/01/01 |
|
|
| 566 |
Reynolds JA et al. Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus. Arthritis Rheumatol 2016 12;68(12):2929-2935 Reynolds JA et al 2016/01/01 |
|
|
| 567 |
Maeda K et al. CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway. Arthritis Rheumatol 2015 May;67(8):2185-95 Maeda K et al 2015/01/01 |
|
|
| 568 |
Parchim NF et al. Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension 2015 Feb;65(2):430-9 Parchim NF et al 2015/01/01 |
|
|
| 569 |
Doridot L et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 2013 Mar;61(3):662-8 Doridot L et al 2013/01/01 |
|
|
| 570 |
Paravicini TM et al. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009 Feb;53(2):423-9 Paravicini TM et al 2009/01/01 |
|
|
| 571 |
Francois H et al. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 2004 Feb;43(2):364-9 Francois H et al 2004/01/01 |
|
|
| 572 |
Luo X et al. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector. Mol. Ther. 2011 Nov;19(11):1961-70 Luo X et al 2011/01/01 |
|
|
| 573 |
Qiao M et al. Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2009 Nov;29(11):1779-86 Qiao M et al 2009/01/01 |
|
|
| 574 |
Chenxu G et al. iRhom2 loss alleviates renal injury in long-term PM2.5-exposed mice by suppression of inflammation and oxidative stress. Redox Biol 2018 10;19:147-157 Chenxu G et al 2018/01/01 |
|
|
| 575 |
Vasko R et al. Endothelial peroxisomal dysfunction and impaired pexophagy promotes oxidative damage in lipopolysaccharide-induced acute kidney injury. Antioxid. Redox Signal. 2013 Jul;19(3):211-30 Vasko R et al 2013/01/01 |
|
|
| 576 |
Lefevre GM et al. Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype. PLoS Genet. 2010 Oct;6(10):e1001142 Lefevre GM et al 2010/01/01 |
|
|
| 577 |
Lo CS et al. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes. Diabetologia 2015 Oct;58(10):2443-54 Lo CS et al 2015/01/01 |
|
|
| 578 |
He F et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 2014 Aug;57(8):1726-36 He F et al 2014/01/01 |
|
|
| 579 |
Guan TH et al. Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy. Diabetologia 2013 Sep;56(9):2068-77 Guan TH et al 2013/01/01 |
|
|
| 580 |
Abdo S et al. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia 2013 Jul;56(7):1649-60 Abdo S et al 2013/01/01 |
|
|
| 581 |
Lim XL et al. KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes. Diabetologia 2012 Sep;55(9):2402-6 Lim XL et al 2012/01/01 |
|
|
| 582 |
Liu GC et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 2012 Sep;55(9):2522-32 Liu GC et al 2012/01/01 |
|
|
| 583 |
Suzuki H et al. Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice. Diabetologia 2011 Nov;54(11):2953-62 Suzuki H et al 2011/01/01 |
|
|
| 584 |
Veron D et al. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 2011 May;54(5):1227-41 Veron D et al 2011/01/01 |
|
|
| 585 |
Ii S et al. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. Diabetologia 2004 Mar;47(3):541-548 Ii S et al 2004/01/01 |
|
|
| 586 |
Liu Y et al. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 2018 12;3(23) Liu Y et al 2018/01/01 |
|
|
| 587 |
Srivastava SP et al. SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis. Cell Death Dis 2018 Sep;9(10):997 Srivastava SP et al 2018/01/01 |
|
|
| 588 |
Strope S et al. Mouse amnionless, which is required for primitive streak assembly, mediates cell-surface localization and endocytic function of cubilin on visceral endoderm and kidney proximal tubules. Development 2004 Oct;131(19):4787-95 Strope S et al 2004/01/01 |
|
|
| 589 |
Bjarneg奪rd M et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004 Apr;131(8):1847-57 Bjarneg奪rd M et al 2004/01/01 |
|
|
| 590 |
Doke T et al. Lacking ketohexokinase-A exacerbates renal injury in streptozotocin-induced diabetic mice. Metab. Clin. Exp. 2018 08;85:161-170 Doke T et al 2018/01/01 |
|
|
| 591 |
Fujita H et al. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice. Metab. Clin. Exp. 2012 Dec;61(12):1714-24 Fujita H et al 2012/01/01 |
|
|
| 592 |
Tanimoto M et al. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. Metab. Clin. Exp. 2004 Nov;53(11):1473-9 Tanimoto M et al 2004/01/01 |
|
|
| 593 |
Ueda S et al. ENOS deficiency causes podocyte injury with mitochondrial abnormality. Free Radic. Biol. Med. 2015 Oct;87:181-92 Ueda S et al 2015/01/01 |
|
|
| 594 |
Lasagni L et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 2010 Sep;28(9):1674-85 Lasagni L et al 2010/01/01 |
|
|
| 595 |
Tskitishvili E et al. The effect of tumor-associated protein RCAS1 gene silencing on blood pressure and urinary protein excretion in pregnant mouse: a pilot study. Am. J. Obstet. Gynecol. 2010 Oct;203(4):364.e6-364.e12 Tskitishvili E et al 2010/01/01 |
|
|
| 596 |
Falcao S et al. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. Am. J. Obstet. Gynecol. 2009 Feb;200(2):198.e1-5 Falcao S et al 2009/01/01 |
|
|
| 597 |
Guha M et al. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 2007 Oct;21(12):3355-68 Guha M et al 2007/01/01 |
|
|
| 598 |
Leinonen H et al. Lack of P4H-TM in mice results in age-related retinal and renal alterations. Hum. Mol. Genet. 2016 09;25(17):3810-3823 Leinonen H et al 2016/01/01 |
|
|
| 599 |
Tang W et al. RNA-sequencing reveals genome-wide long non-coding RNAs profiling associated with early development of diabetic nephropathy. Oncotarget 2017 Dec;8(62):105832-105847 Tang W et al 2017/01/01 |
|
|
| 600 |
Ding W et al. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice. Cell. Physiol. Biochem. 2015;36(6):2170-82 Ding W et al 2015/01/01 |
|
|
| 601 |
Shi Y et al. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin. Sci. 2015 May;128(10):649- Shi Y et al 2015/01/01 |
|
|
| 602 |
Nasrallah R et al. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental. Clin. Sci. 2013 Jun;124(11):685-94 Nasrallah R et al 2013/01/01 |
|
|
| 603 |
Luo R et al. Transglutaminase is a Critical Link Between Inflammation and Hypertension. J Am Heart Assoc 2016 06;5(7) Luo R et al 2016/01/01 |
|
|
| 604 |
Liu C et al. Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia. J Am Heart Assoc 2015 Dec;4(12) Liu C et al 2015/01/01 |
|
|
| 605 |
Zhong J et al. Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts. Lab. Invest. 2014 Jun;94(6):633-44 Zhong J et al 2014/01/01 |
|
|
| 606 |
Mohan S et al. Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab. Invest. 2008 May;88(5):515-28 Mohan S et al 2008/01/01 |
|
|
| 607 |
Zhao W et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J. Immunol. 2009 Aug;183(4):2729-40 Zhao W et al 2009/01/01 |
|
|
| 608 |
Taneja D et al. Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J. Lipid Res. 2010 Jun;51(6):1464-70 Taneja D et al 2010/01/01 |
|
|
| 609 |
Zhao Y et al. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. J. Mol. Med. 2017 08;95(8):887-898 Zhao Y et al 2017/01/01 |
|
|
| 610 |
Maier C et al. Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II. J. Mol. Med. 2017 05;95(5):473-486 Maier C et al 2017/01/01 |
|
|
| 611 |
Meek RL et al. Glomerular cell death and inflammation with high-protein diet and diabetes. Nephrol. Dial. Transplant. 2013 Jul;28(7):1711-20 Meek RL et al 2013/01/01 |
|
|
| 612 |
Ishimoto T et al. Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol. Dial. Transplant. 2013 Jun;28(6):1439-46 Ishimoto T et al 2013/01/01 |
|
|
| 613 |
Park J et al. Renoprotective antioxidant effect of alagebrium in experimental diabetes. Nephrol. Dial. Transplant. 2011 Nov;26(11):3474-84 Park J et al 2011/01/01 |
|
|
| 614 |
Zuo N et al. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy. Nephrol. Dial. Transplant. 2011 Jul;26(7):2127-37 Zuo N et al 2011/01/01 |
|
|
| 615 |
Gao Q et al. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol. Dial. Transplant. 2010 Nov;25(11):3539-47 Gao Q et al 2010/01/01 |
|
|
| 616 |
Chin HJ et al. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. Nephrol. Dial. Transplant. 2010 May;25(5):1450-7 Chin HJ et al 2010/01/01 |
|
|
| 617 |
Sakurai N et al. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy. Nephrol. Dial. Transplant. 2009 Aug;24(8):2378-83 Sakurai N et al 2009/01/01 |
|
|
| 618 |
Kamijo-Ikemori A et al. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice. Nephrol. Dial. Transplant. 2009 Mar;24(3):788-800 Kamijo-Ikemori A et al 2009/01/01 |
|
|
| 619 |
Iyoda M et al. All-trans-retinoic acid aggravates cryoglobulin-associated membranoproliferative glomerulonephritis in mice. Nephrol. Dial. Transplant. 2007 Dec;22(12):3451-61 Iyoda M et al 2007/01/01 |
|
|
| 620 |
Hamada Y et al. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol. Dial. Transplant. 2007 Jun;22(6):1547-57 Hamada Y et al 2007/01/01 |
|
|
| 621 |
Ogawa M et al. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats. Nephrol. Dial. Transplant. 2006 Apr;21(4):924-34 Ogawa M et al 2006/01/01 |
|
|
| 622 |
Shike T et al. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice. Nephrol. Dial. Transplant. 2005 May;20(5):879-85 Shike T et al 2005/01/01 |
|
|
| 623 |
Fan Q et al. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Nephrol. Dial. Transplant. 2004 Dec;19(12):3012-20 Fan Q et al 2004/01/01 |
|
|
| 624 |
Kim DY et al. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. Mol Nutr Food Res 2018 10;62(19):e1800302 Kim DY et al 2018/01/01 |
|
|
| 625 |
Zhao S et al. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice. Endocrinology 2018 02;159(2):836-852 Zhao S et al 2018/01/01 |
|
|
| 626 |
Ghosh A et al. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice. Endocrinology 2017 04;158(4):903-919 Ghosh A et al 2017/01/01 |
|
|
| 627 |
Kumar V et al. Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton. Sci Rep 2019 03;9(1):3582 Kumar V et al 2019/01/01 |
|
|
| 628 |
Albers RE et al. Trophoblast-Specific Expression of Hif-1α Results in Preeclampsia-Like Symptoms and Fetal Growth Restriction. Sci Rep 2019 02;9(1):2742 Albers RE et al 2019/01/01 |
|
|
| 629 |
Hinder LM et al. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Sci Rep 2019 01;9(1):881 Hinder LM et al 2019/01/01 |
|
|
| 630 |
Masum MA et al. Modified scanning electron microscopy reveals pathological crosstalk between endothelial cells and podocytes in a murine model of membranoproliferative glomerulonephritis. Sci Rep 2018 07;8(1):10276 Masum MA et al 2018/01/01 |
|
|
| 631 |
Stangenberg S et al. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy. Sci Rep 2018 06;8(1):9423 Stangenberg S et al 2018/01/01 |
|
|
| 632 |
Sukjamnong S et al. MitoQ supplementation prevent long-term impact of maternal smoking on renal development, oxidative stress and mitochondrial density in male mice offspring. Sci Rep 2018 04;8(1):6631 Sukjamnong S et al 2018/01/01 |
|
|
| 633 |
Zhao XP et al. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes. Sci Rep 2018 Apr;8(1):5958 Zhao XP et al 2018/01/01 |
|
|
| 634 |
Chen C et al. Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis. Sci Rep 2017 12;7(1):17737 Chen C et al 2017/01/01 |
|
|
| 635 |
Sagar A et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep 2017 09;7(1):12047 Sagar A et al 2017/01/01 |
|
|
| 636 |
Wang H et al. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus. Sci Rep 2016 06;6:28997 Wang H et al 2016/01/01 |
|
|
| 637 |
Liang H et al. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension. Sci Rep 2016 06;6:28715 Liang H et al 2016/01/01 |
|
|
| 638 |
Atanasio A et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep 2016 Mar;6:23204 Atanasio A et al 2016/01/01 |
|
|
| 639 |
Kimura J et al. Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep 2014 Dec;4:7290 Kimura J et al 2014/01/01 |
|
|
| 640 |
Ullevig SL et al. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 2011 Dec;219(2):409-16 Ullevig SL et al 2011/01/01 |
|
|
| 641 |
Yoon JJ et al. <i>Dianthus superbus</i> Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model. Nutrients 2019 Mar;11(3) Yoon JJ et al 2019/01/01 |
|
|
| 642 |
Drapeau N et al. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes. Am. J. Physiol. Endocrinol. Metab. 2013 Jun;304(11):E1188-98 Drapeau N et al 2013/01/01 |
|
|
| 643 |
Potthoff SA et al. P2Y2 receptor deficiency aggravates chronic kidney disease progression. Front Physiol 2013;4:234 Potthoff SA et al 2013/01/01 |
|
|
| 644 |
Hu S et al. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis. J. Biol. Chem. 2018 12;293(52):20227-20239 Hu S et al 2018/01/01 |
|
|
| 645 |
Wang XX et al. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice. J. Biol. Chem. 2017 07;292(29):12018-12024 Wang XX et al 2017/01/01 |
|
|
| 646 |
Denhez B et al. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes. J. Biol. Chem. 2015 Jan;290(1):350-8 Denhez B et al 2015/01/01 |
|
|
| 647 |
Singhal SS et al. RLIP76 protein knockdown attenuates obesity due to a high-fat diet. J. Biol. Chem. 2013 Aug;288(32):23394-406 Singhal SS et al 2013/01/01 |
|
|
| 648 |
Long J et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 2011 Apr;286(13):11837-48 Long J et al 2011/01/01 |
|
|
| 649 |
Jiang T et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 2005 Sep;280(37):32317-25 Jiang T et al 2005/01/01 |
|
|
| 650 |
Yogi A et al. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. J. Hypertens. 2011 Jul;29(7):1400-10 Yogi A et al 2011/01/01 |
|
|
| 651 |
Baek JH et al. Deletion of the Mitochondrial Complex-IV Cofactor Heme A:Farnesyltransferase Causes Focal Segmental Glomerulosclerosis and Interferon Response. Am. J. Pathol. 2018 Dec;188(12):2745-2762 Baek JH et al 2018/01/01 |
|
|
| 652 |
Bornfeldt KE et al. A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. Am. J. Pathol. 2018 02;188(2):343-352 Bornfeldt KE et al 2018/01/01 |
|
|
| 653 |
Du Q et al. Transfusion of CD206<sup>+</sup> M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice. Am. J. Pathol. 2016 12;186(12):3176-3188 Du Q et al 2016/01/01 |
|
|
| 654 |
Okamoto K et al. Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney. Am. J. Pathol. 2015 Jul;185(7):1889-98 Okamoto K et al 2015/01/01 |
|
|
| 655 |
Bae EH et al. Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome. Am. J. Pathol. 2015 May;185(5):1423-35 Bae EH et al 2015/01/01 |
|
|
| 656 |
Migliorini A et al. The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am. J. Pathol. 2013 Aug;183(2):431- Migliorini A et al 2013/01/01 |
|
|
| 657 |
Hashimoto A et al. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes. Am. J. Pathol. 2012 Oct;181(4):1338-47 Hashimoto A et al 2012/01/01 |
|
|
| 658 |
Lu A et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am. J. Pathol. 2011 Jun;178(6):2573-86 Lu A et al 2011/01/01 |
|
|
| 659 |
Puliti A et al. Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1. Am. J. Pathol. 2011 Mar;178(3):1257-69 Puliti A et al 2011/01/01 |
|
|
| 660 |
Steenhard BM et al. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria. Am. J. Pat Steenhard BM et al 2010/01/01 |
|
|
| 661 |
Nakayama T et al. Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney. Am. J. Pathol. 2010 May;176(5):2198-208 Nakayama T et al 2010/01/01 |
|
|
| 662 |
Li J et al. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 2009 Oct;175(4):1380-8 Li J et al 2009/01/01 |
|
|
| 663 |
Guo S et al. Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis. Am. J. Pathol. 2009 Jul;175(1):107-18 Guo S et al 2009/01/01 |
|
|
| 664 |
Yokoyama T et al. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am. J. Pathol. 2009 Jun;174(6):2096-106 Yokoyama T et al 2009/01/01 |
|
|
| 665 |
Williams KJ et al. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am. J. Pathol. 2007 Nov;171(5):1441-50 Williams KJ et al 2007/01/01 |
|
|
| 666 |
Kanetsuna Y et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am. J. Pathol. 2007 May;170(5):1473-84 Kanetsuna Y et al 2007/01/01 |
|
|
| 667 |
Inada A et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am. J. Pathol. 2005 Aug;167(2):327-36 Inada A et al 2005/01/01 |
|
|
| 668 |
Chin M et al. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am. J. Pathol. 2005 Jun;166(6):1629-36 Chin M et al 2005/01/01 |
|
|
| 669 |
Wendt TM et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 2003 Apr;162(4):1123-37 Wendt TM et al 2003/01/01 |
|
|
| 670 |
Taneda S et al. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am. J. Pathol. 2001 Dec;159(6):2355-69 Taneda S et al 2001/01/01 |
|
|
| 671 |
Edwards LJ et al. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice. Clin. Immunol. 2015 Jun;158(2):221-30 Edwards LJ et al 2015/01/01 |
|
|
| 672 |
Yu L et al. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cell. Signal. 2014 Dec;26(12):2979-91 Yu L et al 2014/01/01 |
|
|
| 673 |
Vaisman BL et al. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency. J. Pharmacol. Exp. Ther. 2019 03;368(3):423-434 Vaisman BL et al 2019/01/01 |
|
|
| 674 |
Nam BY et al. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis 2012 Jan;17(1):1-13 Nam BY et al 2012/01/01 |
|
|
| 675 |
Potthoff SA et al. The glomerular proteome in a model of chronic kidney disease. Proteomics Clin Appl 2008 Jul;2(7-8):1127-39 Potthoff SA et al 2008/01/01 |
|
|
| 676 |
Worni-Schudel IM et al. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models. J Transl Med 2015 Jun;13:185 Worni-Schudel IM et al 2015/01/01 |
|
|
| 677 |
Hong YA et al. Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J Transl Med 2014 Feb;12:50 Hong YA et al 2014/01/01 |
|
|
| 678 |
Barsha G et al. Sex- and age-related differences in arterial pressure and albuminuria in mice. Biol Sex Differ 2016;7:57 Barsha G et al 2016/01/01 |
|
|
| 679 |
Li MS et al. NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage. Am. J. Physiol., Cell Physiol. 2017 Jan;312(1):C47-C55 Li MS et al 2017/01/01 |
|
|
| 680 |
Breyer MD. Drug discovery for diabetic nephropathy: trying the leap from mouse to man. Semin. Nephrol. 2012 Sep;32(5):445-51 Breyer MD 2012/01/01 |
|
|
| 681 |
Matsubara K et al. Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice. Hypertens. Res. 2016 Jun;39(6):407-14 Matsubara K et al 2016/01/01 |
|
|
| 682 |
Fujita H et al. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice. Hypertens. Res. 2012 Feb;35(2):213-20 Fujita H et al 2012/01/01 |
|
|
| 683 |
Jang IA et al. Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney. Nutrients 2018 Nov;10(11) Jang IA et al 2018/01/01 |
|
|
| 684 |
Kang MK et al. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice. Nutrients 2016 Dec;8(12) Kang MK et al 2016/01/01 |
|
|
| 685 |
Takeda-Matsubara Y et al. Roles of angiotensin type 1 and 2 receptors in pregnancy-associated blood pressure change. Am. J. Hypertens. 2004 Aug;17(8):684-9 Takeda-Matsubara Y et al 2004/01/01 |
|
|
| 686 |
Fowlkes JL et al. Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes. Exp Diabetes Res 2011;2011:269378 Fowlkes JL et al 2011/01/01 |
|
|
| 687 |
Kamada Y et al. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009 Feb;296(2):G157-67 Kamada Y et al 2009/01/01 |
|
|
| 688 |
Tsuchida T et al. Lipocalin-type prostaglandin D synthase in urine in adriamycin-induced nephropathy of mice. Nephron Physiol 2004;96(2):p42-51 Tsuchida T et al 2004/01/01 |
|
|
| 689 |
Thomas CM et al. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 2014 Oct;307(7):H1036-45 Thomas CM et al 2014/01/01 |
|
|
| 690 |
Falcao S et al. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice. Am. J. Physiol. Heart Circ. Physiol. 2009 Jan;296(1):H119-26 Falcao S et al 2009/01/01 |
|
|
| 691 |
Kim EN et al. PPARα agonist, fenofibrate, ameliorates age-related renal injury. Exp. Gerontol. 2016 08;81:42-50 Kim EN et al 2016/01/01 |
|
|
| 692 |
DeLoach S et al. Endothelin-1 response to glucose and insulin among African Americans. J Am Soc Hypertens ;4(5):227-35 DeLoach S et al |
|
|
| 693 |
Kokura S et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int J Hyperthermia 2007 May;23(3):259-65 Kokura S et al 2007/01/01 |
|
|
| 694 |
Naito Y et al. Reduction of diabetes-induced renal oxidative stress by a cantaloupe melon extract/gliadin biopolymers, oxykine, in mice. Biofactors 2005;23(2):85-95 Naito Y et al 2005/01/01 |
|
|
| 695 |
Naito Y et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004;20(1):49-59 Naito Y et al 2004/01/01 |
|
|
| 696 |
Chen XW et al. Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice. Mediators Inflamm. 2016;2016:1405924 Chen XW et al 2016/01/01 |
|
|
| 697 |
Peters V et al. Protective Actions of Anserine Under Diabetic Conditions. Int J Mol Sci 2018 Sep;19(9) Peters V et al 2018/01/01 |
|
|
| 698 |
Wang D et al. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. Int J Mol Sci 2018 Jan;19(1) Wang D et al 2018/01/01 |
|
|
| 699 |
Yuan Y et al. A vital role for myosin-9 in puromycin aminonucleoside-induced podocyte injury by affecting actin cytoskeleton. Free Radic. Res. 2016 Jun;50(6):627-37 Yuan Y et al 2016/01/01 |
|
|
| 700 |
Wicks SE et al. Diet-induced obesity and kidney disease - In search of a susceptible mouse model. Biochimie 2016 May;124:65-73 Wicks SE et al 2016/01/01 |
|
|
| 701 |
Liu F et al. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy. Kidney Blood Press. Res. 2018;43(5):1425-1436 Liu F et al 2018/01/01 |
|
|
| 702 |
Xu H et al. Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice. Kidney Blood Press. Res. 2017;42(6):1128-1140 Xu H et al 2017/01/01 |
|
|
| 703 |
Sato E et al. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques. Toxins (Basel) 2017 12;10(1) Sato E et al 2017/01/01 |
|
|
| 704 |
Iwamuro M et al. Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 2010;19(6):841-7 Iwamuro M et al 2010/01/01 |
|
|
| 705 |
Martin B et al. Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease. Exp. Physiol. 2018 01;103(1):125-140 Martin B et al 2018/01/01 |
|
|
| 706 |
Aliou Y et al. Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr. Res. 2016 Mar;79(3):416-24 Aliou Y et al 2016/01/01 |
|
|
| 707 |
Major TC et al. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes. Cardiovasc Drugs Ther 2008 Dec;22(6):469-78 Major TC et al 2008/01/01 |
|
|
| 708 |
Spencer NY et al. Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes. PLoS ONE 2018;13(7):e0200249 Spencer NY et al 2018/01/01 |
|
|
| 709 |
Huang C et al. The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy. PLoS ONE 2018;13(2):e0192800 Huang C et al 2018/01/01 |
|
|
| 710 |
Lin JS et al. ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics. PLoS ONE 2017;12(9):e0184575 Lin JS et al 2017/01/01 |
|
|
| 711 |
Chen S et al. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes. PLoS ONE 2017;12(3):e0173918 Chen S et al 2017/01/01 |
|
|
| 712 |
Papeta N et al. Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains. PLoS ONE 2016;11(10):e0163860 Papeta N et al 2016/01/01 |
|
|
| 713 |
Bruder-Nascimento T et al. Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3. PLoS ONE 2016;11(9):e0162731 Bruder-Nascimento T et al 2016/01/01 |
|
|
| 714 |
Hokke S et al. Maternal Fat Feeding Augments Offspring Nephron Endowment in Mice. PLoS ONE 2016;11(8):e0161578 Hokke S et al 2016/01/01 |
|
|
| 715 |
Liang X et al. Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS ONE 2016;11(5):e0155534 Liang X et al 2016/01/01 |
|
|
| 716 |
Ishida T et al. Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model. PLoS ONE 2016;11(1):e0146871 Ishida T et al 2016/01/01 |
|
|
| 717 |
Kim M et al. Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment. PLoS ONE 2015;10(11):e0141231 Kim M et al 2015/01/01 |
|
|
| 718 |
Huang L et al. Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1. PLoS ONE 2015;10(9):e0138440 Huang L et al 2015/01/01 |
|
|
| 719 |
Awad AS et al. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury. PLoS ONE 2015;10(7):e0133777 Awad AS et al 2015/01/01 |
|
|
| 720 |
Maggiorani D et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE 2015;10(7):e0131416 Maggiorani D et al 2015/01/01 |
|
|
| 721 |
Honjo T et al. Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice. PLoS ONE 2015;10(6):e0131731 Honjo T et al 2015/01/01 |
|
|
| 722 |
He J et al. Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents. PLoS ONE 2015;10(4):e0124469 He J et al 2015/01/01 |
|
|
| 723 |
Szalai G et al. Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. PLoS ONE 2015;10(4):e0119547 Szalai G et al 2015/01/01 |
|
|
| 724 |
Maimaitiyiming H et al. Thrombospondin1 deficiency attenuates obesity-associated microvascular complications in ApoE-/- mice. PLoS ONE 2015;10(3):e0121403 Maimaitiyiming H et al 2015/01/01 |
|
|
| 725 |
Zhang J et al. A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1. PLoS ONE 2015;10(2):e0116888 Zhang J et al 2015/01/01 |
|
|
| 726 |
Szalai G et al. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS ONE 2014;9(11):e110867 Szalai G et al 2014/01/01 |
|
|
| 727 |
Ichii O et al. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS ONE 2014;9(10):e110383 Ichii O et al 2014/01/01 |
|
|
| 728 |
Ichii O et al. Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand. PLoS ONE 2014;9(9):e108448 Ichii O et al 2014/01/01 |
|
|
| 729 |
Al-Odat I et al. The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring. PLoS ONE 2014;9(7):e103443 Al-Odat I et al 2014/01/01 |
|
|
| 730 |
Carson JM et al. Podocytes degrade endocytosed albumin primarily in lysosomes. PLoS ONE 2014;9(6):e99771 Carson JM et al 2014/01/01 |
|
|
| 731 |
Townley-Tilson WH et al. The ubiquitin ligase ASB4 promotes trophoblast differentiation through the degradation of ID2. PLoS ONE 2014;9(2):e89451 Townley-Tilson WH et al 2014/01/01 |
|
|
| 732 |
Yamada S et al. Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury. PLoS ONE 2014;9(2):e89135 Yamada S et al 2014/01/01 |
|
|
| 733 |
Riera M et al. Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse. PLoS ONE 2014;9(1):e84683 Riera M et al 2014/01/01 |
|
|
| 734 |
Gurusinghe S et al. Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity? PLoS ONE 2013;8(9):e73095 Gurusinghe S et al 2013/01/01 |
|
|
| 735 |
Yong R et al. Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling. PLoS ONE 2013;8(8):e73428 Yong R et al 2013/01/01 |
|
|
| 736 |
Suzuki N et al. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability. PLoS ONE 2013;8(8):e71187 Suzuki N et al 2013/01/01 |
|
|
| 737 |
Johnstone DB et al. Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy. PLoS ONE 2013;8(7):e67839 Johnstone DB et al 2013/01/01 |
|
|
| 738 |
Lan X et al. Morphine induces albuminuria by compromising podocyte integrity. PLoS ONE 2013;8(3):e55748 Lan X et al 2013/01/01 |
|
|
| 739 |
Baczyk D et al. DREAM mediated regulation of GCM1 in the human placental trophoblast. PLoS ONE 2013;8(1):e51837 Baczyk D et al 2013/01/01 |
|
|
| 740 |
Chen HM et al. Heart-type fatty acid binding protein is associated with proteinuria in obesity. PLoS ONE 2012;7(9):e45691 Chen HM et al 2012/01/01 |
|
|
| 741 |
Veron D et al. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS ONE 2012;7(7):e40589 Veron D et al 2012/01/01 |
|
|
| 742 |
Guillot N et al. BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling. PLoS ONE 2012;7(6):e39406 Guillot N et al 2012/01/01 |
|
|
| 743 |
Zhang Y et al. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS ONE 2012;7(6):e38745 Zhang Y et al 2012/01/01 |
|
|
| 744 |
Zhang HM et al. Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes. PLoS ONE 2012;7(3):e32746 Zhang HM et al 2012/01/01 |
|
|
| 745 |
Maher P et al. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS ONE 2011;6(6):e21226 Maher P et al 2011/01/01 |
|
|
| 746 |
Ahmed A et al. A new mouse model to explore therapies for preeclampsia. PLoS ONE 2010 Oct;5(10):e13663 Ahmed A et al 2010/01/01 |
|
|
| 747 |
Kawaguchi R et al. Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice. Placenta 2012 Jul;33(7):540-7 Kawaguchi R et al 2012/01/01 |
|
|
| 748 |
Burke SD et al. Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta 2011 Dec;32(12):949-55 Burke SD et al 2011/01/01 |
|
|
| 749 |
Kimura T et al. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice. Cancer Chemother. Pharmacol. 2015 May;75(5):1057-63 Kimura T et al 2015/01/01 |
|
|
| 750 |
Nojiri T et al. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury. Cancer Chemother. Pharmacol. 2015 Jan;75(1):123-9 Nojiri T et al 2015/01/01 |
|
|
| 751 |
El Boustany R et al. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes. J. Diabetes Complicat. 2017 Jun;31(6):929-932 El Boustany R et al 2017/01/01 |
|
|
| 752 |
Abouzed TK et al. Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy. J Diabetes Res 2016;2016:1786789 Abouzed TK et al 2016/01/01 |
|
|
| 753 |
Mascarenhas D et al. Mammalian target of rapamycin complex 2 regulates inflammatory response to stress. Inflamm. Res. 2012 Dec;61(12):1395-404 Mascarenhas D et al 2012/01/01 |
|
|
| 754 |
Roche C et al. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice. Prostaglandins Other Lipid Mediat. 2015 Jul;120:148-54 Roche C et al 2015/01/01 |
|
|
| 755 |
Masum MA et al. Overexpression of toll-like receptor 9 correlates with podocyte injury in a murine model of autoimmune membranoproliferative glomerulonephritis. Autoimmunity 2018 12;51(8):386-398 Masum MA et al 2018/01/01 |
|
|
| 756 |
Detsika MG et al. Effect of Heme Oxygenase-1 Deficiency on Glomerular Proteomics. Am. J. Nephrol. 2016;43(6):441-50 Detsika MG et al 2016/01/01 |
|
|
| 757 |
Kimura J et al. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models. Am. J. Nephrol. 2013;38(1):27-38 Kimura J et al 2013/01/01 |
|
|
| 758 |
Chen L et al. Renal failure in mice with Gsalpha deletion in juxtaglomerular cells. Am. J. Nephrol. 2010;32(1):83-94 Chen L et al 2010/01/01 |
|
|
| 759 |
Kimura J et al. BXSB-type genome causes murine autoimmune glomerulonephritis: pathological correlation between telomeric region of chromosome 1 and Yaa. Genes Immun. ;15(3):182-9 Kimura J et al |
|
|
| 760 |
Chen YW et al. Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr. Nephrol. 2010 Jul;25(7):1319-29 Chen YW et al 2010/01/01 |
|
|
| 761 |
Kyttaris VC et al. Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice. Biomed Res Int 2013;2013:861028 Kyttaris VC et al 2013/01/01 |
|
|
| 762 |
Mirzoyan K et al. Increased urine acylcarnitines in diabetic ApoE-/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia. Biochem. Biophys. Res. Commun. 2017 05;487(1):109-115 Mirzoyan K et al 2017/01/01 |
|
|
| 763 |
Stec DF et al. Alterations of urinary metabolite profile in model diabetic nephropathy. Biochem. Biophys. Res. Commun. 2015 Jan;456(2):610-4 Stec DF et al 2015/01/01 |
|
|
| 764 |
Ozawa S et al. Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse. Biochem. Biophys. Res. Commun. 2014 11;454(4):531-6 Ozawa S et al 2014/01/01 |
|
|
| 765 |
Mori H et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 2009 Jul;384(4):471-5 Mori H et al 2009/01/01 |
|
|
| 766 |
Suzuki H et al. Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice. Biochem. Biophys. Res. Commun. 2009 Jan;379(1):38-42 Suzuki H et al 2009/01/01 |
|
|
| 767 |
Ishigaki N et al. Involvement of glomerular SREBP-1c in diabetic nephropathy. Biochem. Biophys. Res. Commun. 2007 Dec;364(3):502-8 Ishigaki N et al 2007/01/01 |
|
|
| 768 |
Mishra R et al. Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys. Biochem. Biophys. Res. Commun. 2006 Jan;339(1):65-70 Mishra R et al 2006/01/01 |
|
|
| 769 |
Fujimoto M et al. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem. Biophys. Res. Commun. 2003 Jun;305(4):1002-7 Fujimoto M et al 2003/01/01 |
|
|
| 770 |
Masum MA et al. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions. BMC Nephrol 2017 Sep;18(1):280 Masum MA et al 2017/01/01 |
|
|
| 771 |
Hartono SP et al. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrol 2014;15:58 Hartono SP et al 2014/01/01 |
|
|
| 772 |
Blauwkamp MN et al. Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol 2008 Jul;9:7 Blauwkamp MN et al 2008/01/01 |
|
|
| 773 |
Ma J et al. Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med 2010 Nov;10:67 Ma J et al 2010/01/01 |
|
|
| 774 |
Lee SJ et al. Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury. Nephron Exp. Nephrol. 2012;121(3-4):e86-96 Lee SJ et al 2012/01/01 |
|
|
| 775 |
Wang P et al. The inhibitory effect of BKCa channels induced by autoantibodies against angiotensin II type 1 receptor is independent of AT1R. Acta Biochim. Biophys. Sin. (Shanghai) 2018 Jun;50(6):560-566 Wang P et al 2018/01/01 |
|
|
| 776 |
Kim IH et al. Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice. Age (Dordr) 2016 Aug;38(4):291-302 Kim IH et al 2016/01/01 |
|
|
| 777 |
Smith SW et al. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Histol. Histopathol. 2012 12;27(12):1503-14 Smith SW et al 2012/01/01 |
|
|
| 778 |
Ichikawa H et al. Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin. Int Heart J 2018 Nov;59(6):1445-1453 Ichikawa H et al 2018/01/01 |
|
|
| 779 |
Singh BK et al. A nuclear complex of rictor and insulin receptor substrate-2 is associated with albuminuria in diabetic mice. Metab Syndr Relat Disord 2010 Aug;8(4):355-63 Singh BK et al 2010/01/01 |
|
|
| 780 |
Li S et al. Rhododendron groenlandicum (Labrador tea), an antidiabetic plant from the traditional pharmacopoeia of the Canadian Eastern James Bay Cree, improves renal integrity in the diet-induced obese mouse model. Pharm Biol 2016 Oct;54(10):1998-2006 Li S et al 2016/01/01 |
|
|
| 781 |
Zhang S et al. Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure. Cytotechnology 2018 Aug;70(4):1131-1141 Zhang S et al 2018/01/01 |
|
|
| 782 |
Tang T et al. Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice. Connect. Tissue Res. 2013;54(1):5-13 Tang T et al 2013/01/01 |
|
|
| 783 |
Park HS et al. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice. Transpl. Immunol. 2016 Feb;34:42-9 Park HS et al 2016/01/01 |
|
|
| 784 |
Kadoya H et al. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice. Clin. Exp. Nephrol. 2016 Oct;20(5):671-678 Kadoya H et al 2016/01/01 |
|
|
| 785 |
Moriyama T et al. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. Clin. Exp. Nephrol. 2004 Sep;8(3):230-6 Moriyama T et al 2004/01/01 |
|
|
| 786 |
Cao Y et al. EP4 knockdown alleviates glomerulosclerosis through Smad and MAPK pathways in mesangial cells. Mol Med Rep 2018 Dec;18(6):5141-5150 Cao Y et al 2018/01/01 |
|
|
| 787 |
Jia ZH et al. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Exp. Clin. Endocrinol. Diabetes 2007 Oct;115(9):571-6 Jia ZH et al 2007/01/01 |
|
|
| 788 |
Watanabe T et al. Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice. Biol. Pharm. Bull. 2013;36(5):741-7 Watanabe T et al 2013/01/01 |
|
|
| 789 |
Tsujimura T et al. Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats. Biol. Pharm. Bull. 2009 Dec;32(12):1991-6 Tsujimura T et al 2009/01/01 |
|
|
| 790 |
Toyoda Y et al. Metabolomics of an in vitro liver model containing primary hepatocytes assembling around an endothelial cell network: comparative study on the metabolic stability and the effect of acetaminophen treatment. J Toxicol Sci 2017;42(4):445-454 Toyoda Y et al 2017/01/01 |
|
|
| 791 |
Chang SY et al. Overexpression of angiotensinogen downregulates aquaporin 1 expression via modulation of Nrf2-HO-1 pathway in renal proximal tubular cells of transgenic mice. J Renin Angiotensin Aldosterone Syst 2016 Jul;17(3) Chang SY et al 2016/01/01 |
|
|
| 792 |
Kidokoro K et al. Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice. J Renin Angiotensin Aldosterone Syst ;17(2):1470320315625704 Kidokoro K et al |
|
|
| 793 |
Zhang J et al. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. J Renin Angiotensin Aldosterone Syst 2015 Jun;16(2):234-48 Zhang J et al 2015/01/01 |
|
|
| 794 |
Maeda M et al. Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice. Exp. Anim. 2016 Nov;65(4):427-436 Maeda M et al 2016/01/01 |
|
|
| 795 |
Sasaki H et al. Genetic background-dependent diversity in renal failure caused by the tensin2 gene deficiency in the mouse. Biomed. Res. 2015;36(5):323-30 Sasaki H et al 2015/01/01 |
|
|
| 796 |
Nishino T et al. The 129 genetic background affects susceptibility to glomerulosclerosis in tensin2-deficient mice. Biomed. Res. 2012 Feb;33(1):53-6 Nishino T et al 2012/01/01 |
|
|
| 797 |
Soni H et al. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. Ren Fail 2018 Nov;40(1):314-322 Soni H et al 2018/01/01 |
|
|
| 798 |
Breyer MD. Translating experimental diabetic nephropathy studies from mice to men. Contrib Nephrol 2011;170:156-164 Breyer MD 2011/01/01 |
|
|
| 799 |
Chan YL et al. Impact of maternal cigarette smoke exposure on brain and kidney health outcomes in female offspring. Clin. Exp. Pharmacol. Physiol. 2016 12;43(12):1168-1176 Chan YL et al 2016/01/01 |
|
|
| 800 |
Hokke S et al. Maternal glucose intolerance reduces offspring nephron endowment and increases glomerular volume in adult offspring. Diabetes Metab. Res. Rev. 2016 11;32(8):816-826 Hokke S et al 2016/01/01 |
|
|
| 801 |
Tamai M et al. Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils. Tissue Eng Part A 2013 Nov;19(21-22):2527-35 Tamai M et al 2013/01/01 |
|
|
| 802 |
Kato I et al. A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells. Diabetes Metab. Res. Rev. 2008 Sep;24(6):486-97 Kato I et al 2008/01/01 |
|
|
| 803 |
Maezawa Y et al. Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab. Res. Rev. ;22(4):313-22 Maezawa Y et al |
|
|
| 804 |
Gordon AD et al. MALAT1: A regulator of inflammatory cytokines in diabetic complications. Endocrinol Diabetes Metab 2018 Apr;1(2):e00010 Gordon AD et al 2018/01/01 |
|
|
| 805 |
Ma Y et al. Comparison of diabetic nephropathy between male and female eNOS<sup>-/-</sup><i>db</i>/<i>db</i> mice. Am. J. Physiol. Renal Physiol. 2019 05;316(5):F889-F897 Ma Y et al 2019/01/01 |
|
|
| 806 |
Hashikami K et al. Establishment of X-linked Alport syndrome model mice with a <i>Col4a5</i> R471X mutation. Biochem Biophys Rep 2019 Mar;17:81-86 Hashikami K et al 2019/01/01 |
|
|
| 807 |
Chung S et al. TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. JCI Insight 2018 11;3(21) Chung S et al 2018/01/01 |
|
|
| 808 |
Ma Z et al. Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3. Am. J. Physiol. Renal Physiol. 2018 Dec;315(6):F1822-F1832 Ma Z et al 2018/01/01 |
|
|
| 809 |
Manigrasso MB et al. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney. Am. J. Physiol. Renal Physiol. 2018 12;315(6):F1601-F1612 Manigrasso MB et al 2018/01/01 |
|
|
| 810 |
Privratsky JR et al. Interleukin 1 receptor (IL-1R1) activation exacerbates toxin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 2018 09;315(3):F682-F691 Privratsky JR et al 2018/01/01 |
|
|
| 811 |
Li Y et al. Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control. JCI Insight 2018 05;3(10) Li Y et al 2018/01/01 |
|
|
| 812 |
Garrett N et al. Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice. JCI Insight 2018 04;3(8) Garrett N et al 2018/01/01 |
|
|
| 813 |
Oh HJ et al. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 10;315(4):F791-F805 Oh HJ et al 2018/01/01 |
|
|
| 814 |
Jung JH et al. Human CD36 overexpression in renal tubules accelerates the progression of renal diseases in a mouse model of folic acid-induced acute kidney injury. Kidney Res Clin Pract 2018 Mar;37(1):30-40 Jung JH et al 2018/01/01 |
|
|
| 815 |
Eriguchi M et al. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 04;314(4):F531-F542 Eriguchi M et al 2018/01/01 |
|
|
| 816 |
Norlander AE et al. A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage. JCI Insight 2017 Jul;2(13) Norlander AE et al 2017/01/01 |
|
|
| 817 |
Orellana JM et al. Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling. Physiol Rep 2017 May;5(10) Orellana JM et al 2017/01/01 |
|
|
| 818 |
Wysocki J et al. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease. Am. J. Physiol. Renal Physiol. 2017 Aug;313(2):F487-F494 Wysocki J et al 2017/01/01 |
|
|
| 819 |
Morris SM et al. Distinct roles of arginases 1 and 2 in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2017 Oct;313(4):F899-F905 Morris SM et al 2017/01/01 |
|
|
| 820 |
Yi M et al. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am. J. Physiol. Renal Physiol. 2017 07;313(1):F74-F84 Yi M et al 2017/01/01 |
|
|
| 821 |
Saleh MA et al. Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension. JACC Basic Transl Sci 2016 Dec;1(7):606-616 Saleh MA et al 2016/01/01 |
|
|
| 822 |
Roncal-Jimenez CA et al. Effects of exogenous desmopressin on a model of heat stress nephropathy in mice. Am. J. Physiol. Renal Physiol. 2017 03;312(3):F418-F426 Roncal-Jimenez CA et al 2017/01/01 |
|
|
| 823 |
Nakagawa N et al. Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight 2016 Dec;1(20):e87446 Nakagawa N et al 2016/01/01 |
|
|
| 824 |
Yadranji Aghdam S et al. Proteasome Activators, PA28<i>α</i> and PA28<i>β</i>, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy. Int J Nephrol 2016;2016:3846573 Yadranji Aghdam S et al 2016/01/01 |
|
|
| 825 |
Nolin AC et al. Proteinuria causes dysfunctional autophagy in the proximal tubule. Am. J. Physiol. Renal Physiol. 2016 12;311(6):F1271-F1279 Nolin AC et al 2016/01/01 |
|
|
| 826 |
Riera M et al. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am. J. Physiol. Renal Physiol. 2016 Mar;310(6):F534-46 Riera M et al 2016/01/01 |
|
|
| 827 |
Souza AC et al. TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep 2015 Sep;3(9) Souza AC et al 2015/01/01 |
|
|
| 828 |
Santamaria B et al. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim. Biophys. Acta 2015 Dec;1853(12):3224-34 Santamaria B et al 2015/01/01 |
|
|
| 829 |
Dobrinskikh E et al. Shank2 Regulates Renal Albumin Endocytosis. Physiol Rep 2015 Sep;3(9) Dobrinskikh E et al 2015/01/01 |
|
|
| 830 |
Hirsch S et al. A mouse model of Townes-Brocks syndrome expressing a truncated mutant Sall1 protein is protected from acute kidney injury. Am. J. Physiol. Renal Physiol. 2015 Nov;309(10):F852-63 Hirsch S et al 2015/01/01 |
|
|
| 831 |
You H et al. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2015 Sep;309(5):F447-55 You H et al 2015/01/01 |
|
|
| 832 |
Chung CH et al. Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy. Nephron Extra ;5(1):1-18 Chung CH et al |
|
|
| 833 |
O'Sullivan L et al. Excess prenatal corticosterone exposure results in albuminuria, sex-specific hypotension, and altered heart rate responses to restraint stress in aged adult mice. Am. J. Physiol. Renal Physiol. 2015 May;308(10):F1065-73 O'Sullivan L et al 2015/01/01 |
|
|
| 834 |
Nguyen LT et al. L-Carnitine reverses maternal cigarette smoke exposure-induced renal oxidative stress and mitochondrial dysfunction in mouse offspring. Am. J. Physiol. Renal Physiol. 2015 Apr;308(7):F689-96 Nguyen LT et al 2015/01/01 |
|
|
| 835 |
Zhao J et al. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys. Am. J. Physiol. Renal Physiol. 2015 May;308(10):F1167-77 Zhao J et al 2015/01/01 |
|
|
| 836 |
Hulkko J et al. Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis. Nephron Extra 2014 S Hulkko J et al 2014/01/01 |
|
|
| 837 |
You H et al. Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation. Am. J. Physiol. Renal Physiol. 2014 Dec;307(11):F1292-301 You H et al 2014/01/01 |
|
|
| 838 |
Novitskaya T et al. A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Am. J. Physiol. Renal Physiol. 2014 Mar;306(5):F496-504 Novitskaya T et al 2014/01/01 |
|
|
| 839 |
You H et al. Macrophages directly mediate diabetic renal injury. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1719-27 You H et al 2013/01/01 |
|
|
| 840 |
Zhang MZ et al. Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1680-6 Zhang MZ et al 2013/01/01 |
|
|
| 841 |
Decl竪ves AE et al. Effects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging. Am. J. Physiol. Renal Physiol. 2013 Nov;305(9):F1343-51 Decl竪ves AE et al 2013/01/01 |
|
|
| 842 |
Awad AS et al. Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F891-900 Awad AS et al 2013/01/01 |
|
|
| 843 |
Cui W et al. Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F871-80 Cui W et al 2013/01/01 |
|
|
| 844 |
Takahashi S et al. SIRPα signaling regulates podocyte structure and function. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F861-70 Takahashi S et al 2013/01/01 |
|
|
| 845 |
Wysocki J et al. Regulation of urinary ACE2 in diabetic mice. Am. J. Physiol. Renal Physiol. 2013 Aug;305(4):F600-11 Wysocki J et al 2013/01/01 |
|
|
| 846 |
Su M et al. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am. J. Physiol. Renal Physiol. 2013 Aug;305(4):F520-31 Su M et al 2013/01/01 |
|
|
| 847 |
Shi Y et al. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. Am. J. Physiol. Renal Physiol. 2013 Jun;304(11):F1335-46 Shi Y et al 2013/01/01 |
|
|
| 848 |
You YH et al. Role of Nox2 in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 2013 Apr;304(7):F840-8 You YH et al 2013/01/01 |
|
|
| 849 |
Vallon V et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am. J. Physiol. Renal Physiol. 2013 Jan;304(2):F156-67 Vallon V et al 2013/01/01 |
|
|
| 850 |
Vashistha H et al. Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am. J. Physiol. Renal Physiol. 2012 Dec;303(12):F1629-40 Vashistha H et al 2012/01/01 |
|
|
| 851 |
Kumar D et al. Inhibition of renin activity slows down the progression of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 2012 Sep;303(5):F711-20 Kumar D et al 2012/01/01 |
|
|
| 852 |
Lo CS et al. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F840-52 Lo CS et al 2012/01/01 |
|
|
| 853 |
Irita J et al. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney. Am. J. Physiol. Renal Physiol. 2011 Oct;301(4):F833-44 Irita J et al 2011/01/01 |
|
|
| 854 |
Ma LJ et al. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am. J. Physiol. Renal Physiol. 2011 May;300(5):F1203-13 Ma LJ et al 2011/01/01 |
|
|
| 855 |
Wang XX et al. Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. Am. J. Physiol. Renal Physiol. 2011 Mar;300(3):F801-10 Wang XX et al 2011/01/01 |
|
|
| 856 |
Sedeek M et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2010 Dec;299(6):F1348-58 Sedeek M et al 2010/01/01 |
|
|
| 857 |
Dilauro M et al. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1523-32 Dilauro M et al 2010/01/01 |
|
|
| 858 |
Ruta LA et al. High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1384-92 Ruta LA et al 2010/01/01 |
|
|
| 859 |
Gurley SB et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F788-95 Gurley SB et al 2010/01/01 |
|
|
| 860 |
Kosugi T et al. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F609-16 Kosugi T et al 2010/01/01 |
|
|
| 861 |
Wang XX et al. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am. J. Physiol. Renal Physiol. 2009 Dec;297(6):F1587-96 Wang XX et al 2009/01/01 |
|
|
| 862 |
van Meurs M et al. Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am. J. Physiol. Renal Physiol. 2009 Aug;297(2):F272-81 van Meurs M et al 2009/01/01 |
|
|
| 863 |
Nakayama T et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F317-27 Nakayama T et al 2009/01/01 |
|
|
| 864 |
Zhang H et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2008 Oct;295(4):F1071-81 Zhang H et al 2008/01/01 |
|
|
| 865 |
Yuan H et al. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F605-17 Yuan H et al 2008/01/01 |
|
|
| 866 |
Boesen EI et al. Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F446-53 Boesen EI et al 2008/01/01 |
|
|
| 867 |
Shi H et al. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1512-7 Shi H et al 2007/01/01 |
|
|
| 868 |
Liu S et al. Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1727-35 Liu S et al 2007/01/01 |
|
|
| 869 |
Wang A et al. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1657-65 Wang A et al 2007/01/01 |
|
|
| 870 |
Ideura H et al. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 2007 Oct;293(4):F1214-21 Ideura H et al 2007/01/01 |
|
|
| 871 |
Hamada Y et al. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 2007;53(1-2):53-61 Hamada Y et al 2007/01/01 |
|
|
| 872 |
Kanetsuna Y et al. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes. Am. J. Physiol. Renal Physiol. 2006 Dec;291(6):F1315-22 Kanetsuna Y et al 2006/01/01 |
|
|
| 873 |
Gurley SB et al. Impact of genetic background on nephropathy in diabetic mice. Am. J. Physiol. Renal Physiol. 2006 Jan;290(1):F214-22 Gurley SB et al 2006/01/01 |
|
|
| 874 |
Yang T et al. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am. J. Physiol. Renal Physiol. 2005 Jun;288(6):F1125-32 Yang T et al 2005/01/01 |
|
|
| 875 |
Kralisch S et al. The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease. Eur. J. Endocrinol. 2019 Aug;181(2):151-159 Kralisch S et al 2019/01/01 |
|
|
| 876 |
Wen Y et al. TNF-α in T lymphocytes attenuates renal injury and fibrosis during nephrotoxic nephritis. Am. J. Physiol. Renal Physiol. 2020 01;318(1):F107-F116 Wen Y et al 2020/01/01 |
|
|
| 877 |
Lo CS et al. Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice. Sci Rep 2019 10;9(1):15765 Lo CS et al 2019/01/01 |
|
|
| 878 |
Saleh MA et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J. Clin. Invest. 2015 Mar;125(3):1189-202 Saleh MA et al 2015/01/01 |
|
|
| 879 |
Rubio-Navarro A et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J. Pathol. 2018 03;244(3):296-310 Rubio-Navarro A et al 2018/01/01 |
|
|
| 880 |
Elmarakby AA et al. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats. Clin. Sci. 2013 Oct;125(7):349-59 Elmarakby AA et al 2013/01/01 |
|
|
| 881 |
Heimlich JB et al. ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus. Acta Physiol (Oxf) 2015 Mar;213(3):722-30 Heimlich JB et al 2015/01/01 |
|
|
| 882 |
Elmarakby AA et al. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011 Nov;301(5):R1307-17 Elmarakby AA et al 2011/01/01 |
|
|
| 883 |
Cechova S et al. <i>MYH9</i> E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. J. Am. Soc. Nephrol. 2018 01;29(1):155-167 Cechova S et al 2018/01/01 |
|
|
| 884 |
Wang W et al. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 2014 Dec;15(4):384-95 Wang W et al 2014/01/01 |
|
|
| 885 |
Koshikawa M et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 2005 Sep;16(9):2690-701 Koshikawa M et al 2005/01/01 |
|
|
| 886 |
Mima A et al. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy. FASEB J. 2012 Jul;26(7):2963-74 Mima A et al 2012/01/01 |
|
|
| 887 |
Li XQ et al. Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage. Sci Rep 2016 05;6:26854 Li XQ et al 2016/01/01 |
|
|
| 888 |
Tesch GH et al. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007 Jun;12(3):261-6 Tesch GH et al 2007/01/01 |
|
|
| 889 |
Awad AS et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2006 Apr;290(4):F828-37 Awad AS et al 2006/01/01 |
|
|
| 890 |
Kolavennu V et al. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2008 Mar;57(3):714-23 Kolavennu V et al 2008/01/01 |
|
|
| 891 |
Cohen MP et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int. 2005 Oct;68(4):1554-61 Cohen MP et al 2005/01/01 |
|
|
| 892 |
Sugaru E et al. Enhanced effect of combined treatment with SMP-534 (antifibrotic agent) and losartan in diabetic nephropathy. Am. J. Nephrol. 2006;26(1):50-8 Sugaru E et al 2006/01/01 |
|
|
| 893 |
Sugaru E et al. Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice. Nephron Exp. Nephrol. 2007;105(2):e45-52 Sugaru E et al 2007/01/01 |
|
|
| 894 |
Quigley JE et al. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension. Clin. Exp. Pharmacol. Physiol. 2009 Jul;36(7):724-8 Quigley JE et al 2009/01/01 |
|
|
| 895 |
Cohen MP et al. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am. J. Physiol. Renal Physiol. 2007 Feb;292(2):F789-95 Cohen MP et al 2007/01/01 |
|
|
| 896 |
Sugaru E et al. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice. Am. J. Physiol. Renal Physiol. 2006 Apr;290(4):F813-20 Sugaru E et al 2006/01/01 |
|
|
| 897 |
Soto-Gutierrez A et al. Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric. Transplantation 2007 Jan;83(2):129-37 Soto-Gutierrez A et al 2007/01/01 |
|
- No.： 1
-
文献情報：
Tammela T et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 Jul;454(7204):656-60
Tammela T et al
2008/01/01
-
備考：
-
参照：
- No.： 2
-
文献情報：
Beckerman P et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat. Med. 2017 Apr;23(4):429-438
Beckerman P et al
2017/01/01
-
備考：
-
参照：
- No.： 3
-
文献情報：
Okamoto K et al. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat. Genet. 2011 May;43(5):459-63
Okamoto K et al
2011/01/01
-
備考：
-
参照：
- No.： 4
-
文献情報：
Belcik JT et al. Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer. J. Am. Coll. Cardiol. 2012 Aug;60(7):618-25
Belcik JT et al
2012/01/01
-
備考：
-
参照：
- No.： 5
-
文献情報：
Sun XN et al. T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma. Circ. Res. 2017 May;120(10):1584-1597
Sun XN et al
2017/01/01
-
備考：
-
参照：
- No.： 6
-
文献情報：
Dharaneeswaran H et al. FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. Circ. Res. 2014 Jul;115(2):238-251
Dharaneeswaran H et al
2014/01/01
-
備考：
-
参照：
- No.： 7
-
文献情報：
Zhang MZ et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 2012 Dec;122(12):4519-32
Zhang MZ et al
2012/01/01
-
備考：
-
参照：
- No.： 8
-
文献情報：
Sachs N et al. Blood pressure influences end-stage renal disease of Cd151 knockout mice. J. Clin. Invest. 2012 Jan;122(1):348-58
Sachs N et al
2012/01/01
-
備考：
-
参照：
- No.： 9
-
文献情報：
Jeansson M et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 2011 Jun;121(6):2278-89
Jeansson M et al
2011/01/01
-
備考：
-
参照：
- No.： 10
-
文献情報：
Moreth K et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J. Clin. Invest. 2010 Dec;120(12):4251-72
Moreth K et al
2010/01/01
-
備考：
-
参照：
- No.： 11
-
文献情報：
Kume S et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 2010 Apr;120(4):1043-55
Kume S et al
2010/01/01
-
備考：
-
参照：
- No.： 12
-
文献情報：
Tanaka M et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J. Clin. Invest. 2010 Mar;120(3):768-77
Tanaka M et al
2010/01/01
-
備考：
-
参照：
- No.： 13
-
文献情報：
Timmins JM et al. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J. Clin. Invest. 2009 Oct;119(10):2925-41
Timmins JM et al
2009/01/01
-
備考：
-
参照：
- No.： 14
-
文献情報：
Crowley SD et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J. Clin. Invest. 2009 Apr;119(4):943-53
Crowley SD et al
2009/01/01
-
備考：
-
参照：
- No.： 15
-
文献情報：
Yanagita M et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Invest. 2002 Jul;110(2):239-46
Yanagita M et al
2002/01/01
-
備考：
-
参照：
- No.： 16
-
文献情報：
Saji Y et al. Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J. Hepatol. 2004 Oct;41(4):545-50
Saji Y et al
2004/01/01
-
備考：
-
参照：
- No.： 17
-
文献情報：
Peng H et al. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun 2017 11;8(1):1493
Peng H et al
2017/01/01
-
備考：
-
参照：
- No.： 18
-
文献情報：
Andres-Hernando A et al. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice. Nat Commun 2017 02;8:14181
Andres-Hernando A et al
2017/01/01
-
備考：
-
参照：
- No.： 19
-
文献情報：
Song A et al. Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. Nat Commun 2017 02;8:14108
Song A et al
2017/01/01
-
備考：
-
参照：
- No.： 20
-
文献情報：
Bai X et al. The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension. Nat Commun 2013;4:2910
Bai X et al
2013/01/01
-
備考：
-
参照：
- No.： 21
-
文献情報：
Carota IA et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury. J. Exp. Med. 2019 04;216(4):936-949
Carota IA et al
2019/01/01
-
備考：
-
参照：
- No.： 22
-
文献情報：
Li F et al. Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia. Proc. Natl. Acad. Sci. U.S.A. 2016 11;113(47):13450-13455
Li F et al
2016/01/01
-
備考：
-
参照：
- No.： 23
-
文献情報：
Wang CH et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc. Natl. Acad. Sci. U.S.A. 2011 Feb;108(5):2070-5
Wang CH et al
2011/01/01
-
備考：
-
参照：
- No.： 24
-
文献情報：
Kakoki M et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(22):10190-5
Kakoki M et al
2010/01/01
-
備考：
-
参照：
- No.： 25
-
文献情報：
Kakoki M et al. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc. Natl. Acad. Sci. U.S.A. 2004 Sep;101(36):13302-5
Kakoki M et al
2004/01/01
-
備考：
-
参照：
- No.： 26
-
文献情報：
Ziyadeh FN et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl. Acad. Sci
Ziyadeh FN et al
2000/01/01
-
備考：
-
参照：
- No.： 27
-
文献情報：
Lindblom P et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 2003 Aug;17(15):1835-40
Lindblom P et al
2003/01/01
-
備考：
-
参照：
- No.： 28
-
文献情報：
Eriguchi M et al. The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2018 10;29(10):2546-2561
Eriguchi M et al
2018/01/01
-
備考：
-
参照：
- No.： 29
-
文献情報：
Zimmerman SE et al. Nephronectin Regulates Mesangial Cell Adhesion and Behavior in Glomeruli. J. Am. Soc. Nephrol. 2018 04;29(4):1128-1140
Zimmerman SE et al
2018/01/01
-
備考：
-
参照：
- No.： 30
-
文献情報：
Zhang MZ et al. Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model. J. Am. Soc. Nephrol. 2017 Nov;28(11):3300-3311
Zhang MZ et al
2017/01/01
-
備考：
-
参照：
- No.： 31
-
文献情報：
Lichtnekert J et al. Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage. J. Am. Soc. Nephrol. 2016 Dec;27(12):3611-3627
Lichtnekert J et al
2016/01/01
-
備考：
-
参照：
- No.： 32
-
文献情報：
Ayanga BA et al. Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 09;27(9):2733-47
Ayanga BA et al
2016/01/01
-
備考：
-
参照：
- No.： 33
-
文献情報：
Takaori K et al. Severity and Frequency of Proximal Tubule Injury Determines Renal Prognosis. J. Am. Soc. Nephrol. 2016 08;27(8):2393-406
Takaori K et al
2016/01/01
-
備考：
-
参照：
- No.： 34
-
文献情報：
Zhou X et al. Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. J. Am. Soc. Nephrol. 2016 06;27(6):1765-76
Zhou X et al
2016/01/01
-
備考：
-
参照：
- No.： 35
-
文献情報：
Gagliardini E et al. B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 Apr;27(4):999-1005
Gagliardini E et al
2016/01/01
-
備考：
-
参照：
- No.： 36
-
文献情報：
Erpenbeck L et al. ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy. J. Am. Soc. Nephrol. 2016 Jan;27(1):120-31
Erpenbeck L et al
2016/01/01
-
備考：
-
参照：
- No.： 37
-
文献情報：
Fukuda R et al. Podocyte p53 Limits the Severity of Experimental Alport Syndrome. J. Am. Soc. Nephrol. 2016 Jan;27(1):144-57
Fukuda R et al
2016/01/01
-
備考：
-
参照：
- No.： 38
-
文献情報：
Li SY et al. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2015 Dec;26(12):3072-84
Li SY et al
2015/01/01
-
備考：
-
参照：
- No.： 39
-
文献情報：
Lazzeri E et al. Human Urine-Derived Renal Progenitors for Personalized Modeling of Genetic Kidney Disorders. J. Am. Soc. Nephrol. 2015 Aug;26(8):1961-74
Lazzeri E et al
2015/01/01
-
備考：
-
参照：
- No.： 40
-
文献情報：
Xavier S et al. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J. Am. Soc. Nephrol. 2015 Apr;26(4):817-29
Xavier S et al
2015/01/01
-
備考：
-
参照：
- No.： 41
-
文献情報：
Kawakami T et al. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS. J. Am. Soc. Nephrol. 2015 May;26(5):1040-52
Kawakami T et al
2015/01/01
-
備考：
-
参照：
- No.： 42
-
文献情報：
Morito N et al. Overexpression of Mafb in podocytes protects against diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Nov;25(11):2546-57
Morito N et al
2014/01/01
-
備考：
-
参照：
- No.： 43
-
文献情報：
Locatelli M et al. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J. Am. Soc. Nephrol. 2014 Aug;25(8):1786-98
Locatelli M et al
2014/01/01
-
備考：
-
参照：
- No.： 44
-
文献情報：
Tak E et al. CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Mar;25(3):547-63
Tak E et al
2014/01/01
-
備考：
-
参照：
- No.： 45
-
文献情報：
Peired A et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J. Am. Soc. Nephrol. 2013 Nov;24(11):1756-68
Peired A et al
2013/01/01
-
備考：
-
参照：
- No.： 46
-
文献情報：
Kidokoro K et al. Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy. J. Am. Soc. Nephrol. 2013 Jun;24(7):1139-50
Kidokoro K et al
2013/01/01
-
備考：
-
参照：
- No.： 47
-
文献情報：
Rutkowski JM et al. Adiponectin promotes functional recovery after podocyte ablation. J. Am. Soc. Nephrol. 2013 Feb;24(2):268-82
Rutkowski JM et al
2013/01/01
-
備考：
-
参照：
- No.： 48
-
文献情報：
Ogawa Y et al. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J. Am. Soc. Nephrol. 2012 Jul;23(7):1198-209
Ogawa Y et al
2012/01/01
-
備考：
-
参照：
- No.： 49
-
文献情報：
Yi X et al. Reduced expression of lipoic acid synthase accelerates diabetic nephropathy. J. Am. Soc. Nephrol. 2012 Jan;23(1):103-11
Yi X et al
2012/01/01
-
備考：
-
参照：
- No.： 50
-
文献情報：
Iyoda M et al. Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2009 Jan;20(1):68-77
Iyoda M et al
2009/01/01
-
備考：
-
参照：
- No.： 51
-
文献情報：
Suzuki H et al. Toll-like receptor 9 affects severity of IgA nephropathy. J. Am. Soc. Nephrol. 2008 Dec;19(12):2384-95
Suzuki H et al
2008/01/01
-
備考：
-
参照：
- No.： 52
-
文献情報：
Yuzawa Y et al. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J. Am. Soc. Nephrol. 2008 Sep;19(9):1701-11
Yuzawa Y et al
2008/01/01
-
備考：
-
参照：
- No.： 53
-
文献情報：
Wilkinson L et al. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development. J. Am. Soc. Nephrol. 2007 Jun;18(6):1697-708
Wilkinson L et al
2007/01/01
-
備考：
-
参照：
- No.： 54
-
文献情報：
Meier M et al. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J. Am. Soc. Nephrol. 2007 Apr;18(4):1190-8
Meier M et al
2007/01/01
-
備考：
-
参照：
- No.： 55
-
文献情報：
Nakagawa T et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 2007 Feb;18(2):539-50
Nakagawa T et al
2007/01/01
-
備考：
-
参照：
- No.： 56
-
文献情報：
Peltier J et al. Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice. J. Am. Soc. Nephrol. 2006 Dec;17(12):3415-23
Peltier J et al
2006/01/01
-
備考：
-
参照：
- No.： 57
-
文献情報：
Wang L et al. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. J. Am. Soc. Nephrol. 2005 Dec;16(12):3611-22
Wang L et al
2005/01/01
-
備考：
-
参照：
- No.： 58
-
文献情報：
Suzuki H et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J. Am. Soc. Nephrol. 2005 May;16(5):1289-99
Suzuki H et al
2005/01/01
-
備考：
-
参照：
- No.： 59
-
文献情報：
Takahashi N et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J. Am. Soc. Nephrol. 2005 Jan;16(1):125-32
Takahashi N et al
2005/01/01
-
備考：
-
参照：
- No.： 60
-
文献情報：
Suganami T et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J. Am. Soc. Nephrol. 2001 Dec;12(12):2652-63
Suganami T et al
2001/01/01
-
備考：
-
参照：
- No.： 61
-
文献情報：
Kasahara M et al. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J. Am. Soc. Nephrol. 2000 Sep;11(9):1691-701
Kasahara M et al
2000/01/01
-
備考：
-
参照：
- No.： 62
-
文献情報：
Denhez B et al. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy. Diabetes 2019 05;68(5):1026-1039
Denhez B et al
2019/01/01
-
備考：
-
参照：
- No.： 63
-
文献情報：
Kruger C et al. Proximal Tubular Cell-Specific Ablation of Carnitine Acetyltransferase Causes Tubular Disease and Secondary Glomerulosclerosis. Diabetes 2019 04;68(4):819-831
Kruger C et al
2019/01/01
-
備考：
-
参照：
- No.： 64
-
文献情報：
Cassis P et al. ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental Diabetes. Diabetes 2018 10;67(10):2069-2083
Cassis P et al
2018/01/01
-
備考：
-
参照：
- No.： 65
-
文献情報：
Li Z et al. Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes. Diabetes 2018 09;67(9):1847-1857
Li Z et al
2018/01/01
-
備考：
-
参照：
- No.： 66
-
文献情報：
Sun SF et al. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in <i>db/db</i> Mice by Targeting miR-29b. Diabetes 2018 04;67(4):731-744
Sun SF et al
2018/01/01
-
備考：
-
参照：
- No.： 67
-
文献情報：
Dogn辿 S et al. Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes. Diabetes 2016 09;65(9):2742-53
Dogn辿 S et al
2016/01/01
-
備考：
-
参照：
- No.： 68
-
文献情報：
Kaida Y et al. DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy. Diabetes 2013 Sep;62(9):3241-50
Kaida Y et al
2013/01/01
-
備考：
-
参照：
- No.： 69
-
文献情報：
Menne J et al. Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. Diabetes 2013 Apr;62(4):1167-74
Menne J et al
2013/01/01
-
備考：
-
参照：
- No.： 70
-
文献情報：
Zhang MZ et al. Intrarenal dopamine inhibits progression of diabetic nephropathy. Diabetes 2012 Oct;61(10):2575-84
Zhang MZ et al
2012/01/01
-
備考：
-
参照：
- No.： 71
-
文献情報：
Cha DR et al. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes 2007 Aug;56(8):2036-45
Cha DR et al
2007/01/01
-
備考：
-
参照：
- No.： 72
-
文献情報：
Ohshiro Y et al. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 2006 Nov;55(11):3112-20
Ohshiro Y et al
2006/01/01
-
備考：
-
参照：
- No.： 73
-
文献情報：
Shibuya K et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 2005 Mar;54(3):838-45
Shibuya K et al
2005/01/01
-
備考：
-
参照：
- No.： 74
-
文献情報：
Zhang H et al. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice. Kidney Int. 2017 10;92(4):909-921
Zhang H et al
2017/01/01
-
備考：
-
参照：
- No.： 75
-
文献情報：
Bae EH et al. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney Int. 2017 06;91(6):1347-1361
Bae EH et al
2017/01/01
-
備考：
-
参照：
- No.： 76
-
文献情報：
Klemis V et al. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney Int. 2017 06;91(6):1374-1385
Klemis V et al
2017/01/01
-
備考：
-
参照：
- No.： 77
-
文献情報：
Wnuk M et al. Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney. Kidney Int. 2017 04;91(4):868-879
Wnuk M et al
2017/01/01
-
備考：
-
参照：
- No.： 78
-
文献情報：
Giani JF et al. Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity. Kidney Int. 2017 04;91(4):856-867
Giani JF et al
2017/01/01
-
備考：
-
参照：
- No.： 79
-
文献情報：
He X et al. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney Int. 2017 03;91(3):642-657
He X et al
2017/01/01
-
備考：
-
参照：
- No.： 80
-
文献情報：
Baumann B et al. Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney Int. 2016 10;90(4):797-808
Baumann B et al
2016/01/01
-
備考：
-
参照：
- No.： 81
-
文献情報：
Souza AC et al. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int. 2016 Apr;89(4):809-22
Souza AC et al
2016/01/01
-
備考：
-
参照：
- No.： 82
-
文献情報：
Zhang A et al. Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int. 2011 Jul;80(1):51-60
Zhang A et al
2011/01/01
-
備考：
-
参照：
- No.： 83
-
文献情報：
Tanaka Y et al. Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int. 2011 Apr;79(8):871-82
Tanaka Y et al
2011/01/01
-
備考：
-
参照：
- No.： 84
-
文献情報：
Ren S et al. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int. 2009 Oct;76(8):857-67
Ren S et al
2009/01/01
-
備考：
-
参照：
- No.： 85
-
文献情報：
Bodin S et al. Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int. 2009 Aug;76(4):395-403
Bodin S et al
2009/01/01
-
備考：
-
参照：
- No.： 86
-
文献情報：
Kuwabara T et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009 Feb;75(3):285-94
Kuwabara T et al
2009/01/01
-
備考：
-
参照：
- No.： 87
-
文献情報：
Chen S et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int. 2008 Aug;74(3):289-99
Chen S et al
2008/01/01
-
備考：
-
参照：
- No.： 88
-
文献情報：
Yokoi H et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 2008 Feb;73(4):446-55
Yokoi H et al
2008/01/01
-
備考：
-
参照：
- No.： 89
-
文献情報：
Tapia R et al. Semaphorin3a disrupts podocyte foot processes causing acute proteinuria. Kidney Int. 2008 Mar;73(6):733-40
Tapia R et al
2008/01/01
-
備考：
-
参照：
- No.： 90
-
文献情報：
Suzuki H et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 2007 Aug;72(3):319-27
Suzuki H et al
2007/01/01
-
備考：
-
参照：
- No.： 91
-
文献情報：
Brodeur AC et al. Type I collagen glomerulopathy: postnatal collagen deposition follows glomerular maturation. Kidney Int. 2007 May;71(10):985-93
Brodeur AC et al
2007/01/01
-
備考：
-
参照：
- No.： 92
-
文献情報：
Brezniceanu ML et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 2007 May;71(9):912-23
Brezniceanu ML et al
2007/01/01
-
備考：
-
参照：
- No.： 93
-
文献情報：
Jiang T et al. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int. 2005 Dec;68(6):2608-20
Jiang T et al
2005/01/01
-
備考：
-
参照：
- No.： 94
-
文献情報：
Mishra R et al. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int. 2005 Jan;67(1):82-93
Mishra R et al
2005/01/01
-
備考：
-
参照：
- No.： 95
-
文献情報：
Fan Q et al. Gene expression profile in diabetic KK/Ta mice. Kidney Int. 2003 Dec;64(6):1978-85
Fan Q et al
2003/01/01
-
備考：
-
参照：
- No.： 96
-
文献情報：
Hishikawa A et al. Decreased KAT5 Expression Impairs DNA Repair and Induces Altered DNA Methylation in Kidney Podocytes. Cell Rep 2019 Jan;26(5):1318-1332.e4
Hishikawa A et al
2019/01/01
-
備考：
-
参照：
- No.： 97
-
文献情報：
Fan X et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2012 Jul;2(1):52-61
Fan X et al
2012/01/01
-
備考：
-
参照：
- No.： 98
-
文献情報：
Li G et al. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J. Cell Biol. 2010 Dec;191(6):1113-25
Li G et al
2010/01/01
-
備考：
-
参照：
- No.： 99
-
文献情報：
Sachs N et al. Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 2006 Oct;175(1):33-9
Sachs N et al
2006/01/01
-
備考：
-
参照：
- No.： 100
-
文献情報：
Wang JH et al. Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice. Arthritis Rheum. 2013 Oct;65(10):2703-12
Wang JH et al
2013/01/01
-
備考：
-
参照：
- No.： 101
-
文献情報：
Hsu HC et al. Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum. 2011 Jul;63(7):2038-48
Hsu HC et al
2011/01/01
-
備考：
-
参照：
- No.： 102
-
文献情報：
Wang JH et al. Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice. Arthritis Rheum. 2011 Apr;63(4):1054-64
Wang JH et al
2011/01/01
-
備考：
-
参照：
- No.： 103
-
文献情報：
Hsu HC et al. Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum. 2006 Jan;54(1):343-55
Hsu HC et al
2006/01/01
-
備考：
-
参照：
- No.： 104
-
文献情報：
Clark KL et al. Epidermal injury promotes nephritis flare in lupus-prone mice. J. Autoimmun. 2015 Dec;65:38-48
Clark KL et al
2015/01/01
-
備考：
-
参照：
- No.： 105
-
文献情報：
Segerer S et al. Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am. J. Kidney Dis. 2002 Apr;39(4):876-88
Segerer S et al
2002/01/01
-
備考：
-
参照：
- No.： 106
-
文献情報：
Nastase MV et al. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 2018 08;68-69:293-317
Nastase MV et al
2018/01/01
-
備考：
-
参照：
- No.： 107
-
文献情報：
Kahlenberg JM et al. An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheumatol 2014 Jan;66(1):152-62
Kahlenberg JM et al
2014/01/01
-
備考：
-
参照：
- No.： 108
-
文献情報：
Li F et al. Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice. Hypertension 2018 05;71(5):894-903
Li F et al
2018/01/01
-
備考：
-
参照：
- No.： 109
-
文献情報：
He B et al. TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia. Hypertension 2018 04;71(4)
He B et al
2018/01/01
-
備考：
-
参照：
- No.： 110
-
文献情報：
Liu Z et al. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation. Hypertension 2017 10;70(4):822-830
Liu Z et al
2017/01/01
-
備考：
-
参照：
- No.： 111
-
文献情報：
Norlander AE et al. Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension. Hypertension 2016 07;68(1):167-74
Norlander AE et al
2016/01/01
-
備考：
-
参照：
- No.： 112
-
文献情報：
Hyndman KA et al. Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure. Hypertension 2013 07;62(1):91-8
Hyndman KA et al
2013/01/01
-
備考：
-
参照：
- No.： 113
-
文献情報：
Lai EY et al. Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass. Hypertension 2010 Apr;55(4):983-9
Lai EY et al
2010/01/01
-
備考：
-
参照：
- No.： 114
-
文献情報：
Jia Z et al. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 2010 Feb;55(2):539-46
Jia Z et al
2010/01/01
-
備考：
-
参照：
- No.： 115
-
文献情報：
Facemire CS et al. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. Hypertension 2010 Feb;55(2):531-8
Facemire CS et al
2010/01/01
-
備考：
-
参照：
- No.： 116
-
文献情報：
Crowley SD et al. A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension. Hypertension 2010 Jan;55(1):99-108
Crowley SD et al
2010/01/01
-
備考：
-
参照：
- No.： 117
-
文献情報：
Suzuki H et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension 2009 Nov;54(5):1129-35
Suzuki H et al
2009/01/01
-
備考：
-
参照：
- No.： 118
-
文献情報：
Wang Y et al. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension 2008 Aug;52(2):264-70
Wang Y et al
2008/01/01
-
備考：
-
参照：
- No.： 119
-
文献情報：
Bowers MC et al. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension 2005 Jul;46(1):51-7
Bowers MC et al
2005/01/01
-
備考：
-
参照：
- No.： 120
-
文献情報：
Supowit SC et al. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension 2005 Jan;45(1):109-14
Supowit SC et al
2005/01/01
-
備考：
-
参照：
- No.： 121
-
文献情報：
Russo L et al. Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene. Mol Metab 2018 03;9:98-113
Russo L et al
2018/01/01
-
備考：
-
参照：
- No.： 122
-
文献情報：
Chen HY et al. MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol. Ther. 2014 Apr;22(4):842-53
Chen HY et al
2014/01/01
-
備考：
-
参照：
- No.： 123
-
文献情報：
Ohashi K et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vasc. Biol. 2007 Sep;27(9):1910-7
Ohashi K et al
2007/01/01
-
備考：
-
参照：
- No.： 124
-
文献情報：
Holterman CE et al. Podocyte NADPH Oxidase 5 Promotes Renal Inflammation Regulated by the Toll-Like Receptor Pathway. Antioxid. Redox Signal. 2019 05;30(15):1817-1830
Holterman CE et al
2019/01/01
-
備考：
-
参照：
- No.： 125
-
文献情報：
Yuan H et al. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy. Antioxid. Redox Signal. 2016 Mar;24(7):361-75
Yuan H et al
2016/01/01
-
備考：
-
参照：
- No.： 126
-
文献情報：
Lee WJ et al. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy. Antioxid. Redox Signal. 2016 Feb;24(4):217-231
Lee WJ et al
2016/01/01
-
備考：
-
参照：
- No.： 127
-
文献情報：
Han JH et al. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE <sup>-/-</sup> mice fed a western diet. Diabetologia 2017 02;60(2):364-376
Han JH et al
2017/01/01
-
備考：
-
参照：
- No.： 128
-
文献情報：
Kuwabara T et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 2012 Aug;55(8):2256-66
Kuwabara T et al
2012/01/01
-
備考：
-
参照：
- No.： 129
-
文献情報：
Ka SM et al. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia 2012 Feb;55(2):509-19
Ka SM et al
2012/01/01
-
備考：
-
参照：
- No.： 130
-
文献情報：
Zhou T et al. Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 2012 Jan;55(1):255-66
Zhou T et al
2012/01/01
-
備考：
-
参照：
- No.： 131
-
文献情報：
Liu F et al. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia 2011 Oct;54(10):2713-23
Liu F et al
2011/01/01
-
備考：
-
参照：
- No.： 132
-
文献情報：
Makino H et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia 2006 Oct;49(10):2514-24
Makino H et al
2006/01/01
-
備考：
-
参照：
- No.： 133
-
文献情報：
Ishii H et al. Recombinant annexin-2 inhibits the progress of diabetic nephropathy in a diabetic mouse model via recovery of hypercoagulability. Thromb. Haemost. 2007 Jan;97(1):124-8
Ishii H et al
2007/01/01
-
備考：
-
参照：
- No.： 134
-
文献情報：
Ka SM et al. A low toxicity synthetic cinnamaldehyde derivative ameliorates renal inflammation in mice by inhibiting NLRP3 inflammasome and its related signaling pathways. Free Radic. Biol. Med. 2016 Feb;91:10-24
Ka SM et al
2016/01/01
-
備考：
-
参照：
- No.： 135
-
文献情報：
Hisamichi M et al. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension. FASEB J. 2017 01;31(1):72-84
Hisamichi M et al
2017/01/01
-
備考：
-
参照：
- No.： 136
-
文献情報：
Xu Y et al. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J. 2010 Feb;24(2):609-16
Xu Y et al
2010/01/01
-
備考：
-
参照：
- No.： 137
-
文献情報：
Arakawa K et al. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br. J. Pharmacol. 2001 Jan;132(2):578-86
Arakawa K et al
2001/01/01
-
備考：
-
参照：
- No.： 138
-
文献情報：
Yates LL et al. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation. Hum. Mol. Genet. 2010 Dec;19(23):4663-76
Yates LL et al
2010/01/01
-
備考：
-
参照：
- No.： 139
-
文献情報：
Wang B et al. Overexpressed cyclophilin B suppresses aldosterone-induced proximal tubular cell injury both in vitro and in vivo. Oncotarget 2016 10;7(43):69309-69320
Wang B et al
2016/01/01
-
備考：
-
参照：
- No.： 140
-
文献情報：
Zhao M et al. PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria. Oncotarget 2016 Mar;7(11):12150-62
Zhao M et al
2016/01/01
-
備考：
-
参照：
- No.： 141
-
文献情報：
Meng XM et al. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin. Oncotarget 2015 Nov;6(35):36984-97
Meng XM et al
2015/01/01
-
備考：
-
参照：
- No.： 142
-
文献情報：
Zhang Q et al. Activation of the Nrf2-ARE Pathway Ameliorates Hyperglycemia-Mediated Mitochondrial Dysfunction in Podocytes Partly Through Sirt1. Cell. Physiol. Biochem. 2018;48(1):1-15
Zhang Q et al
2018/01/01
-
備考：
-
参照：
- No.： 143
-
文献情報：
Bonnemaison ML et al. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice. Clin. Sci. 2019 01;133(2):167-180
Bonnemaison ML et al
2019/01/01
-
備考：
-
参照：
- No.： 144
-
文献情報：
Wei X et al. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension. Clin. Sci. 2017 Apr;131(7):567-581
Wei X et al
2017/01/01
-
備考：
-
参照：
- No.： 145
-
文献情報：
Kim EN et al. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging (Albany NY) 2018 01;10(1):83-99
Kim EN et al
2018/01/01
-
備考：
-
参照：
- No.： 146
-
文献情報：
Zhao L et al. High-salt diet induces outward remodelling of efferent arterioles in mice with reduced renal mass. Acta Physiol (Oxf) 2017 03;219(3):652-659
Zhao L et al
2017/01/01
-
備考：
-
参照：
- No.： 147
-
文献情報：
Nagasu H et al. Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice. Lab. Invest. 2016 Jan;96(1):25-36
Nagasu H et al
2016/01/01
-
備考：
-
参照：
- No.： 148
-
文献情報：
Burnworth B et al. SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab. Invest. 2012 Apr;92(4):499-510
Burnworth B et al
2012/01/01
-
備考：
-
参照：
- No.： 149
-
文献情報：
Du SW et al. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells. J. Immunol. 2018 12;201(11):3258-3268
Du SW et al
2018/01/01
-
備考：
-
参照：
- No.： 150
-
文献情報：
Wolf SJ et al. TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling. J. Immunol. 2018 07;201(2):393-405
Wolf SJ et al
2018/01/01
-
備考：
-
参照：
- No.： 151
-
文献情報：
Fujita Y et al. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J. Immunol. 2014 Feb;192(3):979-84
Fujita Y et al
2014/01/01
-
備考：
-
参照：
- No.： 152
-
文献情報：
Ding Y et al. IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells. J. Immunol. 2013 Aug;191(4):1614-24
Ding Y et al
2013/01/01
-
備考：
-
参照：
- No.： 153
-
文献情報：
Anders HJ et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J. Immunol. 2003 Jun;170(11):5658-66
Anders HJ et al
2003/01/01
-
備考：
-
参照：
- No.： 154
-
文献情報：
Kawahata K et al. Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self. J. Immunol. 1999 Jun;162(11):6482-91
Kawahata K et al
1999/01/01
-
備考：
-
参照：
- No.： 155
-
文献情報：
Grove KJ et al. Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J. Lipid Res. 2014 07;55(7):1375-85
Grove KJ et al
2014/01/01
-
備考：
-
参照：
- No.： 156
-
文献情報：
Buga GM et al. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J. Lipid Res. 2008 Jan;49(1):192-205
Buga GM et al
2008/01/01
-
備考：
-
参照：
- No.： 157
-
文献情報：
Lin Y et al. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. J. Endocrinol. 2011 May;209(2):185-91
Lin Y et al
2011/01/01
-
備考：
-
参照：
- No.： 158
-
文献情報：
Carlson RP et al. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases. Ann. N. Y. Acad. Sci. 1993 Jun;685:86-113
Carlson RP et al
1993/01/01
-
備考：
-
参照：
- No.： 159
-
文献情報：
He T et al. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway. J. Mol. Med. 2016 12;94(12):1359-1371
He T et al
2016/01/01
-
備考：
-
参照：
- No.： 160
-
文献情報：
Tak E et al. Protective role for netrin-1 during diabetic nephropathy. J. Mol. Med. 2013 Sep;91(9):1071-80
Tak E et al
2013/01/01
-
備考：
-
参照：
- No.： 161
-
文献情報：
Stelloh C et al. Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res 2012 Feb;159(2):80-9
Stelloh C et al
2012/01/01
-
備考：
-
参照：
- No.： 162
-
文献情報：
Yu J et al. MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy. Oxid Med Cell Longev 2016;2016:7496930
Yu J et al
2016/01/01
-
備考：
-
参照：
- No.： 163
-
文献情報：
Laping NJ et al. Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells. Biochem. Pharmacol. 2000 Apr;59(7):847-53
Laping NJ et al
2000/01/01
-
備考：
-
参照：
- No.： 164
-
文献情報：
Mozaffari MS et al. Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage. J. Nutr. Biochem. 2012 Aug;23(8):977-85
Mozaffari MS et al
2012/01/01
-
備考：
-
参照：
- No.： 165
-
文献情報：
Soni H et al. γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling. J. Cell. Mol. Med. 2019 01;23(1):260-270
Soni H et al
2019/01/01
-
備考：
-
参照：
- No.： 166
-
文献情報：
Mortuza R et al. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1. J. Cell. Mol. Med. 2015 Aug;19(8):1857-67
Mortuza R et al
2015/01/01
-
備考：
-
参照：
- No.： 167
-
文献情報：
Huang C et al. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrol. Dial. Transplant. 2014 Feb;29(2):313-24
Huang C et al
2014/01/01
-
備考：
-
参照：
- No.： 168
-
文献情報：
Seok SJ et al. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol. Dial. Transplant. 2013 Jul;28(7):1700-10
Seok SJ et al
2013/01/01
-
備考：
-
参照：
- No.： 169
-
文献情報：
Nakata J et al. Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs. Nephrol. Dial. Transplant. 2013 Feb;28(2):320-6
Nakata J et al
2013/01/01
-
備考：
-
参照：
- No.： 170
-
文献情報：
Takamiya Y et al. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice. Nephrol. Dial. Transplant. 2012 Sep;
Takamiya Y et al
2012/01/01
-
備考：
-
参照：
- No.： 171
-
文献情報：
Park JK et al. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Nephrol. Dial. Transplant. 2008 Jun;23(6):1844-53
Park JK et al
2008/01/01
-
備考：
-
参照：
- No.： 172
-
文献情報：
Lee S et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol. Dial. Transplant. 2007 Feb;22(2):396-408
Lee S et al
2007/01/01
-
備考：
-
参照：
- No.： 173
-
文献情報：
Schadde E et al. Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol. Dial. Transplant. 2000 Jul;15(7):1046-53
Schadde E et al
2000/01/01
-
備考：
-
参照：
- No.： 174
-
文献情報：
Arimura E et al. Deteriorated glucose metabolism with a high-protein, low-carbohydrate diet in db mice, an animal model of type 2 diabetes, might be caused by insufficient insulin secretion. Eur J Nutr 2017 Feb;56(1):237-246
Arimura E et al
2017/01/01
-
備考：
-
参照：
- No.： 175
-
文献情報：
Arimura E et al. Low-protein diet improves blood and urinary glucose levels and renal manifestations of diabetes in C57BLKS-db/db mice. Eur J Nutr 2013 Mar;52(2):813-24
Arimura E et al
2013/01/01
-
備考：
-
参照：
- No.： 176
-
文献情報：
Chao CY et al. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 2010 Mar;54(3):388-95
Chao CY et al
2010/01/01
-
備考：
-
参照：
- No.： 177
-
文献情報：
Lin CC et al. Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice. Mol Nutr Food Res 2008 Nov;52(11):1358-64
Lin CC et al
2008/01/01
-
備考：
-
参照：
- No.： 178
-
文献情報：
Van Krieken R et al. Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice. Endocrinology 2018 03;159(3):1479-1495
Van Krieken R et al
2018/01/01
-
備考：
-
参照：
- No.： 179
-
文献情報：
Luo J et al. FSP-1 Impairs the Function of Endothelium Leading to Failure of Arteriovenous Grafts in Diabetic Mice. Endocrinology 2015 Jun;156(6):2200-10
Luo J et al
2015/01/01
-
備考：
-
参照：
- No.： 180
-
文献情報：
Lin Y et al. Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology 2013 Oct;154(10):3855-63
Lin Y et al
2013/01/01
-
備考：
-
参照：
- No.： 181
-
文献情報：
Wang Y et al. Role of substance P in renal injury during DOCA-salt hypertension. Endocrinology 2012 Dec;153(12):5972-9
Wang Y et al
2012/01/01
-
備考：
-
参照：
- No.： 182
-
文献情報：
Kawamura M et al. Undernutrition in utero augments systolic blood pressure and cardiac remodeling in adult mouse offspring: possible involvement of local cardiac angiotensin system in developmental origins of cardiovascular disease. Endocrinology 2007 Mar
Kawamura M et al
2007/01/01
-
備考：
-
参照：
- No.： 183
-
文献情報：
Saritas T et al. Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis. Sci Rep 2019 03;9(1):4596
Saritas T et al
2019/01/01
-
備考：
-
参照：
- No.： 184
-
文献情報：
Oe Y et al. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep 2019 Feb;9(1):2986
Oe Y et al
2019/01/01
-
備考：
-
参照：
- No.： 185
-
文献情報：
Ono H et al. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy. Sci Rep 2018 Jul;8(1):10548
Ono H et al
2018/01/01
-
備考：
-
参照：
- No.： 186
-
文献情報：
Zambrano S et al. FYVE domain-containing protein ZFYVE28 regulates EGFR-signaling in podocytes but is not critical for the function of filtration barrier in mice. Sci Rep 2018 Mar;8(1):4712
Zambrano S et al
2018/01/01
-
備考：
-
参照：
- No.： 187
-
文献情報：
Oe Y et al. Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase. Sci Rep 2018 01;8(1):102
Oe Y et al
2018/01/01
-
備考：
-
参照：
- No.： 188
-
文献情報：
Marks ES et al. Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria. Sci Rep 2017 10;7(1):12821
Marks ES et al
2017/01/01
-
備考：
-
参照：
- No.： 189
-
文献情報：
Walton SL et al. Prenatal hypoxia leads to hypertension, renal renin-angiotensin system activation and exacerbates salt-induced pathology in a sex-specific manner. Sci Rep 2017 Aug;7(1):8241
Walton SL et al
2017/01/01
-
備考：
-
参照：
- No.： 190
-
文献情報：
Kato Y et al. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci Rep 2017 Apr;7:46624
Kato Y et al
2017/01/01
-
備考：
-
参照：
- No.： 191
-
文献情報：
Rao J et al. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells. Sci Rep 2017 01;7:39727
Rao J et al
2017/01/01
-
備考：
-
参照：
- No.： 192
-
文献情報：
Futatsugi K et al. Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules. Sci Rep 2016 Nov;6:36533
Futatsugi K et al
2016/01/01
-
備考：
-
参照：
- No.： 193
-
文献情報：
Wang X et al. Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions. Sci Rep 2016 08;6:31506
Wang X et al
2016/01/01
-
備考：
-
参照：
- No.： 194
-
文献情報：
Araki M et al. Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis. Sci Rep 2016 Aug;6:31216
Araki M et al
2016/01/01
-
備考：
-
参照：
- No.： 195
-
文献情報：
Morigi M et al. A previously unrecognized role of C3a in proteinuric progressive nephropathy. Sci Rep 2016 06;6:28445
Morigi M et al
2016/01/01
-
備考：
-
参照：
- No.： 196
-
文献情報：
Glastras SJ et al. Maternal Obesity Promotes Diabetic Nephropathy in Rodent Offspring. Sci Rep 2016 06;6:27769
Glastras SJ et al
2016/01/01
-
備考：
-
参照：
- No.： 197
-
文献情報：
Ohno S et al. Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure. Sci Rep 2016 Jun;6:27192
Ohno S et al
2016/01/01
-
備考：
-
参照：
- No.： 198
-
文献情報：
Rosenquist TA et al. Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse. Drug Metab. Dispos. 2010 May;38(5):761-8
Rosenquist TA et al
2010/01/01
-
備考：
-
参照：
- No.： 199
-
文献情報：
Yi X et al. Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice. Atherosclerosis 2012 Jul;223(1):137-43
Yi X et al
2012/01/01
-
備考：
-
参照：
- No.： 200
-
文献情報：
Guo J et al. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome. Hum. Gene Ther. 2019 07;30(7):865-881
Guo J et al
2019/01/01
-
備考：
-
参照：
- No.： 201
-
文献情報：
Teixeira SR et al. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J. Nutr. 2003 Mar;133(3):673-8
Teixeira SR et al
2003/01/01
-
備考：
-
参照：
- No.： 202
-
文献情報：
Tamaki M et al. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element. Am. J. Physiol. Endocrinol. Metab. 2019 03;316(3):E418-E431
Tamaki M et al
2019/01/01
-
備考：
-
参照：
- No.： 203
-
文献情報：
Thomas AA et al. ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications. Am. J. Physiol. Endocrinol. Metab. 2018 03;314(3):E191-E200
Thomas AA et al
2018/01/01
-
備考：
-
参照：
- No.： 204
-
文献情報：
Wu D et al. A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2016 Feb;310(3):E225-37
Wu D et al
2016/01/01
-
備考：
-
参照：
- No.： 205
-
文献情報：
Li C et al. High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. Am. J. Physiol. Endocrinol. Metab. 2015 Nov;309(9):E802-10
Li C et al
2015/01/01
-
備考：
-
参照：
- No.： 206
-
文献情報：
Chen G et al. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am. J. Physiol. Endocrinol. Metab. 2012 Sep;303(5):E563-75
Chen G et al
2012/01/01
-
備考：
-
参照：
- No.： 207
-
文献情報：
Zhang D et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2011 Feb;300(2):E287-95
Zhang D et al
2011/01/01
-
備考：
-
参照：
- No.： 208
-
文献情報：
An X et al. Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression. Front Physiol 2018;9:1195
An X et al
2018/01/01
-
備考：
-
参照：
- No.： 209
-
文献情報：
Song K et al. Loss of mucin-type <i>O</i>-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney. J. Biol. Chem. 2017 10;292(40):16491-16497
Song K et al
2017/01/01
-
備考：
-
参照：
- No.： 210
-
文献情報：
Verma R et al. Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J. Biol. Chem. 2003 Jun;278(23):20716-23
Verma R et al
2003/01/01
-
備考：
-
参照：
- No.： 211
-
文献情報：
Rhaleb NE et al. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice. J. Hypertens. 2011 Feb;29(2):330-8
Rhaleb NE et al
2011/01/01
-
備考：
-
参照：
- No.： 212
-
文献情報：
Inada A et al. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell. Physiol. 2008 May;215(2):383-91
Inada A et al
2008/01/01
-
備考：
-
参照：
- No.： 213
-
文献情報：
Bagavant H et al. Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease. Am. J. Pathol. 2011 Aug;179(2):651-60
Bagavant H et al
2011/01/01
-
備考：
-
参照：
- No.： 214
-
文献情報：
Alikhan MA et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am. J. Pathol. 2011 Sep;179(3):1243-56
Alikhan MA et al
2011/01/01
-
備考：
-
参照：
- No.： 215
-
文献情報：
Thompson J et al. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am. J. Pathol. 2011 Sep;179(3):1179-87
Thompson J et al
2011/01/01
-
備考：
-
参照：
- No.： 216
-
文献情報：
Zhu C et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ. Am. J. Pathol. 2011 May;178(5):2020-31
Zhu C et al
2011/01/01
-
備考：
-
参照：
- No.： 217
-
文献情報：
Veron D et al. Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome. Am. J. Pathol. 2010 Nov;177(5):2225-33
Veron D et al
2010/01/01
-
備考：
-
参照：
- No.： 218
-
文献情報：
Abrass CK et al. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am. J. Pathol. 2010 Feb;176(2):839-49
Abrass CK et al
2010/01/01
-
備考：
-
参照：
- No.： 219
-
文献情報：
Tanaka T et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am. J. Pathol. 2009 Apr;174(4):1203-11
Tanaka T et al
2009/01/01
-
備考：
-
参照：
- No.： 220
-
文献情報：
Wong DW et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 2007 Aug;171(2):438-51
Wong DW et al
2007/01/01
-
備考：
-
参照：
- No.： 221
-
文献情報：
Harvey SJ et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am. J. Pathol. 2007 Jul;171(1):139-52
Harvey SJ et al
2007/01/01
-
備考：
-
参照：
- No.： 222
-
文献情報：
Xu C et al. Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis. Clin. Immunol. 2018 12;197:179-185
Xu C et al
2018/01/01
-
備考：
-
参照：
- No.： 223
-
文献情報：
Inage M et al. Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin. Int. J. Biol. Sci. 2009;5(4):304-10
Inage M et al
2009/01/01
-
備考：
-
参照：
- No.： 224
-
文献情報：
Chen Y et al. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation 2005 May;79(10):1378-85
Chen Y et al
2005/01/01
-
備考：
-
参照：
- No.： 225
-
文献情報：
Schaper M et al. Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis. Infect. Immun. 2003 Jul;71(7):4087-92
Schaper M et al
2003/01/01
-
備考：
-
参照：
- No.： 226
-
文献情報：
Hisamichi M et al. Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury. Hypertens. Res. 2018 Jan;41(1):8-17
Hisamichi M et al
2018/01/01
-
備考：
-
参照：
- No.： 227
-
文献情報：
Wang Y et al. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension. Mol. Med. 2011;17(11-12):1204-12
Wang Y et al
2011/01/01
-
備考：
-
参照：
- No.： 228
-
文献情報：
Yang Y et al. Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice. AAPS J 2017 11;19(6):1791-1803
Yang Y et al
2017/01/01
-
備考：
-
参照：
- No.： 229
-
文献情報：
Lee DL et al. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2006 Mar;290(3):H935-40
Lee DL et al
2006/01/01
-
備考：
-
参照：
- No.： 230
-
文献情報：
Ito Y et al. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Exp. Gerontol. 2005 Apr;40(4):315-23
Ito Y et al
2005/01/01
-
備考：
-
参照：
- No.： 231
-
文献情報：
Ichihara A et al. Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice. J Am Soc Hypertens ;2(5):332-40
Ichihara A et al
-
備考：
-
参照：
- No.： 232
-
文献情報：
Ren X et al. Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-<i>β</i> Signal Pathway. Mediators Inflamm. 2016;2016:5147571
Ren X et al
2016/01/01
-
備考：
-
参照：
- No.： 233
-
文献情報：
Bowman-Colin C et al. The Role of Endocrine System in the Inflammatory Process. Mediators Inflamm. 2016;2016:6081752
Bowman-Colin C et al
2016/01/01
-
備考：
-
参照：
- No.： 234
-
文献情報：
Guo H et al. Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury. Mediators Inflamm. 2016;2016:4387031
Guo H et al
2016/01/01
-
備考：
-
参照：
- No.： 235
-
文献情報：
Zhang X et al. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice. Int J Mol Sci 2016 Aug;17(8)
Zhang X et al
2016/01/01
-
備考：
-
参照：
- No.： 236
-
文献情報：
Lin CY et al. Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice. J. Agric. Food Chem. 2011 May;59(9):5117-24
Lin CY et al
2011/01/01
-
備考：
-
参照：
- No.： 237
-
文献情報：
Chen KH et al. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 2011 Mar;190(1):45-53
Chen KH et al
2011/01/01
-
備考：
-
参照：
- No.： 238
-
文献情報：
Wang L et al. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press. Res. 2008;31(2):111-21
Wang L et al
2008/01/01
-
備考：
-
参照：
- No.： 239
-
文献情報：
Manhiani MM et al. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension. Kidney Blood Press. Res. 2007;30(4):195-202
Manhiani MM et al
2007/01/01
-
備考：
-
参照：
- No.： 240
-
文献情報：
Okada H et al. Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes. J Diabetes Investig 2015 Jan;6(1):35-43
Okada H et al
2015/01/01
-
備考：
-
参照：
- No.： 241
-
文献情報：
Engler FA et al. Investigation of the influence of nephropathy on monoclonal antibody disposition: a pharmacokinetic study in a mouse model of diabetic nephropathy. Pharm. Res. 2014 May;31(5):1185-93
Engler FA et al
2014/01/01
-
備考：
-
参照：
- No.： 242
-
文献情報：
Crowley SD et al. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010 Apr;298(4):R1089-97
Crowley SD et al
2010/01/01
-
備考：
-
参照：
- No.： 243
-
文献情報：
Escano CS et al. Renal dopaminergic defect in C57Bl/6J mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Dec;297(6):R1660-9
Escano CS et al
2009/01/01
-
備考：
-
参照：
- No.： 244
-
文献情報：
do Carmo JM et al. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Sep;297(3):R803-12
do Carmo JM et al
2009/01/01
-
備考：
-
参照：
- No.： 245
-
文献情報：
Levine DZ et al. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Apr;290(4):R975-81
Levine DZ et al
2006/01/01
-
備考：
-
参照：
- No.： 246
-
文献情報：
Sakata N et al. Effect of rat-to-mouse bioartificial pancreas xenotransplantation on diabetic renal damage and survival. Pancreas 2006 Apr;32(3):249-57
Sakata N et al
2006/01/01
-
備考：
-
参照：
- No.： 247
-
文献情報：
Wang Z et al. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice. Inflammation 2014 Dec;37(6):2020-9
Wang Z et al
2014/01/01
-
備考：
-
参照：
- No.： 248
-
文献情報：
Song R et al. Prorenin receptor is critical for nephron progenitors. Dev. Biol. 2016 Jan;409(2):382-91
Song R et al
2016/01/01
-
備考：
-
参照：
- No.： 249
-
文献情報：
Zha D et al. Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1. Life Sci. 2019 Mar;221:109-120
Zha D et al
2019/01/01
-
備考：
-
参照：
- No.： 250
-
文献情報：
Kajiyama T et al. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy. Clin. Dev. Immunol. 2011;2011:819646
Kajiyama T et al
2011/01/01
-
備考：
-
参照：
- No.： 251
-
文献情報：
Declèves AÉ et al. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets. Exp. Physiol. 2016 Jan;101(1):193-206
Declèves AÉ et al
2016/01/01
-
備考：
-
参照：
- No.： 252
-
文献情報：
Wang ZH et al. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur. J. Pharmacol. 2010 Feb;628(1-3):255-60
Wang ZH et al
2010/01/01
-
備考：
-
参照：
- No.： 253
-
文献情報：
Katoh M et al. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur. J. Pharmacol. 2000 Jun;398(3):381-7
Katoh M et al
2000/01/01
-
備考：
-
参照：
- No.： 254
-
文献情報：
Sims-Lucas S et al. Augmented and accelerated nephrogenesis in TGF-beta2 heterozygous mutant mice. Pediatr. Res. 2008 Jun;63(6):607-12
Sims-Lucas S et al
2008/01/01
-
備考：
-
参照：
- No.： 255
-
文献情報：
Zhang S et al. Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1-Induced Preeclampsia Phenotype in Mice. G3 (Bethesda) 2018 10;8(10):3377-3382
Zhang S et al
2018/01/01
-
備考：
-
参照：
- No.： 256
-
文献情報：
Verschuren L et al. A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone. BMC Med Genomics 2014 Jun;7:35
Verschuren L et al
2014/01/01
-
備考：
-
参照：
- No.： 257
-
文献情報：
Lee DL et al. Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension. PPAR Res 2011;2011:502631
Lee DL et al
2011/01/01
-
備考：
-
参照：
- No.： 258
-
文献情報：
Dylewski J et al. Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo. PLoS ONE 2019;14(2):e0209732
Dylewski J et al
2019/01/01
-
備考：
-
参照：
- No.： 259
-
文献情報：
Dieter BP et al. Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease. PLoS ONE 2019;14(2):e0211555
Dieter BP et al
2019/01/01
-
備考：
-
参照：
- No.： 260
-
文献情報：
Zheng X et al. Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy. PLoS ONE 2017;12(9):e0185250
Zheng X et al
2017/01/01
-
備考：
-
参照：
- No.： 261
-
文献情報：
Schoemaker MH et al. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. PLoS ONE 2017;12(7):e0180648
Schoemaker MH et al
2017/01/01
-
備考：
-
参照：
- No.： 262
-
文献情報：
Glastras SJ et al. The renal consequences of maternal obesity in offspring are overwhelmed by postnatal high fat diet. PLoS ONE 2017;12(2):e0172644
Glastras SJ et al
2017/01/01
-
備考：
-
参照：
- No.： 263
-
文献情報：
Toffoli B et al. Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. PLoS ONE 2017;12(2):e0171474
Toffoli B et al
2017/01/01
-
備考：
-
参照：
- No.： 264
-
文献情報：
Xu L et al. Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy. PLoS ONE 2016;11(10):e0163208
Xu L et al
2016/01/01
-
備考：
-
参照：
- No.： 265
-
文献情報：
Glastras SJ et al. Mouse Models of Diabetes, Obesity and Related Kidney Disease. PLoS ONE 2016;11(8):e0162131
Glastras SJ et al
2016/01/01
-
備考：
-
参照：
- No.： 266
-
文献情報：
Song K et al. Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury. PLoS ONE 2016;11(7):e0159872
Song K et al
2016/01/01
-
備考：
-
参照：
- No.： 267
-
文献情報：
Kim DH et al. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. PLoS ONE 2016;11(4):e0153965
Kim DH et al
2016/01/01
-
備考：
-
参照：
- No.： 268
-
文献情報：
Ossoli A et al. Lipoprotein X Causes Renal Disease in LCAT Deficiency. PLoS ONE 2016;11(2):e0150083
Ossoli A et al
2016/01/01
-
備考：
-
参照：
- No.： 269
-
文献情報：
Gangadharan Komala M et al. Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin. PLoS ONE 2015;10(10):e0141143
Gangadharan Komala M et al
2015/01/01
-
備考：
-
参照：
- No.： 270
-
文献情報：
Gangadharan Komala M et al. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS ONE 2014;9(11):e108994
Gangadharan Komala M et al
2014/01/01
-
備考：
-
参照：
- No.： 271
-
文献情報：
Jia Z et al. COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes. PLoS ONE 2014;9(7):e93182
Jia Z et al
2014/01/01
-
備考：
-
参照：
- No.： 272
-
文献情報：
Komers R et al. Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment. PLoS ONE 2014;9(5):e96987
Komers R et al
2014/01/01
-
備考：
-
参照：
- No.： 273
-
文献情報：
Aizawa M et al. Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy. PLoS ONE 2014;9(4):e95365
Aizawa M et al
2014/01/01
-
備考：
-
参照：
- No.： 274
-
文献情報：
Hua KF et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway. PLoS ONE 2013;8(10):e77794
Hua KF et al
2013/01/01
-
備考：
-
参照：
- No.： 275
-
文献情報：
James LR et al. Connective tissue growth factor (CTGF) expression modulates response to high glucose. PLoS ONE 2013;8(8):e70441
James LR et al
2013/01/01
-
備考：
-
参照：
- No.： 276
-
文献情報：
Radonjic M et al. Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PLoS ONE 2013;8(2):e56122
Radonjic M et al
2013/01/01
-
備考：
-
参照：
- No.： 277
-
文献情報：
Mortuza R et al. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE 2013;8(1):e54514
Mortuza R et al
2013/01/01
-
備考：
-
参照：
- No.： 278
-
文献情報：
Jaffa MA et al. Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes. PLoS ONE 2012;7(9):e44714
Jaffa MA et al
2012/01/01
-
備考：
-
参照：
- No.： 279
-
文献情報：
Steenhard BM et al. Transgenic expression of human LAMA5 suppresses murine Lama5 mRNA and laminin α5 protein deposition. PLoS ONE 2011;6(9):e23926
Steenhard BM et al
2011/01/01
-
備考：
-
参照：
- No.： 280
-
文献情報：
Li FH et al. The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-κB signaling pathway. Biomed. Pharmacother. 2018 Nov;107:1377-1384
Li FH et al
2018/01/01
-
備考：
-
参照：
- No.： 281
-
文献情報：
Amann K et al. Lack of nidogen-2 increases blood pressure, glomerular and tubulointerstitial damage in DOCA-salt hypertension. Eur. J. Clin. Invest. 2009 Feb;39(2):116-25
Amann K et al
2009/01/01
-
備考：
-
参照：
- No.： 282
-
文献情報：
Xiao T et al. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Mol. Cell. Biochem. 2014 Sep;394(1-2):145-54
Xiao T et al
2014/01/01
-
備考：
-
参照：
- No.： 283
-
文献情報：
Warner LM et al. Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse. Inflamm. Res. 1995 Aug;44 Suppl 2:S205-6
Warner LM et al
1995/01/01
-
備考：
-
参照：
- No.： 284
-
文献情報：
Chen G et al. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):63-71
Chen G et al
2011/01/01
-
備考：
-
参照：
- No.： 285
-
文献情報：
Okamura K et al. Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver. Histochem. Cell Biol. 2006 Mar;125(3):247-57
Okamura K et al
2006/01/01
-
備考：
-
参照：
- No.： 286
-
文献情報：
Nitta K et al. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. Biomed Res Int 2016;2016:9172157
Nitta K et al
2016/01/01
-
備考：
-
参照：
- No.： 287
-
文献情報：
Imaruoka K et al. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide. Biochem. Biophys. Res. Commun. 2019 03;510(4):587-593
Imaruoka K et al
2019/01/01
-
備考：
-
参照：
- No.： 288
-
文献情報：
Tanaka Y et al. Overexpression of acetyl CoA carboxylase β exacerbates podocyte injury in the kidney of streptozotocin-induced diabetic mice. Biochem. Biophys. Res. Commun. 2018 01;495(1):1115-1121
Tanaka Y et al
2018/01/01
-
備考：
-
参照：
- No.： 289
-
文献情報：
Aoyama M et al. Fructose induces tubulointerstitial injury in the kidney of mice. Biochem. Biophys. Res. Commun. 2012 Mar;419(2):244-9
Aoyama M et al
2012/01/01
-
備考：
-
参照：
- No.： 290
-
文献情報：
Kaplan J et al. Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model. Lupus 2008 Sep;17(9):822-31
Kaplan J et al
2008/01/01
-
備考：
-
参照：
- No.： 291
-
文献情報：
Mirzoyan K et al. Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease. J. Physiol. Biochem. 2016 Dec;72(4):803-812
Mirzoyan K et al
2016/01/01
-
備考：
-
参照：
- No.： 292
-
文献情報：
Tamura Y et al. Ezetimibe ameliorates early diabetic nephropathy in db/db mice. J. Atheroscler. Thromb. 2012;19(7):608-18
Tamura Y et al
2012/01/01
-
備考：
-
参照：
- No.： 293
-
文献情報：
Baban B et al. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: role of indoleamine 2,3-dioxygenase and programmed death-1. Exp. Mol. Pathol. 2013 Apr;94(2):343-51
Baban B et al
2013/01/01
-
備考：
-
参照：
- No.： 294
-
文献情報：
Zhang X et al. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling. Biol Trace Elem Res 2016 Oct;173(2):372-83
Zhang X et al
2016/01/01
-
備考：
-
参照：
- No.： 295
-
文献情報：
Gao Q et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med. 2010 Jan;76(1):27-33
Gao Q et al
2010/01/01
-
備考：
-
参照：
- No.： 296
-
文献情報：
Tamura Y et al. Differential effect of statins on diabetic nephropathy in db/db mice. Int. J. Mol. Med. 2011 Nov;28(5):683-7
Tamura Y et al
2011/01/01
-
備考：
-
参照：
- No.： 297
-
文献情報：
Iwai M et al. Investigation of parenchymal cell differentiation in organotypic slice culture of mouse fetal liver under administration of sodium butyrate. Cell Biol. Toxicol. 2002;18(3):147-56
Iwai M et al
2002/01/01
-
備考：
-
参照：
- No.： 298
-
文献情報：
Park JH et al. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin. Arch. Pharm. Res. 2017 Mar;40(3):391-402
Park JH et al
2017/01/01
-
備考：
-
参照：
- No.： 299
-
文献情報：
Choi D et al. Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus. Arch. Pharm. Res. 2011 Aug;34(8):1301-10
Choi D et al
2011/01/01
-
備考：
-
参照：
- No.： 300
-
文献情報：
Milagres T et al. Rehydration with fructose worsens dehydration-induced renal damage. BMC Nephrol 2018 Jul;19(1):180
Milagres T et al
2018/01/01
-
備考：
-
参照：
- No.： 301
-
文献情報：
Mountz JD et al. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol. 2005 Feb;61(2):128-38
Mountz JD et al
2005/01/01
-
備考：
-
参照：
- No.： 302
-
文献情報：
Xiao Z et al. Glomerular podocytes express type 1 adenylate cyclase: inactivation results in susceptibility to proteinuria. Nephron Exp. Nephrol. 2011;118(3):e39-48
Xiao Z et al
2011/01/01
-
備考：
-
参照：
- No.： 303
-
文献情報：
Sakamaki Y et al. Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis. Nephron Exp. Nephrol. 2010;115(2):e22-32
Sakamaki Y et al
2010/01/01
-
備考：
-
参照：
- No.： 304
-
文献情報：
Tsujimura T et al. Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats. Nephron Exp. Nephrol. 2008;110(4):e99-108
Tsujimura T et al
2008/01/01
-
備考：
-
参照：
- No.： 305
-
文献情報：
Jo YI et al. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Nephron Exp. Nephrol. 2007;107(3):e87-94
Jo YI et al
2007/01/01
-
備考：
-
参照：
- No.： 306
-
文献情報：
Collins SJ et al. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice. Nephron Exp. Nephrol. 2006;104(1):e23-34
Collins SJ et al
2006/01/01
-
備考：
-
参照：
- No.： 307
-
文献情報：
Monkawa T et al. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis. Nephron Exp. Nephrol. 2006;102(1):e8-18
Monkawa T et al
2006/01/01
-
備考：
-
参照：
- No.： 308
-
文献情報：
Cheng H et al. Expression of mediators of renal injury in the remnant kidney of ROP mice is attenuated by cyclooxygenase-2 inhibition. Nephron Exp. Nephrol. 2005;101(3):e75-85
Cheng H et al
2005/01/01
-
備考：
-
参照：
- No.： 309
-
文献情報：
Hisamichi M et al. Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury. Biomarkers 2017 Feb;22(1):5-13
Hisamichi M et al
2017/01/01
-
備考：
-
参照：
- No.： 310
-
文献情報：
Steenhard BM et al. Kidney development and gene expression in the HIF2alpha knockout mouse. Dev. Dyn. 2007 Apr;236(4):1115-25
Steenhard BM et al
2007/01/01
-
備考：
-
参照：
- No.： 311
-
文献情報：
Zhang J et al. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. J Nat Med 2016 Oct;70(4):740-8
Zhang J et al
2016/01/01
-
備考：
-
参照：
- No.： 312
-
文献情報：
Zoja C et al. Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy. Nephron 2016;132(1):59-69
Zoja C et al
2016/01/01
-
備考：
-
参照：
- No.： 313
-
文献情報：
Xi W et al. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy. Cell Biol. Int. 2018 Nov;42(11):1523-1532
Xi W et al
2018/01/01
-
備考：
-
参照：
- No.： 314
-
文献情報：
Yamashita M et al. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice. Clin. Exp. Nephrol. 2017 Feb;21(1):16-26
Yamashita M et al
2017/01/01
-
備考：
-
参照：
- No.： 315
-
文献情報：
Zhang X et al. Effect of zinc deficiency on mouse renal interstitial fibrosis in diabetic nephropathy. Mol Med Rep 2016 Dec;14(6):5245-5252
Zhang X et al
2016/01/01
-
備考：
-
参照：
- No.： 316
-
文献情報：
Ichikawa D et al. Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion. Nephrology (Carlton) 2018 Apr;23(4):308-316
Ichikawa D et al
2018/01/01
-
備考：
-
参照：
- No.： 317
-
文献情報：
Gangadharan Komala M et al. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes. Nephrology (Carlton) 2016 May;21(5):423-31
Gangadharan Komala M et al
2016/01/01
-
備考：
-
参照：
- No.： 318
-
文献情報：
Lim SW et al. Ginseng treatment attenuates autophagic cell death in chronic cyclosporine nephropathy. Nephrology (Carlton) 2014 Aug;19(8):490-9
Lim SW et al
2014/01/01
-
備考：
-
参照：
- No.： 319
-
文献情報：
Ali Q et al. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury. J Renin Angiotensin Aldosterone Syst 2016 Jul;17(3)
Ali Q et al
2016/01/01
-
備考：
-
参照：
- No.： 320
-
文献情報：
Colombaro V et al. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover. Acta Histochem. 2015 Jan;117(1):83-91
Colombaro V et al
2015/01/01
-
備考：
-
参照：
- No.： 321
-
文献情報：
Lu X et al. Danshen (Radix Salviae Miltiorrhizae) reverses renal injury induced by myocardial infarction. J Tradit Chin Med 2015 Jun;35(3):306-11
Lu X et al
2015/01/01
-
備考：
-
参照：
- No.： 322
-
文献情報：
Cheng L et al. Everolimus vs. rapamycin for treating diabetic nephropathy in diabetic mouse model. J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):457
Cheng L et al
2011/01/01
-
備考：
-
参照：
- No.： 323
-
文献情報：
Wei P et al. Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail 2009;31(6):503-13
Wei P et al
2009/01/01
-
備考：
-
参照：
- No.： 324
-
文献情報：
Zhu X et al. Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice. Med. Sci. Monit. 2016 Oct;22:3902-3909
Zhu X et al
2016/01/01
-
備考：
-
参照：
- No.： 325
-
文献情報：
Takiyama Y et al. Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8. EBioMedicine 2018 Oct;36:329-346
Takiyama Y et al
2018/01/01
-
備考：
-
参照：
- No.： 326
-
文献情報：
Sun WY et al. Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury. JCI Insight 2018 09;3(17)
Sun WY et al
2018/01/01
-
備考：
-
参照：
- No.： 327
-
文献情報：
Zhao M et al. Angiotensin II Stimulates the NLRP3 Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction. Kidney Dis (Basel) 2018 Jun;4(2):83-94
Zhao M et al
2018/01/01
-
備考：
-
参照：
- No.： 328
-
文献情報：
Trostel J et al. Different effects of global osteopontin and macrophage osteopontin in glomerular injury. Am. J. Physiol. Renal Physiol. 2018 10;315(4):F759-F768
Trostel J et al
2018/01/01
-
備考：
-
参照：
- No.： 329
-
文献情報：
Sharp CN et al. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease. Am. J. Physiol. Renal Physiol. 2018 07;315(1):F161-F172
Sharp CN et al
2018/01/01
-
備考：
-
参照：
- No.： 330
-
文献情報：
Sharma I et al. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 01;314(1):F107-F121
Sharma I et al
2018/01/01
-
備考：
-
参照：
- No.： 331
-
文献情報：
Bai M et al. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury. Am. J. Physiol. Renal Physiol. 2017 04;312(4):F556-F564
Bai M et al
2017/01/01
-
備考：
-
参照：
- No.： 332
-
文献情報：
Roncal-Jimenez CA et al. Aging-associated renal disease in mice is fructokinase dependent. Am. J. Physiol. Renal Physiol. 2016 10;311(4):F722-F730
Roncal-Jimenez CA et al
2016/01/01
-
備考：
-
参照：
- No.： 333
-
文献情報：
Herrera M et al. Inhibition of T-cell activation by CTLA4-Fc is sufficient to ameliorate proteinuric kidney disease. Am. J. Physiol. Renal Physiol. 2016 Jul;:ajprenal.00179.2016
Herrera M et al
2016/01/01
-
備考：
-
参照：
- No.： 334
-
文献情報：
Lemos DR et al. Maintenance of vascular integrity by pericytes is essential for normal kidney function. Am. J. Physiol. Renal Physiol. 2016 12;311(6):F1230-F1242
Lemos DR et al
2016/01/01
-
備考：
-
参照：
- No.： 335
-
文献情報：
Zeng F et al. Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion. Am. J. Physiol. Renal Physiol. 2016 10;311(4):F695-F707
Zeng F et al
2016/01/01
-
備考：
-
参照：
- No.： 336
-
文献情報：
Kitsunai H et al. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. Physiol Rep 2016 Mar;4(6)
Kitsunai H et al
2016/01/01
-
備考：
-
参照：
- No.： 337
-
文献情報：
Zhu J et al. Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production. Am. J. Physiol. Renal Physiol. 2016 05;310(9):F895-908
Zhu J et al
2016/01/01
-
備考：
-
参照：
- No.： 338
-
文献情報：
Sas KM et al. Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease. J Proteomics Bioinform 2015 Oct;Suppl 14
Sas KM et al
2015/01/01
-
備考：
-
参照：
- No.： 339
-
文献情報：
Ramkumar N et al. Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension. Physiol Rep 2016 Jan;4(1)
Ramkumar N et al
2016/01/01
-
備考：
-
参照：
- No.： 340
-
文献情報：
Munusamy S et al. Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. Am. J. Physiol. Renal Physiol. 2015 Oct;309(8):F731-43
Munusamy S et al
2015/01/01
-
備考：
-
参照：
- No.： 341
-
文献情報：
Eadon MT et al. A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice. Antivir. Chem. Chemother. 2015 Apr;24(2):72-6
Eadon MT et al
2015/01/01
-
備考：
-
参照：
- No.： 342
-
文献情報：
Zhuang Y et al. Albumin impairs renal tubular tight junctions via targeting the NLRP3 inflammasome. Am. J. Physiol. Renal Physiol. 2015 May;308(9):F1012-9
Zhuang Y et al
2015/01/01
-
備考：
-
参照：
- No.： 343
-
文献情報：
Wang Y et al. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension. Exp. Biol. Med. (Maywood) 2015 Sep;240(9
Wang Y et al
2015/01/01
-
備考：
-
参照：
- No.： 344
-
文献情報：
Ichikawa D et al. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury. Am. J. Physiol. Renal Physiol. 2015 Jan;308(2):F114-21
Ichikawa D et al
2015/01/01
-
備考：
-
参照：
- No.： 345
-
文献情報：
Ichikawa D et al. Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation. Am. J. Physiol. Renal Physiol. 2014 Mar;306(6):F655-63
Ichikawa D et al
2014/01/01
-
備考：
-
参照：
- No.： 346
-
文献情報：
Vallon V et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am. J. Physiol. Renal Physiol. 2014 Jan;306(2):F194-204
Vallon V et al
2014/01/01
-
備考：
-
参照：
- No.： 347
-
文献情報：
Liu Y et al. Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice. Am. J. Physiol. Renal Physiol. 2013 Dec;305(11):F1555-62
Liu Y et al
2013/01/01
-
備考：
-
参照：
- No.： 348
-
文献情報：
Liu S et al. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. Am. J. Physiol. Renal Physiol. 2013 Dec;305(11):F1533-41
Liu S et al
2013/01/01
-
備考：
-
参照：
- No.： 349
-
文献情報：
Li J et al. Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. Am. J. Physiol. Renal Physiol. 2013 Apr;304(7):F1000-8
Li J et al
2013/01/01
-
備考：
-
参照：
- No.： 350
-
文献情報：
Day RT et al. Apelin retards the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2013 Mar;304(6):F788-800
Day RT et al
2013/01/01
-
備考：
-
参照：
- No.： 351
-
文献情報：
Basu R et al. Loss of TIMP3 selectively exacerbates diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2012 Nov;303(9):F1341-52
Basu R et al
2012/01/01
-
備考：
-
参照：
- No.： 352
-
文献情報：
Ji X et al. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Am. J. Physiol. Renal Physiol. 2012 Oct;303(8):F1207-15
Ji X et al
2012/01/01
-
備考：
-
参照：
- No.： 353
-
文献情報：
Rabadi MM et al. HMGB1 in renal ischemic injury. Am. J. Physiol. Renal Physiol. 2012 Sep;303(6):F873-85
Rabadi MM et al
2012/01/01
-
備考：
-
参照：
- No.： 354
-
文献情報：
Nagao T et al. Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy. Nephron Extra 2012 Jan;2(1):87-103
Nagao T et al
2012/01/01
-
備考：
-
参照：
- No.： 355
-
文献情報：
Walker KA et al. High nephron endowment protects against salt-induced hypertension. Am. J. Physiol. Renal Physiol. 2012 Jul;303(2):F253-8
Walker KA et al
2012/01/01
-
備考：
-
参照：
- No.： 356
-
文献情報：
Lai EY et al. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am. J. Physiol. Renal Physiol. 2012 Jul;303(1):F64-74
Lai EY et al
2012/01/01
-
備考：
-
参照：
- No.： 357
-
文献情報：
Nagasu H et al. Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice. Am. J. Physiol. Renal Physiol. 2012 Jun;302(11):F1402-8
Nagasu H et al
2012/01/01
-
備考：
-
参照：
- No.： 358
-
文献情報：
Tanabe K et al. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Am. J. Physiol. Renal Physiol. 2012 May;302(9):F1151-60
Tanabe K et al
2012/01/01
-
備考：
-
参照：
- No.： 359
-
文献情報：
Yang S et al. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am. J. Physiol. Renal Physiol. 2012 Mar;302(6):F742-9
Yang S et al
2012/01/01
-
備考：
-
参照：
- No.： 360
-
文献情報：
Zhang MZ et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Am. J. Physiol. Renal Physiol. 2012 Feb;302(4):F433-8
Zhang MZ et al
2012/01/01
-
備考：
-
参照：
- No.： 361
-
文献情報：
McKittrick IB et al. Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am. J. Physiol. Renal Physiol. 2011 Dec;301(6):F1326-33
McKittrick IB et al
2011/01/01
-
備考：
-
参照：
- No.： 362
-
文献情報：
Awad AS et al. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am. J. Physiol. Renal Physiol. 2011 Dec;301(6):F1358-66
Awad AS et al
2011/01/01
-
備考：
-
参照：
- No.： 363
-
文献情報：
Sanchez AP et al. Role of the USF1 transcription factor in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 2011 Aug;301(2):F271-9
Sanchez AP et al
2011/01/01
-
備考：
-
参照：
- No.： 364
-
文献情報：
Rosenquist TA. Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse. Am. J. Physiol. Renal Physiol. 2011 Jun;300(6):F1360-7
Rosenquist TA
2011/01/01
-
備考：
-
参照：
- No.： 365
-
文献情報：
Bivona BJ et al. Glomerular filtration rate determinations in conscious type II diabetic mice. Am. J. Physiol. Renal Physiol. 2011 Mar;300(3):F618-25
Bivona BJ et al
2011/01/01
-
備考：
-
参照：
- No.： 366
-
文献情報：
Li F et al. Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J. Thromb. Haemost. 2010 Oct;8(10):2122-32
Li F et al
2010/01/01
-
備考：
-
参照：
- No.： 367
-
文献情報：
Wang Y et al. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am. J. Physiol. Renal Physiol. 2009 Dec;297(6):F1550-9
Wang Y et al
2009/01/01
-
備考：
-
参照：
- No.： 368
-
文献情報：
Manhiani M et al. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am. J. Physiol. Renal Physiol. 2009 Sep;297(3):F740-8
Manhiani M et al
2009/01/01
-
備考：
-
参照：
- No.： 369
-
文献情報：
Nakhoul FM et al. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am. J. Physiol. Renal Physiol. 2009 Apr;296(4):F830-8
Nakhoul FM et al
2009/01/01
-
備考：
-
参照：
- No.： 370
-
文献情報：
Kim SY et al. Role of kidney ADP-ribosyl cyclase in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F291-7
Kim SY et al
2009/01/01
-
備考：
-
参照：
- No.： 371
-
文献情報：
Deji N et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009 Jan;296(1):F118-26
Deji N et al
2009/01/01
-
備考：
-
参照：
- No.： 372
-
文献情報：
Park S et al. Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am. J. Physiol. Renal Physiol. 2008 Nov;295(5):F1504-11
Park S et al
2008/01/01
-
備考：
-
参照：
- No.： 373
-
文献情報：
Francois H et al. A role for the thromboxane receptor in L-NAME hypertension. Am. J. Physiol. Renal Physiol. 2008 Oct;295(4):F1096-102
Francois H et al
2008/01/01
-
備考：
-
参照：
- No.： 374
-
文献情報：
Crowley SD et al. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F515-24
Crowley SD et al
2008/01/01
-
備考：
-
参照：
- No.： 375
-
文献情報：
Tan Y et al. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2007 Oct;293(4):F1026-35
Tan Y et al
2007/01/01
-
備考：
-
参照：
- No.： 376
-
文献情報：
Ju叩rez P et al. Soluble betaglycan reduces renal damage progression in db/db mice. Am. J. Physiol. Renal Physiol. 2007 Jan;292(1):F321-9
Ju叩rez P et al
2007/01/01
-
備考：
-
参照：
- No.： 377
-
文献情報：
Mishra R et al. Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney. Am. J. Physiol. Renal Physiol. 2004 May;286(5):F913-21
Mishra R et al
2004/01/01
-
備考：
-
参照：
- No.： 378
-
文献情報：
Hashimoto N et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am. J. Physiol. Renal Physiol. 2004 Mar;286(3):F516-25
Hashimoto N et al
2004/01/01
-
備考：
-
参照：
- No.： 379
-
文献情報：
Mori T et al. Parenchymal cells proliferate and differentiate in an organotypic slice culture of the neonatal liver. Anat. Embryol. 1999 Apr;199(4):319-27
Mori T et al
1999/01/01
-
備考：
-
参照：
- No.： 380
-
文献情報：
Kidokoro K et al. Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging. Circulation 2019 07;140(4):303-315
Kidokoro K et al
2019/01/01
-
備考：
-
参照：
- No.： 381
-
文献情報：
Galvan DL et al. Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice. J. Clin. Invest. 2019 05;129(7):2807-2823
Galvan DL et al
2019/01/01
-
備考：
-
参照：
- No.： 382
-
文献情報：
Wen Y et al. KLF4 in Macrophages Attenuates TNF<i>α</i>-Mediated Kidney Injury and Fibrosis. J. Am. Soc. Nephrol. 2019 10;30(10):1925-1938
Wen Y et al
2019/01/01
-
備考：
-
参照：
- No.： 383
-
文献情報：
Zhang MZ et al. The Role of the EGF Receptor in Sex Differences in Kidney Injury. J. Am. Soc. Nephrol. 2019 09;30(9):1659-1673
Zhang MZ et al
2019/01/01
-
備考：
-
参照：
- No.： 384
-
文献情報：
Lu X et al. Opposing actions of renal tubular- and myeloid-derived porcupine in obstruction-induced kidney fibrosis. Kidney Int. 2019 12;96(6):1308-1319
Lu X et al
2019/01/01
-
備考：
-
参照：
- No.： 385
-
文献情報：
Das R et al. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis. Kidney Int. 2019 10;96(4):927-941
Das R et al
2019/01/01
-
備考：
-
参照：
- No.： 386
-
文献情報：
Cassis P et al. Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy. Kidney Int. 2019 10;96(4):906-917
Cassis P et al
2019/01/01
-
備考：
-
参照：
- No.： 387
-
文献情報：
Arif E et al. Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019 09;96(3):656-673
Arif E et al
2019/01/01
-
備考：
-
参照：
- No.： 388
-
文献情報：
Tang J et al. Urinary Renin in Patients and Mice With Diabetic Kidney Disease. Hypertension 2019 07;74(1):83-94
Tang J et al
2019/01/01
-
備考：
-
参照：
- No.： 389
-
文献情報：
Krishnan SM et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc. Res. 2019 03;115(4):776-787
Krishnan SM et al
2019/01/01
-
備考：
-
参照：
- No.： 390
-
文献情報：
Xu BH et al. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metab. Clin. Exp. 2020 02;103:154013
Xu BH et al
2020/01/01
-
備考：
-
参照：
- No.： 391
-
文献情報：
Billi AC et al. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. JCI Insight 2019 Apr;4(8)
Billi AC et al
2019/01/01
-
備考：
-
参照：
- No.： 392
-
文献情報：
Lang Y et al. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes. Cell Death Dis 2019 05;10(6):401
Lang Y et al
2019/01/01
-
備考：
-
参照：
- No.： 393
-
文献情報：
Mehta N et al. Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease. Antioxid. Redox Signal. 2019 Sep;31(8):551-571
Mehta N et al
2019/01/01
-
備考：
-
参照：
- No.： 394
-
文献情報：
Felizardo RJF et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. FASEB J. 2019 11;33(11):11894-11908
Felizardo RJF et al
2019/01/01
-
備考：
-
参照：
- No.： 395
-
文献情報：
Ichikawa H et al. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway. J Am Heart Assoc 2019 04;8(8):e012195
Ichikawa H et al
2019/01/01
-
備考：
-
参照：
- No.： 396
-
文献情報：
Elmarakby AA et al. A dual role of 12/15-lipoxygenase in LPS-induced acute renal inflammation and injury. Biochim Biophys Acta Mol Cell Biol Lipids 2019 11;1864(11):1669-1680
Elmarakby AA et al
2019/01/01
-
備考：
-
参照：
- No.： 397
-
文献情報：
Li C et al. (Pro)renin receptor contributes to renal mitochondria dysfunction, apoptosis and fibrosis in diabetic mice. Sci Rep 2019 08;9(1):11667
Li C et al
2019/01/01
-
備考：
-
参照：
- No.： 398
-
文献情報：
Vinel C et al. Apelin affects the mouse aging urinary peptidome with minimal effects on kidney. Sci Rep 2019 07;9(1):10647
Vinel C et al
2019/01/01
-
備考：
-
参照：
- No.： 399
-
文献情報：
Schwarz A et al. Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement. Sci Rep 2019 06;9(1):8888
Schwarz A et al
2019/01/01
-
備考：
-
参照：
- No.： 400
-
文献情報：
Erlandsson L et al. Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model. Sci Rep 2019 06;9(1):8561
Erlandsson L et al
2019/01/01
-
備考：
-
参照：
- No.： 401
-
文献情報：
Takagaki Y et al. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice. Sci Rep 2019 May;9(1):7519
Takagaki Y et al
2019/01/01
-
備考：
-
参照：
- No.： 402
-
文献情報：
Sabapathy V et al. Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy. Front Pharmacol 2019;10:572
Sabapathy V et al
2019/01/01
-
備考：
-
参照：
- No.： 403
-
文献情報：
Hye Khan MA et al. Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice. Front Pharmacol 2019;10:512
Hye Khan MA et al
2019/01/01
-
備考：
-
参照：
- No.： 404
-
文献情報：
Tsuchida Y et al. Lipoprotein modulation of proteinuric renal injury. Lab. Invest. 2019 07;99(8):1107-1116
Tsuchida Y et al
2019/01/01
-
備考：
-
参照：
- No.： 405
-
文献情報：
Arbeeny CM et al. CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy. J. Pharmacol. Exp. Ther. 2019 06;369(3):503-510
Arbeeny CM et al
2019/01/01
-
備考：
-
参照：
- No.： 406
-
文献情報：
Suzuki T et al. Immune-associated renal disease found in caspase 3-deficient mice. Cell Tissue Res. 2020 Feb;379(2):323-335
Suzuki T et al
2020/01/01
-
備考：
-
参照：
- No.： 407
-
文献情報：
Kosaki K et al. Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice. Hypertens. Res. 2019 10;42(10):1518-1527
Kosaki K et al
2019/01/01
-
備考：
-
参照：
- No.： 408
-
文献情報：
Yoshida N et al. T cell-specific STAT3 deficiency abrogates lupus nephritis. Lupus 2019 Oct;28(12):1468-1472
Yoshida N et al
2019/01/01
-
備考：
-
参照：
- No.： 409
-
文献情報：
Gooding J et al. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy. BMC Nephrol 2019 04;20(1):141
Gooding J et al
2019/01/01
-
備考：
-
参照：
- No.： 410
-
文献情報：
Wetzel MD et al. l-Homoarginine supplementation prevents diabetic kidney damage. Physiol Rep 2019 09;7(18):e14235
Wetzel MD et al
2019/01/01
-
備考：
-
参照：
- No.： 411
-
文献情報：
Sato Y et al. Increase of core temperature affected the progression of kidney injury by repeated heat stress exposure. Am. J. Physiol. Renal Physiol. 2019 11;317(5):F1111-F1121
Sato Y et al
2019/01/01
-
備考：
-
参照：
- No.： 412
-
文献情報：
Jain A et al. In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes. J Diabetes Metab Disord 2019 Jun;18(1):133-143
Jain A et al
2019/01/01
-
備考：
-
参照：
- No.： 413
-
文献情報：
Song P et al. Knockout of Na<sup>+</sup>-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration. Am. J. Physiol. Renal Physiol. 2019 07;317(1):F207-F217
Song P et al
2019/01/01
-
備考：
-
参照：
- No.： 414
-
文献情報：
Nilsson D et al. Foxc2 is essential for podocyte function. Physiol Rep 2019 May;7(9):e14083
Nilsson D et al
2019/01/01
-
備考：
-
参照：
- No.： 415
-
文献情報：
Zhong B et al. Ablation of TRPV1 Elevates Nocturnal Blood Pressure in Western Diet-fed Mice. Curr Hypertens Rev 2019;15(2):144-153
Zhong B et al
2019/01/01
-
備考：
-
参照：
- No.： 416
-
文献情報：
Qi W et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 2017 Jun;23(6):753-762
Qi W et al
2017/01/01
-
備考：
-
参照：
- No.： 417
-
文献情報：
Hackl MJ et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat. Med. 2013 Dec;19(12):1661-6
Hackl MJ et al
2013/01/01
-
備考：
-
参照：
- No.： 418
-
文献情報：
Zhou CC et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008 Aug;14(8):855-62
Zhou CC et al
2008/01/01
-
備考：
-
参照：
- No.： 419
-
文献情報：
Wu H et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med 2016 Mar;8(331):331ra40
Wu H et al
2016/01/01
-
備考：
-
参照：
- No.： 420
-
文献情報：
Seshan SV et al. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood 2009 Aug;114(8):1675-83
Seshan SV et al
2009/01/01
-
備考：
-
参照：
- No.： 421
-
文献情報：
Qing X et al. iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling. J. Clin. Invest. 2018 Apr;128(4):1397-1412
Qing X et al
2018/01/01
-
備考：
-
参照：
- No.： 422
-
文献情報：
Majumder S et al. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease. J. Clin. Invest. 2018 Jan;128(1):483-499
Majumder S et al
2018/01/01
-
備考：
-
参照：
- No.： 423
-
文献情報：
Wang J et al. Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. J. Clin. Invest. 2016 06;126(6):2077-92
Wang J et al
2016/01/01
-
備考：
-
参照：
- No.： 424
-
文献情報：
Wu J et al. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. J. Clin. Invest. 2015 Nov;125(11):4091-106
Wu J et al
2015/01/01
-
備考：
-
参照：
- No.： 425
-
文献情報：
Fan X et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J. Clin. Invest. 2014 Nov;124(11):4941-52
Fan X et al
2014/01/01
-
備考：
-
参照：
- No.： 426
-
文献情報：
Daehn I et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 2014 Apr;124(4):1608-21
Daehn I et al
2014/01/01
-
備考：
-
参照：
- No.： 427
-
文献情報：
Dugan LL et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J. Clin. Invest. 2013 Nov;123(11):4888-99
Dugan LL et al
2013/01/01
-
備考：
-
参照：
- No.： 428
-
文献情報：
Knight JS et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 2013 Jul;123(7):2981-93
Knight JS et al
2013/01/01
-
備考：
-
参照：
- No.： 429
-
文献情報：
George B et al. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J. Clin. Invest. 2012 Feb;122(2):674-92
George B et al
2012/01/01
-
備考：
-
参照：
- No.： 430
-
文献情報：
Inoki K et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 2011 Jun;121(6):2181-96
Inoki K et al
2011/01/01
-
備考：
-
参照：
- No.： 431
-
文献情報：
Sharma K et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008 May;118(5):1645-56
Sharma K et al
2008/01/01
-
備考：
-
参照：
- No.： 432
-
文献情報：
Reiser J et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 2004 May;113(10):1390-7
Reiser J et al
2004/01/01
-
備考：
-
参照：
- No.： 433
-
文献情報：
Ashraf S et al. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun 2018 05;9(1):1960
Ashraf S et al
2018/01/01
-
備考：
-
参照：
- No.： 434
-
文献情報：
Zeng B et al. ORAI channels are critical for receptor-mediated endocytosis of albumin. Nat Commun 2017 12;8(1):1920
Zeng B et al
2017/01/01
-
備考：
-
参照：
- No.： 435
-
文献情報：
Becker-Herman S et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J. Exp. Med. 2011 Sep;208(10):2033-42
Becker-Herman S et al
2011/01/01
-
備考：
-
参照：
- No.： 436
-
文献情報：
Balbas MD et al. MAGI-2 scaffold protein is critical for kidney barrier function. Proc. Natl. Acad. Sci. U.S.A. 2014 Oct;111(41):14876-81
Balbas MD et al
2014/01/01
-
備考：
-
参照：
- No.： 437
-
文献情報：
Fox R et al. Mitochondrial DNA polymerase editing mutation, PolgD257A, reduces the diabetic phenotype of Akita male mice by suppressing appetite. Proc. Natl. Acad. Sci. U.S.A. 2011 May;108(21):8779-84
Fox R et al
2011/01/01
-
備考：
-
参照：
- No.： 438
-
文献情報：
Wang XX et al. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J. Am. Soc. Nephrol. 2018 01;29(1):118-137
Wang XX et al
2018/01/01
-
備考：
-
参照：
- No.： 439
-
文献情報：
Nlandu-Khodo S et al. Blocking TGF-<i>β</i> and <i>β</i>-Catenin Epithelial Crosstalk Exacerbates CKD. J. Am. Soc. Nephrol. 2017 Dec;28(12):3490-3503
Nlandu-Khodo S et al
2017/01/01
-
備考：
-
参照：
- No.： 440
-
文献情報：
Velez JCQ et al. Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury. J. Am. Soc. Nephrol. 2017 Jul;28(7):2119-2132
Velez JCQ et al
2017/01/01
-
備考：
-
参照：
- No.： 441
-
文献情報：
Mori KP et al. Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy. J. Am. Soc. Nephrol. 2017 Jan;28(1):278-289
Mori KP et al
2017/01/01
-
備考：
-
参照：
- No.： 442
-
文献情報：
Yao Y et al. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function. J. Am. Soc. Nephrol. 2016 Dec;27(12):3653-3665
Yao Y et al
2016/01/01
-
備考：
-
参照：
- No.： 443
-
文献情報：
Puelles VG et al. Validation of a Three-Dimensional Method for Counting and Sizing Podocytes in Whole Glomeruli. J. Am. Soc. Nephrol. 2016 Oct;27(10):3093-3104
Puelles VG et al
2016/01/01
-
備考：
-
参照：
- No.： 444
-
文献情報：
New LA et al. Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture. J. Am. Soc. Nephrol. 2016 08;27(8):2422-35
New LA et al
2016/01/01
-
備考：
-
参照：
- No.： 445
-
文献情報：
Wang XX et al. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J. Am. Soc. Nephrol. 2016 05;27(5):1362-78
Wang XX et al
2016/01/01
-
備考：
-
参照：
- No.： 446
-
文献情報：
You YH et al. Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. J. Am. Soc. Nephrol. 2016 Feb;27(2):466-81
You YH et al
2016/01/01
-
備考：
-
参照：
- No.： 447
-
文献情報：
Sato Y et al. Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J. Am. Soc. Nephrol. 2015 Aug;26(8):1806-15
Sato Y et al
2015/01/01
-
備考：
-
参照：
- No.： 448
-
文献情報：
Chen J et al. EGF receptor deletion in podocytes attenuates diabetic nephropathy. J. Am. Soc. Nephrol. 2015 May;26(5):1115-25
Chen J et al
2015/01/01
-
備考：
-
参照：
- No.： 449
-
文献情報：
Lal MA et al. Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration. J. Am. Soc. Nephrol. 2015 Mar;26(3):647-62
Lal MA et al
2015/01/01
-
備考：
-
参照：
- No.： 450
-
文献情報：
Zhou X et al. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation. J. Am. Soc. Nephrol. 2015 Jan;26(1):121-32
Zhou X et al
2015/01/01
-
備考：
-
参照：
- No.： 451
-
文献情報：
Lanaspa MA et al. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J. Am. Soc. Nephrol. 2014 Nov;25(11):2526-38
Lanaspa MA et al
2014/01/01
-
備考：
-
参照：
- No.： 452
-
文献情報：
Cathelin D et al. Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. J. Am. Soc. Nephrol. 2014 Aug;25(8):1662-8
Cathelin D et al
2014/01/01
-
備考：
-
参照：
- No.： 453
-
文献情報：
Borsting E et al. Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. J. Am. Soc. Nephrol. 2014 Sep;25(9):2067-78
Borsting E et al
2014/01/01
-
備考：
-
参照：
- No.： 454
-
文献情報：
Marrone AK et al. MicroRNA-17~92 is required for nephrogenesis and renal function. J. Am. Soc. Nephrol. 2014 Jul;25(7):1440-52
Marrone AK et al
2014/01/01
-
備考：
-
参照：
- No.： 455
-
文献情報：
Chen J et al. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J. Am. Soc. Nephrol. 2013 Feb;24(2):198-207
Chen J et al
2013/01/01
-
備考：
-
参照：
- No.： 456
-
文献情報：
Li F et al. eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J. Am. Soc. Nephrol. 2012 Apr;23(4):652-60
Li F et al
2012/01/01
-
備考：
-
参照：
- No.： 457
-
文献情報：
Chen J et al. EGFR signaling promotes TGFβ-dependent renal fibrosis. J. Am. Soc. Nephrol. 2012 Feb;23(2):215-24
Chen J et al
2012/01/01
-
備考：
-
参照：
- No.： 458
-
文献情報：
Papeta N et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J. Am. Soc. Nephrol. 2011 Nov;22(11):1991-6
Papeta N et al
2011/01/01
-
備考：
-
参照：
- No.： 459
-
文献情報：
Decl竪ves AE et al. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011 Oct;22(10):1846-55
Decl竪ves AE et al
2011/01/01
-
備考：
-
参照：
- No.： 460
-
文献情報：
Cheng H et al. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. J. Am. Soc. Nephrol. 2011 Jul;22(7):1240-51
Cheng H et al
2011/01/01
-
備考：
-
参照：
- No.： 461
-
文献情報：
Dai Y et al. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J. Am. Soc. Nephrol. 2011 May;22(5):890-901
Dai Y et al
2011/01/01
-
備考：
-
参照：
- No.： 462
-
文献情報：
Kimura T et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 2011 May;22(5):902-13
Kimura T et al
2011/01/01
-
備考：
-
参照：
- No.： 463
-
文献情報：
Wang Y et al. Peptide nanofibers preconditioned with stem cell secretome are renoprotective. J. Am. Soc. Nephrol. 2011 Apr;22(4):704-17
Wang Y et al
2011/01/01
-
備考：
-
参照：
- No.： 464
-
文献情報：
Eckel J et al. TRPC6 enhances angiotensin II-induced albuminuria. J. Am. Soc. Nephrol. 2011 Mar;22(3):526-35
Eckel J et al
2011/01/01
-
備考：
-
参照：
- No.： 465
-
文献情報：
Stitt-Cavanagh EM et al. A maladaptive role for EP4 receptors in podocytes. J. Am. Soc. Nephrol. 2010 Oct;21(10):1678-90
Stitt-Cavanagh EM et al
2010/01/01
-
備考：
-
参照：
- No.： 466
-
文献情報：
Hudkins KL et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J. Am. Soc. Nephrol. 2010 Sep;21(9):1533-42
Hudkins KL et al
2010/01/01
-
備考：
-
参照：
- No.： 467
-
文献情報：
Brezniceanu ML et al. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J. Am. Soc. Nephrol. 2010 Jun;21(6):943-54
Brezniceanu ML et al
2010/01/01
-
備考：
-
参照：
- No.： 468
-
文献情報：
Xavier S et al. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J. Am. Soc. Nephrol. 2009 Oct;20(10):2127-37
Xavier S et al
2009/01/01
-
備考：
-
参照：
- No.： 469
-
文献情報：
Cheng H et al. Distinct roles for basal and induced COX-2 in podocyte injury. J. Am. Soc. Nephrol. 2009 Sep;20(9):1953-62
Cheng H et al
2009/01/01
-
備考：
-
参照：
- No.： 470
-
文献情報：
Fujita H et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J. Am. Soc. Nephrol. 2009 Jun;20(6):1303-13
Fujita H et al
2009/01/01
-
備考：
-
参照：
- No.： 471
-
文献情報：
Ronconi E et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 2009 Feb;20(2):322-32
Ronconi E et al
2009/01/01
-
備考：
-
参照：
- No.： 472
-
文献情報：
Lorenzen J et al. The role of osteopontin in the development of albuminuria. J. Am. Soc. Nephrol. 2008 May;19(5):884-90
Lorenzen J et al
2008/01/01
-
備考：
-
参照：
- No.： 473
-
文献情報：
Guo S et al. Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J. Am. Soc. Nephrol. 2008 Jun;19(6):1168-76
Guo S et al
2008/01/01
-
備考：
-
参照：
- No.： 474
-
文献情報：
Faulhaber-Walter R et al. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J. Am. Soc. Nephrol. 2008 Apr;19(4):722-30
Faulhaber-Walter R et al
2008/01/01
-
備考：
-
参照：
- No.： 475
-
文献情報：
Guo J et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J. Am. Soc. Nephrol. 2008 May;19(5):961-72
Guo J et al
2008/01/01
-
備考：
-
参照：
- No.： 476
-
文献情報：
Liu F et al. Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J. Am. Soc. Nephrol. 2008 Feb;19(2):269-80
Liu F et al
2008/01/01
-
備考：
-
参照：
- No.： 477
-
文献情報：
Awad AS et al. Activation of adenosine 2A receptors preserves structure and function of podocytes. J. Am. Soc. Nephrol. 2008 Jan;19(1):59-68
Awad AS et al
2008/01/01
-
備考：
-
参照：
- No.： 478
-
文献情報：
Menne J et al. The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury. J. Am. Soc. Nephrol. 2007 Jul;18(7):2046-53
Menne J et al
2007/01/01
-
備考：
-
参照：
- No.： 479
-
文献情報：
Hiramatsu N et al. Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J. Am. Soc. Nephrol. 2007 Feb;18(2):515-27
Hiramatsu N et al
2007/01/01
-
備考：
-
参照：
- No.： 480
-
文献情報：
Cheng H et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J. Am. Soc. Nephrol. 2007 Feb;18(2):551-9
Cheng H et al
2007/01/01
-
備考：
-
参照：
- No.： 481
-
文献情報：
Tchekneva EE et al. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. J. Am. Soc. Nephrol. 2007 Jan;18(1):103-12
Tchekneva EE et al
2007/01/01
-
備考：
-
参照：
- No.： 482
-
文献情報：
Ye M et al. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 2006 Nov;17(11):3067-75
Ye M et al
2006/01/01
-
備考：
-
参照：
- No.： 483
-
文献情報：
Sung SH et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 2006 Nov;17(11):3093-104
Sung SH et al
2006/01/01
-
備考：
-
参照：
- No.： 484
-
文献情報：
Zhao HJ et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J. Am. Soc. Nephrol. 2006 Oct;17(10):2664-9
Zhao HJ et al
2006/01/01
-
備考：
-
参照：
- No.： 485
-
文献情報：
Jiang T et al. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease. J. Am. Soc. Nephrol. 2005 Aug;16(8):2385-94
Jiang T et al
2005/01/01
-
備考：
-
参照：
- No.： 486
-
文献情報：
Lang A et al. Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J. Am. Soc. Nephrol. 2005 Feb;16(2):383-91
Lang A et al
2005/01/01
-
備考：
-
参照：
- No.： 487
-
文献情報：
Michaud JL et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J. Am. Soc. Nephrol. 2003 May;14(5):1200-11
Michaud JL et al
2003/01/01
-
備考：
-
参照：
- No.： 488
-
文献情報：
Taneda S et al. Amelioration of diabetic nephropathy in SPARC-null mice. J. Am. Soc. Nephrol. 2003 Apr;14(4):968-80
Taneda S et al
2003/01/01
-
備考：
-
参照：
- No.： 489
-
文献情報：
Anders HJ et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J. Am. Soc. Nephrol. 2001 May;12(5):919-31
Anders HJ et al
2001/01/01
-
備考：
-
参照：
- No.： 490
-
文献情報：
Pan Y et al. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function. Diabetes 2018 04;67(4):717-730
Pan Y et al
2018/01/01
-
備考：
-
参照：
- No.： 491
-
文献情報：
Lo CS et al. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice. Diabetes 2017 07;66(7):1964-1978
Lo CS et al
2017/01/01
-
備考：
-
参照：
- No.： 492
-
文献情報：
Qi H et al. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility. Diabetes 2017 03;66(3):763-778
Qi H et al
2017/01/01
-
備考：
-
参照：
- No.： 493
-
文献情報：
Wang X et al. Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy. Diabetes 2017 02;66(2):494-504
Wang X et al
2017/01/01
-
備考：
-
参照：
- No.： 494
-
文献情報：
Lizotte F et al. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes. Diabetes 2016 Dec;65(12):3705-3717
Lizotte F et al
2016/01/01
-
備考：
-
参照：
- No.： 495
-
文献情報：
Keshari KR et al. Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance. Diabetes 2015 Feb;64(2):344-52
Keshari KR et al
2015/01/01
-
備考：
-
参照：
- No.： 496
-
文献情報：
Abdo S et al. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes 2014 Oct;63(10):3483-96
Abdo S et al
2014/01/01
-
備考：
-
参照：
- No.： 497
-
文献情報：
Zhang MZ et al. Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy. Diabetes 2014 Jun;63(6):2063-72
Zhang MZ et al
2014/01/01
-
備考：
-
参照：
- No.： 498
-
文献情報：
Taniguchi K et al. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes 2013 Nov;62(11):3874-86
Taniguchi K et al
2013/01/01
-
備考：
-
参照：
- No.： 499
-
文献情報：
Huang C et al. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice. Diabetes 2013 Aug;62(8):2923-34
Huang C et al
2013/01/01
-
備考：
-
参照：
- No.： 500
-
文献情報：
Deshpande SD et al. Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 2013 Sep;62(9):3151-62
Deshpande SD et al
2013/01/01
-
備考：
-
参照：
- No.： 501
-
文献情報：
Mima A et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes. Diabetes 2012 Nov;61(11):2967-79
Mima A et al
2012/01/01
-
備考：
-
参照：
- No.： 502
-
文献情報：
Chang SY et al. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012 Oct;61(10):2565-74
Chang SY et al
2012/01/01
-
備考：
-
参照：
- No.： 503
-
文献情報：
Lo CS et al. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 2012 Oct;61(10):2597-608
Lo CS et al
2012/01/01
-
備考：
-
参照：
- No.： 504
-
文献情報：
Fragiadaki M et al. Hyperglycemia causes renal cell damage via CCN2-induced activation of the TrkA receptor: implications for diabetic nephropathy. Diabetes 2012 Sep;61(9):2280-8
Fragiadaki M et al
2012/01/01
-
備考：
-
参照：
- No.： 505
-
文献情報：
Morris SM et al. Arginase-2 mediates diabetic renal injury. Diabetes 2011 Nov;60(11):3015-22
Morris SM et al
2011/01/01
-
備考：
-
参照：
- No.： 506
-
文献情報：
Naito M et al. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 2011 Sep;60(9):2265-73
Naito M et al
2011/01/01
-
備考：
-
参照：
- No.： 507
-
文献情報：
Wang XX et al. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 2010 Nov;59(11):2916-27
Wang XX et al
2010/01/01
-
備考：
-
参照：
- No.： 508
-
文献情報：
Li J et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 2010 Oct;59(10):2612-24
Li J et al
2010/01/01
-
備考：
-
参照：
- No.： 509
-
文献情報：
Reiniger N et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010 Aug;59(8):2043-54
Reiniger N et al
2010/01/01
-
備考：
-
参照：
- No.： 510
-
文献情報：
Oudit GY et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 2010 Feb;59(2):529-38
Oudit GY et al
2010/01/01
-
備考：
-
参照：
- No.： 511
-
文献情報：
Roxburgh SA et al. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 2009 Jul;58(7):1641-50
Roxburgh SA et al
2009/01/01
-
備考：
-
参照：
- No.： 512
-
文献情報：
Eid AA et al. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009 May;58(5):1201-11
Eid AA et al
2009/01/01
-
備考：
-
参照：
- No.： 513
-
文献情報：
Friedman DJ et al. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes 2009 Apr;58(4):999-1006
Friedman DJ et al
2009/01/01
-
備考：
-
参照：
- No.： 514
-
文献情報：
Brezniceanu ML et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008 Feb;57(2):451-9
Brezniceanu ML et al
2008/01/01
-
備考：
-
参照：
- No.： 515
-
文献情報：
Jiang T et al. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 2007 Oct;56(10):2485-93
Jiang T et al
2007/01/01
-
備考：
-
参照：
- No.： 516
-
文献情報：
Friedman DJ et al. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 2007 Sep;56(9):2371-9
Friedman DJ et al
2007/01/01
-
備考：
-
参照：
- No.： 517
-
文献情報：
Szab坦 C et al. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 2006 Nov;55(11):3004-12
Szab坦 C et al
2006/01/01
-
備考：
-
参照：
- No.： 518
-
文献情報：
Makino H et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006 Oct;55(10):2747-56
Makino H et al
2006/01/01
-
備考：
-
参照：
- No.： 519
-
文献情報：
Proctor G et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006 Sep;55(9):2502-9
Proctor G et al
2006/01/01
-
備考：
-
参照：
- No.： 520
-
文献情報：
Susztak K et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 Jan;55(1):225-33
Susztak K et al
2006/01/01
-
備考：
-
参照：
- No.： 521
-
文献情報：
Xu S et al. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006 Jan;55(1):110-9
Xu S et al
2006/01/01
-
備考：
-
参照：
- No.： 522
-
文献情報：
Qi Z et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005 Sep;54(9):2628-37
Qi Z et al
2005/01/01
-
備考：
-
参照：
- No.： 523
-
文献情報：
Wang Z et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005 Aug;54(8):2328-35
Wang Z et al
2005/01/01
-
備考：
-
参照：
- No.： 524
-
文献情報：
Susztak K et al. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 2004 Mar;53(3):784-94
Susztak K et al
2004/01/01
-
備考：
-
参照：
- No.： 525
-
文献情報：
Oku A et al. T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 1999 Sep;48(9):1794-800
Oku A et al
1999/01/01
-
備考：
-
参照：
- No.： 526
-
文献情報：
Chen X et al. Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney Int. 2019 04;95(4):880-895
Chen X et al
2019/01/01
-
備考：
-
参照：
- No.： 527
-
文献情報：
Kitagawa A et al. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kidney Int. 2019 03;95(3):680-692
Kitagawa A et al
2019/01/01
-
備考：
-
参照：
- No.： 528
-
文献情報：
Arkatkar T et al. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression. Kidney Int. 2018 10;94(4):728-740
Arkatkar T et al
2018/01/01
-
備考：
-
参照：
- No.： 529
-
文献情報：
Anusornvongchai T et al. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response. Kidney Int. 2018 09;94(3):536-550
Anusornvongchai T et al
2018/01/01
-
備考：
-
参照：
- No.： 530
-
文献情報：
Grove KJ et al. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney. Kidney Int. 2018 08;94(2):292-302
Grove KJ et al
2018/01/01
-
備考：
-
参照：
- No.： 531
-
文献情報：
Wong DWL et al. Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuria. Kidney Int. 2018 06;93(6):1367-1383
Wong DWL et al
2018/01/01
-
備考：
-
参照：
- No.： 532
-
文献情報：
Lim BJ et al. Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury. Kidney Int. 2017 12;92(6):1395-1403
Lim BJ et al
2017/01/01
-
備考：
-
参照：
- No.： 533
-
文献情報：
You H et al. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. Kidney Int. 2017 03;91(3):671-682
You H et al
2017/01/01
-
備考：
-
参照：
- No.： 534
-
文献情報：
Zhang MZ et al. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 2017 02;91(2):375-386
Zhang MZ et al
2017/01/01
-
備考：
-
参照：
- No.： 535
-
文献情報：
De Marinis Y et al. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney. Kidney Int. 2016 Feb;89(2):342-53
De Marinis Y et al
2016/01/01
-
備考：
-
参照：
- No.： 536
-
文献情報：
Katagiri D et al. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int. 2016 Feb;89(2):374-85
Katagiri D et al
2016/01/01
-
備考：
-
参照：
- No.： 537
-
文献情報：
Hayashi K et al. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria. Kidney Int. 2015 Oct;88(4):745-53
Hayashi K et al
2015/01/01
-
備考：
-
参照：
- No.： 538
-
文献情報：
Awad AS et al. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. Kidney Int. 2015 Oct;88(4):722-33
Awad AS et al
2015/01/01
-
備考：
-
参照：
- No.： 539
-
文献情報：
Cheng H et al. Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int. 2015 Jul;88(1):85-94
Cheng H et al
2015/01/01
-
備考：
-
参照：
- No.： 540
-
文献情報：
Spinale JM et al. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 2015 Mar;87(3):564-74
Spinale JM et al
2015/01/01
-
備考：
-
参照：
- No.： 541
-
文献情報：
Xu J et al. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy. Kidney Int. 2015 Mar;87(3):543-56
Xu J et al
2015/01/01
-
備考：
-
参照：
- No.： 542
-
文献情報：
Li SY et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int. 2014 Aug;86(2):358-69
Li SY et al
2014/01/01
-
備考：
-
参照：
- No.： 543
-
文献情報：
George B et al. Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis. Kidney Int. 2014 Jun;85(6):1382-1394
George B et al
2014/01/01
-
備考：
-
参照：
- No.： 544
-
文献情報：
Decl竪ves AE et al. Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury. Kidney Int. 2014 Mar;85(3):611-23
Decl竪ves AE et al
2014/01/01
-
備考：
-
参照：
- No.： 545
-
文献情報：
Tao J et al. A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis. Kidney Int. 2014 Apr;85(4):972-80
Tao J et al
2014/01/01
-
備考：
-
参照：
- No.： 546
-
文献情報：
Sugar T et al. Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo. Kidney Int. 2014 Feb;85(2):307-18
Sugar T et al
2014/01/01
-
備考：
-
参照：
- No.： 547
-
文献情報：
Miyazawa T et al. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. Kidney Int. 2013 Dec;84(6):1176-88
Miyazawa T et al
2013/01/01
-
備考：
-
参照：
- No.： 548
-
文献情報：
You H et al. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism. Kidney Int. 2013 Dec;84(6):1189-97
You H et al
2013/01/01
-
備考：
-
参照：
- No.： 549
-
文献情報：
Cheng H et al. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int. 2012 Dec;82(11):1176-83
Cheng H et al
2012/01/01
-
備考：
-
参照：
- No.： 550
-
文献情報：
Finer G et al. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int. 2012 Sep;82(5):525-36
Finer G et al
2012/01/01
-
備考：
-
参照：
- No.： 551
-
文献情報：
Wang W et al. Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia. Kidney Int. 2012 May;81(10):1002-1014
Wang W et al
2012/01/01
-
備考：
-
参照：
- No.： 552
-
文献情報：
Asai O et al. Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int. 2012 Mar;81(6):539-47
Asai O et al
2012/01/01
-
備考：
-
参照：
- No.： 553
-
文献情報：
Guo S et al. Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis. Kidney Int. 2011 Nov;80(9):946-958
Guo S et al
2011/01/01
-
備考：
-
参照：
- No.： 554
-
文献情報：
Qing X et al. Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int. 2011 Feb;79(3):331-9
Qing X et al
2011/01/01
-
備考：
-
参照：
- No.： 555
-
文献情報：
Leelahavanichkul A et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010 Dec;78(11):1136-53
Leelahavanichkul A et al
2010/01/01
-
備考：
-
参照：
- No.： 556
-
文献情報：
Chua S et al. A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8. Kidney Int. 2010 Sep;78(5):453-62
Chua S et al
2010/01/01
-
備考：
-
参照：
- No.： 557
-
文献情報：
Hayashi K et al. Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int. 2010 Jul;78(1):69-78
Hayashi K et al
2010/01/01
-
備考：
-
参照：
- No.： 558
-
文献情報：
Veron D et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 2010 Jun;77(11):989-99
Veron D et al
2010/01/01
-
備考：
-
参照：
- No.： 559
-
文献情報：
Godin N et al. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice. Kidney Int. 2010 Jun;77(12):1086-97
Godin N et al
2010/01/01
-
備考：
-
参照：
- No.： 560
-
文献情報：
Chan KT et al. Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int. 2009 Feb;75(4):366-72
Chan KT et al
2009/01/01
-
備考：
-
参照：
- No.： 561
-
文献情報：
Liu F et al. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int. 2009 Jan;75(2):156-66
Liu F et al
2009/01/01
-
備考：
-
参照：
- No.： 562
-
文献情報：
Salzler HR et al. Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. Kidney Int. 2007 Nov;72(10):1226-32
Salzler HR et al
2007/01/01
-
備考：
-
参照：
- No.： 563
-
文献情報：
Soler MJ et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007 Sep;72(5):614-23
Soler MJ et al
2007/01/01
-
備考：
-
参照：
- No.： 564
-
文献情報：
Andrade D et al. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease. Arthritis Rheum. 2011
Andrade D et al
2011/01/01
-
備考：
-
参照：
- No.： 565
-
文献情報：
Villarino A et al. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. Elife 2016 03;5
Villarino A et al
2016/01/01
-
備考：
-
参照：
- No.： 566
-
文献情報：
Reynolds JA et al. Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus. Arthritis Rheumatol 2016 12;68(12):2929-2935
Reynolds JA et al
2016/01/01
-
備考：
-
参照：
- No.： 567
-
文献情報：
Maeda K et al. CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway. Arthritis Rheumatol 2015 May;67(8):2185-95
Maeda K et al
2015/01/01
-
備考：
-
参照：
- No.： 568
-
文献情報：
Parchim NF et al. Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension 2015 Feb;65(2):430-9
Parchim NF et al
2015/01/01
-
備考：
-
参照：
- No.： 569
-
文献情報：
Doridot L et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 2013 Mar;61(3):662-8
Doridot L et al
2013/01/01
-
備考：
-
参照：
- No.： 570
-
文献情報：
Paravicini TM et al. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009 Feb;53(2):423-9
Paravicini TM et al
2009/01/01
-
備考：
-
参照：
- No.： 571
-
文献情報：
Francois H et al. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 2004 Feb;43(2):364-9
Francois H et al
2004/01/01
-
備考：
-
参照：
- No.： 572
-
文献情報：
Luo X et al. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector. Mol. Ther. 2011 Nov;19(11):1961-70
Luo X et al
2011/01/01
-
備考：
-
参照：
- No.： 573
-
文献情報：
Qiao M et al. Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2009 Nov;29(11):1779-86
Qiao M et al
2009/01/01
-
備考：
-
参照：
- No.： 574
-
文献情報：
Chenxu G et al. iRhom2 loss alleviates renal injury in long-term PM2.5-exposed mice by suppression of inflammation and oxidative stress. Redox Biol 2018 10;19:147-157
Chenxu G et al
2018/01/01
-
備考：
-
参照：
- No.： 575
-
文献情報：
Vasko R et al. Endothelial peroxisomal dysfunction and impaired pexophagy promotes oxidative damage in lipopolysaccharide-induced acute kidney injury. Antioxid. Redox Signal. 2013 Jul;19(3):211-30
Vasko R et al
2013/01/01
-
備考：
-
参照：
- No.： 576
-
文献情報：
Lefevre GM et al. Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype. PLoS Genet. 2010 Oct;6(10):e1001142
Lefevre GM et al
2010/01/01
-
備考：
-
参照：
- No.： 577
-
文献情報：
Lo CS et al. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes. Diabetologia 2015 Oct;58(10):2443-54
Lo CS et al
2015/01/01
-
備考：
-
参照：
- No.： 578
-
文献情報：
He F et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 2014 Aug;57(8):1726-36
He F et al
2014/01/01
-
備考：
-
参照：
- No.： 579
-
文献情報：
Guan TH et al. Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy. Diabetologia 2013 Sep;56(9):2068-77
Guan TH et al
2013/01/01
-
備考：
-
参照：
- No.： 580
-
文献情報：
Abdo S et al. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia 2013 Jul;56(7):1649-60
Abdo S et al
2013/01/01
-
備考：
-
参照：
- No.： 581
-
文献情報：
Lim XL et al. KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes. Diabetologia 2012 Sep;55(9):2402-6
Lim XL et al
2012/01/01
-
備考：
-
参照：
- No.： 582
-
文献情報：
Liu GC et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 2012 Sep;55(9):2522-32
Liu GC et al
2012/01/01
-
備考：
-
参照：
- No.： 583
-
文献情報：
Suzuki H et al. Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice. Diabetologia 2011 Nov;54(11):2953-62
Suzuki H et al
2011/01/01
-
備考：
-
参照：
- No.： 584
-
文献情報：
Veron D et al. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 2011 May;54(5):1227-41
Veron D et al
2011/01/01
-
備考：
-
参照：
- No.： 585
-
文献情報：
Ii S et al. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. Diabetologia 2004 Mar;47(3):541-548
Ii S et al
2004/01/01
-
備考：
-
参照：
- No.： 586
-
文献情報：
Liu Y et al. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 2018 12;3(23)
Liu Y et al
2018/01/01
-
備考：
-
参照：
- No.： 587
-
文献情報：
Srivastava SP et al. SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis. Cell Death Dis 2018 Sep;9(10):997
Srivastava SP et al
2018/01/01
-
備考：
-
参照：
- No.： 588
-
文献情報：
Strope S et al. Mouse amnionless, which is required for primitive streak assembly, mediates cell-surface localization and endocytic function of cubilin on visceral endoderm and kidney proximal tubules. Development 2004 Oct;131(19):4787-95
Strope S et al
2004/01/01
-
備考：
-
参照：
- No.： 589
-
文献情報：
Bjarneg奪rd M et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004 Apr;131(8):1847-57
Bjarneg奪rd M et al
2004/01/01
-
備考：
-
参照：
- No.： 590
-
文献情報：
Doke T et al. Lacking ketohexokinase-A exacerbates renal injury in streptozotocin-induced diabetic mice. Metab. Clin. Exp. 2018 08;85:161-170
Doke T et al
2018/01/01
-
備考：
-
参照：
- No.： 591
-
文献情報：
Fujita H et al. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice. Metab. Clin. Exp. 2012 Dec;61(12):1714-24
Fujita H et al
2012/01/01
-
備考：
-
参照：
- No.： 592
-
文献情報：
Tanimoto M et al. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. Metab. Clin. Exp. 2004 Nov;53(11):1473-9
Tanimoto M et al
2004/01/01
-
備考：
-
参照：
- No.： 593
-
文献情報：
Ueda S et al. ENOS deficiency causes podocyte injury with mitochondrial abnormality. Free Radic. Biol. Med. 2015 Oct;87:181-92
Ueda S et al
2015/01/01
-
備考：
-
参照：
- No.： 594
-
文献情報：
Lasagni L et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 2010 Sep;28(9):1674-85
Lasagni L et al
2010/01/01
-
備考：
-
参照：
- No.： 595
-
文献情報：
Tskitishvili E et al. The effect of tumor-associated protein RCAS1 gene silencing on blood pressure and urinary protein excretion in pregnant mouse: a pilot study. Am. J. Obstet. Gynecol. 2010 Oct;203(4):364.e6-364.e12
Tskitishvili E et al
2010/01/01
-
備考：
-
参照：
- No.： 596
-
文献情報：
Falcao S et al. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. Am. J. Obstet. Gynecol. 2009 Feb;200(2):198.e1-5
Falcao S et al
2009/01/01
-
備考：
-
参照：
- No.： 597
-
文献情報：
Guha M et al. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 2007 Oct;21(12):3355-68
Guha M et al
2007/01/01
-
備考：
-
参照：
- No.： 598
-
文献情報：
Leinonen H et al. Lack of P4H-TM in mice results in age-related retinal and renal alterations. Hum. Mol. Genet. 2016 09;25(17):3810-3823
Leinonen H et al
2016/01/01
-
備考：
-
参照：
- No.： 599
-
文献情報：
Tang W et al. RNA-sequencing reveals genome-wide long non-coding RNAs profiling associated with early development of diabetic nephropathy. Oncotarget 2017 Dec;8(62):105832-105847
Tang W et al
2017/01/01
-
備考：
-
参照：
- No.： 600
-
文献情報：
Ding W et al. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice. Cell. Physiol. Biochem. 2015;36(6):2170-82
Ding W et al
2015/01/01
-
備考：
-
参照：
- No.： 601
-
文献情報：
Shi Y et al. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin. Sci. 2015 May;128(10):649-
Shi Y et al
2015/01/01
-
備考：
-
参照：
- No.： 602
-
文献情報：
Nasrallah R et al. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental. Clin. Sci. 2013 Jun;124(11):685-94
Nasrallah R et al
2013/01/01
-
備考：
-
参照：
- No.： 603
-
文献情報：
Luo R et al. Transglutaminase is a Critical Link Between Inflammation and Hypertension. J Am Heart Assoc 2016 06;5(7)
Luo R et al
2016/01/01
-
備考：
-
参照：
- No.： 604
-
文献情報：
Liu C et al. Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia. J Am Heart Assoc 2015 Dec;4(12)
Liu C et al
2015/01/01
-
備考：
-
参照：
- No.： 605
-
文献情報：
Zhong J et al. Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts. Lab. Invest. 2014 Jun;94(6):633-44
Zhong J et al
2014/01/01
-
備考：
-
参照：
- No.： 606
-
文献情報：
Mohan S et al. Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab. Invest. 2008 May;88(5):515-28
Mohan S et al
2008/01/01
-
備考：
-
参照：
- No.： 607
-
文献情報：
Zhao W et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J. Immunol. 2009 Aug;183(4):2729-40
Zhao W et al
2009/01/01
-
備考：
-
参照：
- No.： 608
-
文献情報：
Taneja D et al. Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J. Lipid Res. 2010 Jun;51(6):1464-70
Taneja D et al
2010/01/01
-
備考：
-
参照：
- No.： 609
-
文献情報：
Zhao Y et al. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. J. Mol. Med. 2017 08;95(8):887-898
Zhao Y et al
2017/01/01
-
備考：
-
参照：
- No.： 610
-
文献情報：
Maier C et al. Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II. J. Mol. Med. 2017 05;95(5):473-486
Maier C et al
2017/01/01
-
備考：
-
参照：
- No.： 611
-
文献情報：
Meek RL et al. Glomerular cell death and inflammation with high-protein diet and diabetes. Nephrol. Dial. Transplant. 2013 Jul;28(7):1711-20
Meek RL et al
2013/01/01
-
備考：
-
参照：
- No.： 612
-
文献情報：
Ishimoto T et al. Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol. Dial. Transplant. 2013 Jun;28(6):1439-46
Ishimoto T et al
2013/01/01
-
備考：
-
参照：
- No.： 613
-
文献情報：
Park J et al. Renoprotective antioxidant effect of alagebrium in experimental diabetes. Nephrol. Dial. Transplant. 2011 Nov;26(11):3474-84
Park J et al
2011/01/01
-
備考：
-
参照：
- No.： 614
-
文献情報：
Zuo N et al. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy. Nephrol. Dial. Transplant. 2011 Jul;26(7):2127-37
Zuo N et al
2011/01/01
-
備考：
-
参照：
- No.： 615
-
文献情報：
Gao Q et al. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol. Dial. Transplant. 2010 Nov;25(11):3539-47
Gao Q et al
2010/01/01
-
備考：
-
参照：
- No.： 616
-
文献情報：
Chin HJ et al. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. Nephrol. Dial. Transplant. 2010 May;25(5):1450-7
Chin HJ et al
2010/01/01
-
備考：
-
参照：
- No.： 617
-
文献情報：
Sakurai N et al. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy. Nephrol. Dial. Transplant. 2009 Aug;24(8):2378-83
Sakurai N et al
2009/01/01
-
備考：
-
参照：
- No.： 618
-
文献情報：
Kamijo-Ikemori A et al. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice. Nephrol. Dial. Transplant. 2009 Mar;24(3):788-800
Kamijo-Ikemori A et al
2009/01/01
-
備考：
-
参照：
- No.： 619
-
文献情報：
Iyoda M et al. All-trans-retinoic acid aggravates cryoglobulin-associated membranoproliferative glomerulonephritis in mice. Nephrol. Dial. Transplant. 2007 Dec;22(12):3451-61
Iyoda M et al
2007/01/01
-
備考：
-
参照：
- No.： 620
-
文献情報：
Hamada Y et al. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol. Dial. Transplant. 2007 Jun;22(6):1547-57
Hamada Y et al
2007/01/01
-
備考：
-
参照：
- No.： 621
-
文献情報：
Ogawa M et al. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats. Nephrol. Dial. Transplant. 2006 Apr;21(4):924-34
Ogawa M et al
2006/01/01
-
備考：
-
参照：
- No.： 622
-
文献情報：
Shike T et al. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice. Nephrol. Dial. Transplant. 2005 May;20(5):879-85
Shike T et al
2005/01/01
-
備考：
-
参照：
- No.： 623
-
文献情報：
Fan Q et al. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Nephrol. Dial. Transplant. 2004 Dec;19(12):3012-20
Fan Q et al
2004/01/01
-
備考：
-
参照：
- No.： 624
-
文献情報：
Kim DY et al. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. Mol Nutr Food Res 2018 10;62(19):e1800302
Kim DY et al
2018/01/01
-
備考：
-
参照：
- No.： 625
-
文献情報：
Zhao S et al. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice. Endocrinology 2018 02;159(2):836-852
Zhao S et al
2018/01/01
-
備考：
-
参照：
- No.： 626
-
文献情報：
Ghosh A et al. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice. Endocrinology 2017 04;158(4):903-919
Ghosh A et al
2017/01/01
-
備考：
-
参照：
- No.： 627
-
文献情報：
Kumar V et al. Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton. Sci Rep 2019 03;9(1):3582
Kumar V et al
2019/01/01
-
備考：
-
参照：
- No.： 628
-
文献情報：
Albers RE et al. Trophoblast-Specific Expression of Hif-1α Results in Preeclampsia-Like Symptoms and Fetal Growth Restriction. Sci Rep 2019 02;9(1):2742
Albers RE et al
2019/01/01
-
備考：
-
参照：
- No.： 629
-
文献情報：
Hinder LM et al. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Sci Rep 2019 01;9(1):881
Hinder LM et al
2019/01/01
-
備考：
-
参照：
- No.： 630
-
文献情報：
Masum MA et al. Modified scanning electron microscopy reveals pathological crosstalk between endothelial cells and podocytes in a murine model of membranoproliferative glomerulonephritis. Sci Rep 2018 07;8(1):10276
Masum MA et al
2018/01/01
-
備考：
-
参照：
- No.： 631
-
文献情報：
Stangenberg S et al. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy. Sci Rep 2018 06;8(1):9423
Stangenberg S et al
2018/01/01
-
備考：
-
参照：
- No.： 632
-
文献情報：
Sukjamnong S et al. MitoQ supplementation prevent long-term impact of maternal smoking on renal development, oxidative stress and mitochondrial density in male mice offspring. Sci Rep 2018 04;8(1):6631
Sukjamnong S et al
2018/01/01
-
備考：
-
参照：
- No.： 633
-
文献情報：
Zhao XP et al. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes. Sci Rep 2018 Apr;8(1):5958
Zhao XP et al
2018/01/01
-
備考：
-
参照：
- No.： 634
-
文献情報：
Chen C et al. Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis. Sci Rep 2017 12;7(1):17737
Chen C et al
2017/01/01
-
備考：
-
参照：
- No.： 635
-
文献情報：
Sagar A et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep 2017 09;7(1):12047
Sagar A et al
2017/01/01
-
備考：
-
参照：
- No.： 636
-
文献情報：
Wang H et al. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus. Sci Rep 2016 06;6:28997
Wang H et al
2016/01/01
-
備考：
-
参照：
- No.： 637
-
文献情報：
Liang H et al. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension. Sci Rep 2016 06;6:28715
Liang H et al
2016/01/01
-
備考：
-
参照：
- No.： 638
-
文献情報：
Atanasio A et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep 2016 Mar;6:23204
Atanasio A et al
2016/01/01
-
備考：
-
参照：
- No.： 639
-
文献情報：
Kimura J et al. Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. Sci Rep 2014 Dec;4:7290
Kimura J et al
2014/01/01
-
備考：
-
参照：
- No.： 640
-
文献情報：
Ullevig SL et al. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 2011 Dec;219(2):409-16
Ullevig SL et al
2011/01/01
-
備考：
-
参照：
- No.： 641
-
文献情報：
Yoon JJ et al. <i>Dianthus superbus</i> Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model. Nutrients 2019 Mar;11(3)
Yoon JJ et al
2019/01/01
-
備考：
-
参照：
- No.： 642
-
文献情報：
Drapeau N et al. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes. Am. J. Physiol. Endocrinol. Metab. 2013 Jun;304(11):E1188-98
Drapeau N et al
2013/01/01
-
備考：
-
参照：
- No.： 643
-
文献情報：
Potthoff SA et al. P2Y2 receptor deficiency aggravates chronic kidney disease progression. Front Physiol 2013;4:234
Potthoff SA et al
2013/01/01
-
備考：
-
参照：
- No.： 644
-
文献情報：
Hu S et al. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis. J. Biol. Chem. 2018 12;293(52):20227-20239
Hu S et al
2018/01/01
-
備考：
-
参照：
- No.： 645
-
文献情報：
Wang XX et al. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice. J. Biol. Chem. 2017 07;292(29):12018-12024
Wang XX et al
2017/01/01
-
備考：
-
参照：
- No.： 646
-
文献情報：
Denhez B et al. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes. J. Biol. Chem. 2015 Jan;290(1):350-8
Denhez B et al
2015/01/01
-
備考：
-
参照：
- No.： 647
-
文献情報：
Singhal SS et al. RLIP76 protein knockdown attenuates obesity due to a high-fat diet. J. Biol. Chem. 2013 Aug;288(32):23394-406
Singhal SS et al
2013/01/01
-
備考：
-
参照：
- No.： 648
-
文献情報：
Long J et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 2011 Apr;286(13):11837-48
Long J et al
2011/01/01
-
備考：
-
参照：
- No.： 649
-
文献情報：
Jiang T et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 2005 Sep;280(37):32317-25
Jiang T et al
2005/01/01
-
備考：
-
参照：
- No.： 650
-
文献情報：
Yogi A et al. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. J. Hypertens. 2011 Jul;29(7):1400-10
Yogi A et al
2011/01/01
-
備考：
-
参照：
- No.： 651
-
文献情報：
Baek JH et al. Deletion of the Mitochondrial Complex-IV Cofactor Heme A:Farnesyltransferase Causes Focal Segmental Glomerulosclerosis and Interferon Response. Am. J. Pathol. 2018 Dec;188(12):2745-2762
Baek JH et al
2018/01/01
-
備考：
-
参照：
- No.： 652
-
文献情報：
Bornfeldt KE et al. A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. Am. J. Pathol. 2018 02;188(2):343-352
Bornfeldt KE et al
2018/01/01
-
備考：
-
参照：
- No.： 653
-
文献情報：
Du Q et al. Transfusion of CD206<sup>+</sup> M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice. Am. J. Pathol. 2016 12;186(12):3176-3188
Du Q et al
2016/01/01
-
備考：
-
参照：
- No.： 654
-
文献情報：
Okamoto K et al. Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney. Am. J. Pathol. 2015 Jul;185(7):1889-98
Okamoto K et al
2015/01/01
-
備考：
-
参照：
- No.： 655
-
文献情報：
Bae EH et al. Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome. Am. J. Pathol. 2015 May;185(5):1423-35
Bae EH et al
2015/01/01
-
備考：
-
参照：
- No.： 656
-
文献情報：
Migliorini A et al. The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am. J. Pathol. 2013 Aug;183(2):431-
Migliorini A et al
2013/01/01
-
備考：
-
参照：
- No.： 657
-
文献情報：
Hashimoto A et al. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes. Am. J. Pathol. 2012 Oct;181(4):1338-47
Hashimoto A et al
2012/01/01
-
備考：
-
参照：
- No.： 658
-
文献情報：
Lu A et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am. J. Pathol. 2011 Jun;178(6):2573-86
Lu A et al
2011/01/01
-
備考：
-
参照：
- No.： 659
-
文献情報：
Puliti A et al. Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1. Am. J. Pathol. 2011 Mar;178(3):1257-69
Puliti A et al
2011/01/01
-
備考：
-
参照：
- No.： 660
-
文献情報：
Steenhard BM et al. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria. Am. J. Pat
Steenhard BM et al
2010/01/01
-
備考：
-
参照：
- No.： 661
-
文献情報：
Nakayama T et al. Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney. Am. J. Pathol. 2010 May;176(5):2198-208
Nakayama T et al
2010/01/01
-
備考：
-
参照：
- No.： 662
-
文献情報：
Li J et al. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 2009 Oct;175(4):1380-8
Li J et al
2009/01/01
-
備考：
-
参照：
- No.： 663
-
文献情報：
Guo S et al. Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis. Am. J. Pathol. 2009 Jul;175(1):107-18
Guo S et al
2009/01/01
-
備考：
-
参照：
- No.： 664
-
文献情報：
Yokoyama T et al. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am. J. Pathol. 2009 Jun;174(6):2096-106
Yokoyama T et al
2009/01/01
-
備考：
-
参照：
- No.： 665
-
文献情報：
Williams KJ et al. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am. J. Pathol. 2007 Nov;171(5):1441-50
Williams KJ et al
2007/01/01
-
備考：
-
参照：
- No.： 666
-
文献情報：
Kanetsuna Y et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am. J. Pathol. 2007 May;170(5):1473-84
Kanetsuna Y et al
2007/01/01
-
備考：
-
参照：
- No.： 667
-
文献情報：
Inada A et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am. J. Pathol. 2005 Aug;167(2):327-36
Inada A et al
2005/01/01
-
備考：
-
参照：
- No.： 668
-
文献情報：
Chin M et al. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am. J. Pathol. 2005 Jun;166(6):1629-36
Chin M et al
2005/01/01
-
備考：
-
参照：
- No.： 669
-
文献情報：
Wendt TM et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 2003 Apr;162(4):1123-37
Wendt TM et al
2003/01/01
-
備考：
-
参照：
- No.： 670
-
文献情報：
Taneda S et al. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am. J. Pathol. 2001 Dec;159(6):2355-69
Taneda S et al
2001/01/01
-
備考：
-
参照：
- No.： 671
-
文献情報：
Edwards LJ et al. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice. Clin. Immunol. 2015 Jun;158(2):221-30
Edwards LJ et al
2015/01/01
-
備考：
-
参照：
- No.： 672
-
文献情報：
Yu L et al. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cell. Signal. 2014 Dec;26(12):2979-91
Yu L et al
2014/01/01
-
備考：
-
参照：
- No.： 673
-
文献情報：
Vaisman BL et al. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency. J. Pharmacol. Exp. Ther. 2019 03;368(3):423-434
Vaisman BL et al
2019/01/01
-
備考：
-
参照：
- No.： 674
-
文献情報：
Nam BY et al. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis 2012 Jan;17(1):1-13
Nam BY et al
2012/01/01
-
備考：
-
参照：
- No.： 675
-
文献情報：
Potthoff SA et al. The glomerular proteome in a model of chronic kidney disease. Proteomics Clin Appl 2008 Jul;2(7-8):1127-39
Potthoff SA et al
2008/01/01
-
備考：
-
参照：
- No.： 676
-
文献情報：
Worni-Schudel IM et al. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models. J Transl Med 2015 Jun;13:185
Worni-Schudel IM et al
2015/01/01
-
備考：
-
参照：
- No.： 677
-
文献情報：
Hong YA et al. Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J Transl Med 2014 Feb;12:50
Hong YA et al
2014/01/01
-
備考：
-
参照：
- No.： 678
-
文献情報：
Barsha G et al. Sex- and age-related differences in arterial pressure and albuminuria in mice. Biol Sex Differ 2016;7:57
Barsha G et al
2016/01/01
-
備考：
-
参照：
- No.： 679
-
文献情報：
Li MS et al. NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage. Am. J. Physiol., Cell Physiol. 2017 Jan;312(1):C47-C55
Li MS et al
2017/01/01
-
備考：
-
参照：
- No.： 680
-
文献情報：
Breyer MD. Drug discovery for diabetic nephropathy: trying the leap from mouse to man. Semin. Nephrol. 2012 Sep;32(5):445-51
Breyer MD
2012/01/01
-
備考：
-
参照：
- No.： 681
-
文献情報：
Matsubara K et al. Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice. Hypertens. Res. 2016 Jun;39(6):407-14
Matsubara K et al
2016/01/01
-
備考：
-
参照：
- No.： 682
-
文献情報：
Fujita H et al. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice. Hypertens. Res. 2012 Feb;35(2):213-20
Fujita H et al
2012/01/01
-
備考：
-
参照：
- No.： 683
-
文献情報：
Jang IA et al. Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney. Nutrients 2018 Nov;10(11)
Jang IA et al
2018/01/01
-
備考：
-
参照：
- No.： 684
-
文献情報：
Kang MK et al. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice. Nutrients 2016 Dec;8(12)
Kang MK et al
2016/01/01
-
備考：
-
参照：
- No.： 685
-
文献情報：
Takeda-Matsubara Y et al. Roles of angiotensin type 1 and 2 receptors in pregnancy-associated blood pressure change. Am. J. Hypertens. 2004 Aug;17(8):684-9
Takeda-Matsubara Y et al
2004/01/01
-
備考：
-
参照：
- No.： 686
-
文献情報：
Fowlkes JL et al. Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes. Exp Diabetes Res 2011;2011:269378
Fowlkes JL et al
2011/01/01
-
備考：
-
参照：
- No.： 687
-
文献情報：
Kamada Y et al. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009 Feb;296(2):G157-67
Kamada Y et al
2009/01/01
-
備考：
-
参照：
- No.： 688
-
文献情報：
Tsuchida T et al. Lipocalin-type prostaglandin D synthase in urine in adriamycin-induced nephropathy of mice. Nephron Physiol 2004;96(2):p42-51
Tsuchida T et al
2004/01/01
-
備考：
-
参照：
- No.： 689
-
文献情報：
Thomas CM et al. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 2014 Oct;307(7):H1036-45
Thomas CM et al
2014/01/01
-
備考：
-
参照：
- No.： 690
-
文献情報：
Falcao S et al. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice. Am. J. Physiol. Heart Circ. Physiol. 2009 Jan;296(1):H119-26
Falcao S et al
2009/01/01
-
備考：
-
参照：
- No.： 691
-
文献情報：
Kim EN et al. PPARα agonist, fenofibrate, ameliorates age-related renal injury. Exp. Gerontol. 2016 08;81:42-50
Kim EN et al
2016/01/01
-
備考：
-
参照：
- No.： 692
-
文献情報：
DeLoach S et al. Endothelin-1 response to glucose and insulin among African Americans. J Am Soc Hypertens ;4(5):227-35
DeLoach S et al
-
備考：
-
参照：
- No.： 693
-
文献情報：
Kokura S et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int J Hyperthermia 2007 May;23(3):259-65
Kokura S et al
2007/01/01
-
備考：
-
参照：
- No.： 694
-
文献情報：
Naito Y et al. Reduction of diabetes-induced renal oxidative stress by a cantaloupe melon extract/gliadin biopolymers, oxykine, in mice. Biofactors 2005;23(2):85-95
Naito Y et al
2005/01/01
-
備考：
-
参照：
- No.： 695
-
文献情報：
Naito Y et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 2004;20(1):49-59
Naito Y et al
2004/01/01
-
備考：
-
参照：
- No.： 696
-
文献情報：
Chen XW et al. Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice. Mediators Inflamm. 2016;2016:1405924
Chen XW et al
2016/01/01
-
備考：
-
参照：
- No.： 697
-
文献情報：
Peters V et al. Protective Actions of Anserine Under Diabetic Conditions. Int J Mol Sci 2018 Sep;19(9)
Peters V et al
2018/01/01
-
備考：
-
参照：
- No.： 698
-
文献情報：
Wang D et al. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. Int J Mol Sci 2018 Jan;19(1)
Wang D et al
2018/01/01
-
備考：
-
参照：
- No.： 699
-
文献情報：
Yuan Y et al. A vital role for myosin-9 in puromycin aminonucleoside-induced podocyte injury by affecting actin cytoskeleton. Free Radic. Res. 2016 Jun;50(6):627-37
Yuan Y et al
2016/01/01
-
備考：
-
参照：
- No.： 700
-
文献情報：
Wicks SE et al. Diet-induced obesity and kidney disease - In search of a susceptible mouse model. Biochimie 2016 May;124:65-73
Wicks SE et al
2016/01/01
-
備考：
-
参照：
- No.： 701
-
文献情報：
Liu F et al. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy. Kidney Blood Press. Res. 2018;43(5):1425-1436
Liu F et al
2018/01/01
-
備考：
-
参照：
- No.： 702
-
文献情報：
Xu H et al. Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice. Kidney Blood Press. Res. 2017;42(6):1128-1140
Xu H et al
2017/01/01
-
備考：
-
参照：
- No.： 703
-
文献情報：
Sato E et al. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques. Toxins (Basel) 2017 12;10(1)
Sato E et al
2017/01/01
-
備考：
-
参照：
- No.： 704
-
文献情報：
Iwamuro M et al. Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 2010;19(6):841-7
Iwamuro M et al
2010/01/01
-
備考：
-
参照：
- No.： 705
-
文献情報：
Martin B et al. Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease. Exp. Physiol. 2018 01;103(1):125-140
Martin B et al
2018/01/01
-
備考：
-
参照：
- No.： 706
-
文献情報：
Aliou Y et al. Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr. Res. 2016 Mar;79(3):416-24
Aliou Y et al
2016/01/01
-
備考：
-
参照：
- No.： 707
-
文献情報：
Major TC et al. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes. Cardiovasc Drugs Ther 2008 Dec;22(6):469-78
Major TC et al
2008/01/01
-
備考：
-
参照：
- No.： 708
-
文献情報：
Spencer NY et al. Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes. PLoS ONE 2018;13(7):e0200249
Spencer NY et al
2018/01/01
-
備考：
-
参照：
- No.： 709
-
文献情報：
Huang C et al. The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy. PLoS ONE 2018;13(2):e0192800
Huang C et al
2018/01/01
-
備考：
-
参照：
- No.： 710
-
文献情報：
Lin JS et al. ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics. PLoS ONE 2017;12(9):e0184575
Lin JS et al
2017/01/01
-
備考：
-
参照：
- No.： 711
-
文献情報：
Chen S et al. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes. PLoS ONE 2017;12(3):e0173918
Chen S et al
2017/01/01
-
備考：
-
参照：
- No.： 712
-
文献情報：
Papeta N et al. Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains. PLoS ONE 2016;11(10):e0163860
Papeta N et al
2016/01/01
-
備考：
-
参照：
- No.： 713
-
文献情報：
Bruder-Nascimento T et al. Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3. PLoS ONE 2016;11(9):e0162731
Bruder-Nascimento T et al
2016/01/01
-
備考：
-
参照：
- No.： 714
-
文献情報：
Hokke S et al. Maternal Fat Feeding Augments Offspring Nephron Endowment in Mice. PLoS ONE 2016;11(8):e0161578
Hokke S et al
2016/01/01
-
備考：
-
参照：
- No.： 715
-
文献情報：
Liang X et al. Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS ONE 2016;11(5):e0155534
Liang X et al
2016/01/01
-
備考：
-
参照：
- No.： 716
-
文献情報：
Ishida T et al. Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model. PLoS ONE 2016;11(1):e0146871
Ishida T et al
2016/01/01
-
備考：
-
参照：
- No.： 717
-
文献情報：
Kim M et al. Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment. PLoS ONE 2015;10(11):e0141231
Kim M et al
2015/01/01
-
備考：
-
参照：
- No.： 718
-
文献情報：
Huang L et al. Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1. PLoS ONE 2015;10(9):e0138440
Huang L et al
2015/01/01
-
備考：
-
参照：
- No.： 719
-
文献情報：
Awad AS et al. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury. PLoS ONE 2015;10(7):e0133777
Awad AS et al
2015/01/01
-
備考：
-
参照：
- No.： 720
-
文献情報：
Maggiorani D et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE 2015;10(7):e0131416
Maggiorani D et al
2015/01/01
-
備考：
-
参照：
- No.： 721
-
文献情報：
Honjo T et al. Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice. PLoS ONE 2015;10(6):e0131731
Honjo T et al
2015/01/01
-
備考：
-
参照：
- No.： 722
-
文献情報：
He J et al. Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents. PLoS ONE 2015;10(4):e0124469
He J et al
2015/01/01
-
備考：
-
参照：
- No.： 723
-
文献情報：
Szalai G et al. Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. PLoS ONE 2015;10(4):e0119547
Szalai G et al
2015/01/01
-
備考：
-
参照：
- No.： 724
-
文献情報：
Maimaitiyiming H et al. Thrombospondin1 deficiency attenuates obesity-associated microvascular complications in ApoE-/- mice. PLoS ONE 2015;10(3):e0121403
Maimaitiyiming H et al
2015/01/01
-
備考：
-
参照：
- No.： 725
-
文献情報：
Zhang J et al. A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1. PLoS ONE 2015;10(2):e0116888
Zhang J et al
2015/01/01
-
備考：
-
参照：
- No.： 726
-
文献情報：
Szalai G et al. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS ONE 2014;9(11):e110867
Szalai G et al
2014/01/01
-
備考：
-
参照：
- No.： 727
-
文献情報：
Ichii O et al. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS ONE 2014;9(10):e110383
Ichii O et al
2014/01/01
-
備考：
-
参照：
- No.： 728
-
文献情報：
Ichii O et al. Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand. PLoS ONE 2014;9(9):e108448
Ichii O et al
2014/01/01
-
備考：
-
参照：
- No.： 729
-
文献情報：
Al-Odat I et al. The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring. PLoS ONE 2014;9(7):e103443
Al-Odat I et al
2014/01/01
-
備考：
-
参照：
- No.： 730
-
文献情報：
Carson JM et al. Podocytes degrade endocytosed albumin primarily in lysosomes. PLoS ONE 2014;9(6):e99771
Carson JM et al
2014/01/01
-
備考：
-
参照：
- No.： 731
-
文献情報：
Townley-Tilson WH et al. The ubiquitin ligase ASB4 promotes trophoblast differentiation through the degradation of ID2. PLoS ONE 2014;9(2):e89451
Townley-Tilson WH et al
2014/01/01
-
備考：
-
参照：
- No.： 732
-
文献情報：
Yamada S et al. Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury. PLoS ONE 2014;9(2):e89135
Yamada S et al
2014/01/01
-
備考：
-
参照：
- No.： 733
-
文献情報：
Riera M et al. Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse. PLoS ONE 2014;9(1):e84683
Riera M et al
2014/01/01
-
備考：
-
参照：
- No.： 734
-
文献情報：
Gurusinghe S et al. Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity? PLoS ONE 2013;8(9):e73095
Gurusinghe S et al
2013/01/01
-
備考：
-
参照：
- No.： 735
-
文献情報：
Yong R et al. Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling. PLoS ONE 2013;8(8):e73428
Yong R et al
2013/01/01
-
備考：
-
参照：
- No.： 736
-
文献情報：
Suzuki N et al. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability. PLoS ONE 2013;8(8):e71187
Suzuki N et al
2013/01/01
-
備考：
-
参照：
- No.： 737
-
文献情報：
Johnstone DB et al. Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy. PLoS ONE 2013;8(7):e67839
Johnstone DB et al
2013/01/01
-
備考：
-
参照：
- No.： 738
-
文献情報：
Lan X et al. Morphine induces albuminuria by compromising podocyte integrity. PLoS ONE 2013;8(3):e55748
Lan X et al
2013/01/01
-
備考：
-
参照：
- No.： 739
-
文献情報：
Baczyk D et al. DREAM mediated regulation of GCM1 in the human placental trophoblast. PLoS ONE 2013;8(1):e51837
Baczyk D et al
2013/01/01
-
備考：
-
参照：
- No.： 740
-
文献情報：
Chen HM et al. Heart-type fatty acid binding protein is associated with proteinuria in obesity. PLoS ONE 2012;7(9):e45691
Chen HM et al
2012/01/01
-
備考：
-
参照：
- No.： 741
-
文献情報：
Veron D et al. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS ONE 2012;7(7):e40589
Veron D et al
2012/01/01
-
備考：
-
参照：
- No.： 742
-
文献情報：
Guillot N et al. BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling. PLoS ONE 2012;7(6):e39406
Guillot N et al
2012/01/01
-
備考：
-
参照：
- No.： 743
-
文献情報：
Zhang Y et al. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS ONE 2012;7(6):e38745
Zhang Y et al
2012/01/01
-
備考：
-
参照：
- No.： 744
-
文献情報：
Zhang HM et al. Geldanamycin derivative ameliorates high fat diet-induced renal failure in diabetes. PLoS ONE 2012;7(3):e32746
Zhang HM et al
2012/01/01
-
備考：
-
参照：
- No.： 745
-
文献情報：
Maher P et al. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS ONE 2011;6(6):e21226
Maher P et al
2011/01/01
-
備考：
-
参照：
- No.： 746
-
文献情報：
Ahmed A et al. A new mouse model to explore therapies for preeclampsia. PLoS ONE 2010 Oct;5(10):e13663
Ahmed A et al
2010/01/01
-
備考：
-
参照：
- No.： 747
-
文献情報：
Kawaguchi R et al. Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice. Placenta 2012 Jul;33(7):540-7
Kawaguchi R et al
2012/01/01
-
備考：
-
参照：
- No.： 748
-
文献情報：
Burke SD et al. Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta 2011 Dec;32(12):949-55
Burke SD et al
2011/01/01
-
備考：
-
参照：
- No.： 749
-
文献情報：
Kimura T et al. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice. Cancer Chemother. Pharmacol. 2015 May;75(5):1057-63
Kimura T et al
2015/01/01
-
備考：
-
参照：
- No.： 750
-
文献情報：
Nojiri T et al. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury. Cancer Chemother. Pharmacol. 2015 Jan;75(1):123-9
Nojiri T et al
2015/01/01
-
備考：
-
参照：
- No.： 751
-
文献情報：
El Boustany R et al. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes. J. Diabetes Complicat. 2017 Jun;31(6):929-932
El Boustany R et al
2017/01/01
-
備考：
-
参照：
- No.： 752
-
文献情報：
Abouzed TK et al. Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy. J Diabetes Res 2016;2016:1786789
Abouzed TK et al
2016/01/01
-
備考：
-
参照：
- No.： 753
-
文献情報：
Mascarenhas D et al. Mammalian target of rapamycin complex 2 regulates inflammatory response to stress. Inflamm. Res. 2012 Dec;61(12):1395-404
Mascarenhas D et al
2012/01/01
-
備考：
-
参照：
- No.： 754
-
文献情報：
Roche C et al. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice. Prostaglandins Other Lipid Mediat. 2015 Jul;120:148-54
Roche C et al
2015/01/01
-
備考：
-
参照：
- No.： 755
-
文献情報：
Masum MA et al. Overexpression of toll-like receptor 9 correlates with podocyte injury in a murine model of autoimmune membranoproliferative glomerulonephritis. Autoimmunity 2018 12;51(8):386-398
Masum MA et al
2018/01/01
-
備考：
-
参照：
- No.： 756
-
文献情報：
Detsika MG et al. Effect of Heme Oxygenase-1 Deficiency on Glomerular Proteomics. Am. J. Nephrol. 2016;43(6):441-50
Detsika MG et al
2016/01/01
-
備考：
-
参照：
- No.： 757
-
文献情報：
Kimura J et al. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models. Am. J. Nephrol. 2013;38(1):27-38
Kimura J et al
2013/01/01
-
備考：
-
参照：
- No.： 758
-
文献情報：
Chen L et al. Renal failure in mice with Gsalpha deletion in juxtaglomerular cells. Am. J. Nephrol. 2010;32(1):83-94
Chen L et al
2010/01/01
-
備考：
-
参照：
- No.： 759
-
文献情報：
Kimura J et al. BXSB-type genome causes murine autoimmune glomerulonephritis: pathological correlation between telomeric region of chromosome 1 and Yaa. Genes Immun. ;15(3):182-9
Kimura J et al
-
備考：
-
参照：
- No.： 760
-
文献情報：
Chen YW et al. Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr. Nephrol. 2010 Jul;25(7):1319-29
Chen YW et al
2010/01/01
-
備考：
-
参照：
- No.： 761
-
文献情報：
Kyttaris VC et al. Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice. Biomed Res Int 2013;2013:861028
Kyttaris VC et al
2013/01/01
-
備考：
-
参照：
- No.： 762
-
文献情報：
Mirzoyan K et al. Increased urine acylcarnitines in diabetic ApoE-/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia. Biochem. Biophys. Res. Commun. 2017 05;487(1):109-115
Mirzoyan K et al
2017/01/01
-
備考：
-
参照：
- No.： 763
-
文献情報：
Stec DF et al. Alterations of urinary metabolite profile in model diabetic nephropathy. Biochem. Biophys. Res. Commun. 2015 Jan;456(2):610-4
Stec DF et al
2015/01/01
-
備考：
-
参照：
- No.： 764
-
文献情報：
Ozawa S et al. Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse. Biochem. Biophys. Res. Commun. 2014 11;454(4):531-6
Ozawa S et al
2014/01/01
-
備考：
-
参照：
- No.： 765
-
文献情報：
Mori H et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 2009 Jul;384(4):471-5
Mori H et al
2009/01/01
-
備考：
-
参照：
- No.： 766
-
文献情報：
Suzuki H et al. Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice. Biochem. Biophys. Res. Commun. 2009 Jan;379(1):38-42
Suzuki H et al
2009/01/01
-
備考：
-
参照：
- No.： 767
-
文献情報：
Ishigaki N et al. Involvement of glomerular SREBP-1c in diabetic nephropathy. Biochem. Biophys. Res. Commun. 2007 Dec;364(3):502-8
Ishigaki N et al
2007/01/01
-
備考：
-
参照：
- No.： 768
-
文献情報：
Mishra R et al. Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys. Biochem. Biophys. Res. Commun. 2006 Jan;339(1):65-70
Mishra R et al
2006/01/01
-
備考：
-
参照：
- No.： 769
-
文献情報：
Fujimoto M et al. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem. Biophys. Res. Commun. 2003 Jun;305(4):1002-7
Fujimoto M et al
2003/01/01
-
備考：
-
参照：
- No.： 770
-
文献情報：
Masum MA et al. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions. BMC Nephrol 2017 Sep;18(1):280
Masum MA et al
2017/01/01
-
備考：
-
参照：
- No.： 771
-
文献情報：
Hartono SP et al. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrol 2014;15:58
Hartono SP et al
2014/01/01
-
備考：
-
参照：
- No.： 772
-
文献情報：
Blauwkamp MN et al. Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol 2008 Jul;9:7
Blauwkamp MN et al
2008/01/01
-
備考：
-
参照：
- No.： 773
-
文献情報：
Ma J et al. Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med 2010 Nov;10:67
Ma J et al
2010/01/01
-
備考：
-
参照：
- No.： 774
-
文献情報：
Lee SJ et al. Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury. Nephron Exp. Nephrol. 2012;121(3-4):e86-96
Lee SJ et al
2012/01/01
-
備考：
-
参照：
- No.： 775
-
文献情報：
Wang P et al. The inhibitory effect of BKCa channels induced by autoantibodies against angiotensin II type 1 receptor is independent of AT1R. Acta Biochim. Biophys. Sin. (Shanghai) 2018 Jun;50(6):560-566
Wang P et al
2018/01/01
-
備考：
-
参照：
- No.： 776
-
文献情報：
Kim IH et al. Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice. Age (Dordr) 2016 Aug;38(4):291-302
Kim IH et al
2016/01/01
-
備考：
-
参照：
- No.： 777
-
文献情報：
Smith SW et al. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Histol. Histopathol. 2012 12;27(12):1503-14
Smith SW et al
2012/01/01
-
備考：
-
参照：
- No.： 778
-
文献情報：
Ichikawa H et al. Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin. Int Heart J 2018 Nov;59(6):1445-1453
Ichikawa H et al
2018/01/01
-
備考：
-
参照：
- No.： 779
-
文献情報：
Singh BK et al. A nuclear complex of rictor and insulin receptor substrate-2 is associated with albuminuria in diabetic mice. Metab Syndr Relat Disord 2010 Aug;8(4):355-63
Singh BK et al
2010/01/01
-
備考：
-
参照：
- No.： 780
-
文献情報：
Li S et al. Rhododendron groenlandicum (Labrador tea), an antidiabetic plant from the traditional pharmacopoeia of the Canadian Eastern James Bay Cree, improves renal integrity in the diet-induced obese mouse model. Pharm Biol 2016 Oct;54(10):1998-2006
Li S et al
2016/01/01
-
備考：
-
参照：
- No.： 781
-
文献情報：
Zhang S et al. Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure. Cytotechnology 2018 Aug;70(4):1131-1141
Zhang S et al
2018/01/01
-
備考：
-
参照：
- No.： 782
-
文献情報：
Tang T et al. Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice. Connect. Tissue Res. 2013;54(1):5-13
Tang T et al
2013/01/01
-
備考：
-
参照：
- No.： 783
-
文献情報：
Park HS et al. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice. Transpl. Immunol. 2016 Feb;34:42-9
Park HS et al
2016/01/01
-
備考：
-
参照：
- No.： 784
-
文献情報：
Kadoya H et al. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice. Clin. Exp. Nephrol. 2016 Oct;20(5):671-678
Kadoya H et al
2016/01/01
-
備考：
-
参照：
- No.： 785
-
文献情報：
Moriyama T et al. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. Clin. Exp. Nephrol. 2004 Sep;8(3):230-6
Moriyama T et al
2004/01/01
-
備考：
-
参照：
- No.： 786
-
文献情報：
Cao Y et al. EP4 knockdown alleviates glomerulosclerosis through Smad and MAPK pathways in mesangial cells. Mol Med Rep 2018 Dec;18(6):5141-5150
Cao Y et al
2018/01/01
-
備考：
-
参照：
- No.： 787
-
文献情報：
Jia ZH et al. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Exp. Clin. Endocrinol. Diabetes 2007 Oct;115(9):571-6
Jia ZH et al
2007/01/01
-
備考：
-
参照：
- No.： 788
-
文献情報：
Watanabe T et al. Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice. Biol. Pharm. Bull. 2013;36(5):741-7
Watanabe T et al
2013/01/01
-
備考：
-
参照：
- No.： 789
-
文献情報：
Tsujimura T et al. Combination therapy with SMP-534 and an angiotensin-converting enzyme inhibitor provides additional renoprotection in 5/6 nephrectomized rats. Biol. Pharm. Bull. 2009 Dec;32(12):1991-6
Tsujimura T et al
2009/01/01
-
備考：
-
参照：
- No.： 790
-
文献情報：
Toyoda Y et al. Metabolomics of an in vitro liver model containing primary hepatocytes assembling around an endothelial cell network: comparative study on the metabolic stability and the effect of acetaminophen treatment. J Toxicol Sci 2017;42(4):445-454
Toyoda Y et al
2017/01/01
-
備考：
-
参照：
- No.： 791
-
文献情報：
Chang SY et al. Overexpression of angiotensinogen downregulates aquaporin 1 expression via modulation of Nrf2-HO-1 pathway in renal proximal tubular cells of transgenic mice. J Renin Angiotensin Aldosterone Syst 2016 Jul;17(3)
Chang SY et al
2016/01/01
-
備考：
-
参照：
- No.： 792
-
文献情報：
Kidokoro K et al. Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice. J Renin Angiotensin Aldosterone Syst ;17(2):1470320315625704
Kidokoro K et al
-
備考：
-
参照：
- No.： 793
-
文献情報：
Zhang J et al. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. J Renin Angiotensin Aldosterone Syst 2015 Jun;16(2):234-48
Zhang J et al
2015/01/01
-
備考：
-
参照：
- No.： 794
-
文献情報：
Maeda M et al. Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice. Exp. Anim. 2016 Nov;65(4):427-436
Maeda M et al
2016/01/01
-
備考：
-
参照：
- No.： 795
-
文献情報：
Sasaki H et al. Genetic background-dependent diversity in renal failure caused by the tensin2 gene deficiency in the mouse. Biomed. Res. 2015;36(5):323-30
Sasaki H et al
2015/01/01
-
備考：
-
参照：
- No.： 796
-
文献情報：
Nishino T et al. The 129 genetic background affects susceptibility to glomerulosclerosis in tensin2-deficient mice. Biomed. Res. 2012 Feb;33(1):53-6
Nishino T et al
2012/01/01
-
備考：
-
参照：
- No.： 797
-
文献情報：
Soni H et al. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. Ren Fail 2018 Nov;40(1):314-322
Soni H et al
2018/01/01
-
備考：
-
参照：
- No.： 798
-
文献情報：
Breyer MD. Translating experimental diabetic nephropathy studies from mice to men. Contrib Nephrol 2011;170:156-164
Breyer MD
2011/01/01
-
備考：
-
参照：
- No.： 799
-
文献情報：
Chan YL et al. Impact of maternal cigarette smoke exposure on brain and kidney health outcomes in female offspring. Clin. Exp. Pharmacol. Physiol. 2016 12;43(12):1168-1176
Chan YL et al
2016/01/01
-
備考：
-
参照：
- No.： 800
-
文献情報：
Hokke S et al. Maternal glucose intolerance reduces offspring nephron endowment and increases glomerular volume in adult offspring. Diabetes Metab. Res. Rev. 2016 11;32(8):816-826
Hokke S et al
2016/01/01
-
備考：
-
参照：
- No.： 801
-
文献情報：
Tamai M et al. Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils. Tissue Eng Part A 2013 Nov;19(21-22):2527-35
Tamai M et al
2013/01/01
-
備考：
-
参照：
- No.： 802
-
文献情報：
Kato I et al. A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells. Diabetes Metab. Res. Rev. 2008 Sep;24(6):486-97
Kato I et al
2008/01/01
-
備考：
-
参照：
- No.： 803
-
文献情報：
Maezawa Y et al. Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab. Res. Rev. ;22(4):313-22
Maezawa Y et al
-
備考：
-
参照：
- No.： 804
-
文献情報：
Gordon AD et al. MALAT1: A regulator of inflammatory cytokines in diabetic complications. Endocrinol Diabetes Metab 2018 Apr;1(2):e00010
Gordon AD et al
2018/01/01
-
備考：
-
参照：
- No.： 805
-
文献情報：
Ma Y et al. Comparison of diabetic nephropathy between male and female eNOS<sup>-/-</sup><i>db</i>/<i>db</i> mice. Am. J. Physiol. Renal Physiol. 2019 05;316(5):F889-F897
Ma Y et al
2019/01/01
-
備考：
-
参照：
- No.： 806
-
文献情報：
Hashikami K et al. Establishment of X-linked Alport syndrome model mice with a <i>Col4a5</i> R471X mutation. Biochem Biophys Rep 2019 Mar;17:81-86
Hashikami K et al
2019/01/01
-
備考：
-
参照：
- No.： 807
-
文献情報：
Chung S et al. TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. JCI Insight 2018 11;3(21)
Chung S et al
2018/01/01
-
備考：
-
参照：
- No.： 808
-
文献情報：
Ma Z et al. Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3. Am. J. Physiol. Renal Physiol. 2018 Dec;315(6):F1822-F1832
Ma Z et al
2018/01/01
-
備考：
-
参照：
- No.： 809
-
文献情報：
Manigrasso MB et al. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney. Am. J. Physiol. Renal Physiol. 2018 12;315(6):F1601-F1612
Manigrasso MB et al
2018/01/01
-
備考：
-
参照：
- No.： 810
-
文献情報：
Privratsky JR et al. Interleukin 1 receptor (IL-1R1) activation exacerbates toxin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 2018 09;315(3):F682-F691
Privratsky JR et al
2018/01/01
-
備考：
-
参照：
- No.： 811
-
文献情報：
Li Y et al. Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control. JCI Insight 2018 05;3(10)
Li Y et al
2018/01/01
-
備考：
-
参照：
- No.： 812
-
文献情報：
Garrett N et al. Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice. JCI Insight 2018 04;3(8)
Garrett N et al
2018/01/01
-
備考：
-
参照：
- No.： 813
-
文献情報：
Oh HJ et al. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 10;315(4):F791-F805
Oh HJ et al
2018/01/01
-
備考：
-
参照：
- No.： 814
-
文献情報：
Jung JH et al. Human CD36 overexpression in renal tubules accelerates the progression of renal diseases in a mouse model of folic acid-induced acute kidney injury. Kidney Res Clin Pract 2018 Mar;37(1):30-40
Jung JH et al
2018/01/01
-
備考：
-
参照：
- No.： 815
-
文献情報：
Eriguchi M et al. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2018 04;314(4):F531-F542
Eriguchi M et al
2018/01/01
-
備考：
-
参照：
- No.： 816
-
文献情報：
Norlander AE et al. A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage. JCI Insight 2017 Jul;2(13)
Norlander AE et al
2017/01/01
-
備考：
-
参照：
- No.： 817
-
文献情報：
Orellana JM et al. Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling. Physiol Rep 2017 May;5(10)
Orellana JM et al
2017/01/01
-
備考：
-
参照：
- No.： 818
-
文献情報：
Wysocki J et al. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease. Am. J. Physiol. Renal Physiol. 2017 Aug;313(2):F487-F494
Wysocki J et al
2017/01/01
-
備考：
-
参照：
- No.： 819
-
文献情報：
Morris SM et al. Distinct roles of arginases 1 and 2 in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2017 Oct;313(4):F899-F905
Morris SM et al
2017/01/01
-
備考：
-
参照：
- No.： 820
-
文献情報：
Yi M et al. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am. J. Physiol. Renal Physiol. 2017 07;313(1):F74-F84
Yi M et al
2017/01/01
-
備考：
-
参照：
- No.： 821
-
文献情報：
Saleh MA et al. Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension. JACC Basic Transl Sci 2016 Dec;1(7):606-616
Saleh MA et al
2016/01/01
-
備考：
-
参照：
- No.： 822
-
文献情報：
Roncal-Jimenez CA et al. Effects of exogenous desmopressin on a model of heat stress nephropathy in mice. Am. J. Physiol. Renal Physiol. 2017 03;312(3):F418-F426
Roncal-Jimenez CA et al
2017/01/01
-
備考：
-
参照：
- No.： 823
-
文献情報：
Nakagawa N et al. Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight 2016 Dec;1(20):e87446
Nakagawa N et al
2016/01/01
-
備考：
-
参照：
- No.： 824
-
文献情報：
Yadranji Aghdam S et al. Proteasome Activators, PA28<i>α</i> and PA28<i>β</i>, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy. Int J Nephrol 2016;2016:3846573
Yadranji Aghdam S et al
2016/01/01
-
備考：
-
参照：
- No.： 825
-
文献情報：
Nolin AC et al. Proteinuria causes dysfunctional autophagy in the proximal tubule. Am. J. Physiol. Renal Physiol. 2016 12;311(6):F1271-F1279
Nolin AC et al
2016/01/01
-
備考：
-
参照：
- No.： 826
-
文献情報：
Riera M et al. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am. J. Physiol. Renal Physiol. 2016 Mar;310(6):F534-46
Riera M et al
2016/01/01
-
備考：
-
参照：
- No.： 827
-
文献情報：
Souza AC et al. TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep 2015 Sep;3(9)
Souza AC et al
2015/01/01
-
備考：
-
参照：
- No.： 828
-
文献情報：
Santamaria B et al. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim. Biophys. Acta 2015 Dec;1853(12):3224-34
Santamaria B et al
2015/01/01
-
備考：
-
参照：
- No.： 829
-
文献情報：
Dobrinskikh E et al. Shank2 Regulates Renal Albumin Endocytosis. Physiol Rep 2015 Sep;3(9)
Dobrinskikh E et al
2015/01/01
-
備考：
-
参照：
- No.： 830
-
文献情報：
Hirsch S et al. A mouse model of Townes-Brocks syndrome expressing a truncated mutant Sall1 protein is protected from acute kidney injury. Am. J. Physiol. Renal Physiol. 2015 Nov;309(10):F852-63
Hirsch S et al
2015/01/01
-
備考：
-
参照：
- No.： 831
-
文献情報：
You H et al. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2015 Sep;309(5):F447-55
You H et al
2015/01/01
-
備考：
-
参照：
- No.： 832
-
文献情報：
Chung CH et al. Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy. Nephron Extra ;5(1):1-18
Chung CH et al
-
備考：
-
参照：
- No.： 833
-
文献情報：
O'Sullivan L et al. Excess prenatal corticosterone exposure results in albuminuria, sex-specific hypotension, and altered heart rate responses to restraint stress in aged adult mice. Am. J. Physiol. Renal Physiol. 2015 May;308(10):F1065-73
O'Sullivan L et al
2015/01/01
-
備考：
-
参照：
- No.： 834
-
文献情報：
Nguyen LT et al. L-Carnitine reverses maternal cigarette smoke exposure-induced renal oxidative stress and mitochondrial dysfunction in mouse offspring. Am. J. Physiol. Renal Physiol. 2015 Apr;308(7):F689-96
Nguyen LT et al
2015/01/01
-
備考：
-
参照：
- No.： 835
-
文献情報：
Zhao J et al. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys. Am. J. Physiol. Renal Physiol. 2015 May;308(10):F1167-77
Zhao J et al
2015/01/01
-
備考：
-
参照：
- No.： 836
-
文献情報：
Hulkko J et al. Neph1 is reduced in primary focal segmental glomerulosclerosis, minimal change nephrotic syndrome, and corresponding experimental animal models of adriamycin-induced nephropathy and puromycin aminonucleoside nephrosis. Nephron Extra 2014 S
Hulkko J et al
2014/01/01
-
備考：
-
参照：
- No.： 837
-
文献情報：
You H et al. Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation. Am. J. Physiol. Renal Physiol. 2014 Dec;307(11):F1292-301
You H et al
2014/01/01
-
備考：
-
参照：
- No.： 838
-
文献情報：
Novitskaya T et al. A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Am. J. Physiol. Renal Physiol. 2014 Mar;306(5):F496-504
Novitskaya T et al
2014/01/01
-
備考：
-
参照：
- No.： 839
-
文献情報：
You H et al. Macrophages directly mediate diabetic renal injury. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1719-27
You H et al
2013/01/01
-
備考：
-
参照：
- No.： 840
-
文献情報：
Zhang MZ et al. Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1680-6
Zhang MZ et al
2013/01/01
-
備考：
-
参照：
- No.： 841
-
文献情報：
Decl竪ves AE et al. Effects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging. Am. J. Physiol. Renal Physiol. 2013 Nov;305(9):F1343-51
Decl竪ves AE et al
2013/01/01
-
備考：
-
参照：
- No.： 842
-
文献情報：
Awad AS et al. Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F891-900
Awad AS et al
2013/01/01
-
備考：
-
参照：
- No.： 843
-
文献情報：
Cui W et al. Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F871-80
Cui W et al
2013/01/01
-
備考：
-
参照：
- No.： 844
-
文献情報：
Takahashi S et al. SIRPα signaling regulates podocyte structure and function. Am. J. Physiol. Renal Physiol. 2013 Sep;305(6):F861-70
Takahashi S et al
2013/01/01
-
備考：
-
参照：
- No.： 845
-
文献情報：
Wysocki J et al. Regulation of urinary ACE2 in diabetic mice. Am. J. Physiol. Renal Physiol. 2013 Aug;305(4):F600-11
Wysocki J et al
2013/01/01
-
備考：
-
参照：
- No.： 846
-
文献情報：
Su M et al. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am. J. Physiol. Renal Physiol. 2013 Aug;305(4):F520-31
Su M et al
2013/01/01
-
備考：
-
参照：
- No.： 847
-
文献情報：
Shi Y et al. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. Am. J. Physiol. Renal Physiol. 2013 Jun;304(11):F1335-46
Shi Y et al
2013/01/01
-
備考：
-
参照：
- No.： 848
-
文献情報：
You YH et al. Role of Nox2 in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 2013 Apr;304(7):F840-8
You YH et al
2013/01/01
-
備考：
-
参照：
- No.： 849
-
文献情報：
Vallon V et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am. J. Physiol. Renal Physiol. 2013 Jan;304(2):F156-67
Vallon V et al
2013/01/01
-
備考：
-
参照：
- No.： 850
-
文献情報：
Vashistha H et al. Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am. J. Physiol. Renal Physiol. 2012 Dec;303(12):F1629-40
Vashistha H et al
2012/01/01
-
備考：
-
参照：
- No.： 851
-
文献情報：
Kumar D et al. Inhibition of renin activity slows down the progression of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 2012 Sep;303(5):F711-20
Kumar D et al
2012/01/01
-
備考：
-
参照：
- No.： 852
-
文献情報：
Lo CS et al. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F840-52
Lo CS et al
2012/01/01
-
備考：
-
参照：
- No.： 853
-
文献情報：
Irita J et al. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney. Am. J. Physiol. Renal Physiol. 2011 Oct;301(4):F833-44
Irita J et al
2011/01/01
-
備考：
-
参照：
- No.： 854
-
文献情報：
Ma LJ et al. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am. J. Physiol. Renal Physiol. 2011 May;300(5):F1203-13
Ma LJ et al
2011/01/01
-
備考：
-
参照：
- No.： 855
-
文献情報：
Wang XX et al. Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. Am. J. Physiol. Renal Physiol. 2011 Mar;300(3):F801-10
Wang XX et al
2011/01/01
-
備考：
-
参照：
- No.： 856
-
文献情報：
Sedeek M et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2010 Dec;299(6):F1348-58
Sedeek M et al
2010/01/01
-
備考：
-
参照：
- No.： 857
-
文献情報：
Dilauro M et al. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1523-32
Dilauro M et al
2010/01/01
-
備考：
-
参照：
- No.： 858
-
文献情報：
Ruta LA et al. High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment. Am. J. Physiol. Renal Physiol. 2010 Jun;298(6):F1384-92
Ruta LA et al
2010/01/01
-
備考：
-
参照：
- No.： 859
-
文献情報：
Gurley SB et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F788-95
Gurley SB et al
2010/01/01
-
備考：
-
参照：
- No.： 860
-
文献情報：
Kosugi T et al. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F609-16
Kosugi T et al
2010/01/01
-
備考：
-
参照：
- No.： 861
-
文献情報：
Wang XX et al. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am. J. Physiol. Renal Physiol. 2009 Dec;297(6):F1587-96
Wang XX et al
2009/01/01
-
備考：
-
参照：
- No.： 862
-
文献情報：
van Meurs M et al. Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am. J. Physiol. Renal Physiol. 2009 Aug;297(2):F272-81
van Meurs M et al
2009/01/01
-
備考：
-
参照：
- No.： 863
-
文献情報：
Nakayama T et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F317-27
Nakayama T et al
2009/01/01
-
備考：
-
参照：
- No.： 864
-
文献情報：
Zhang H et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2008 Oct;295(4):F1071-81
Zhang H et al
2008/01/01
-
備考：
-
参照：
- No.： 865
-
文献情報：
Yuan H et al. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F605-17
Yuan H et al
2008/01/01
-
備考：
-
参照：
- No.： 866
-
文献情報：
Boesen EI et al. Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F446-53
Boesen EI et al
2008/01/01
-
備考：
-
参照：
- No.： 867
-
文献情報：
Shi H et al. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1512-7
Shi H et al
2007/01/01
-
備考：
-
参照：
- No.： 868
-
文献情報：
Liu S et al. Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1727-35
Liu S et al
2007/01/01
-
備考：
-
参照：
- No.： 869
-
文献情報：
Wang A et al. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1657-65
Wang A et al
2007/01/01
-
備考：
-
参照：
- No.： 870
-
文献情報：
Ideura H et al. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 2007 Oct;293(4):F1214-21
Ideura H et al
2007/01/01
-
備考：
-
参照：
- No.： 871
-
文献情報：
Hamada Y et al. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 2007;53(1-2):53-61
Hamada Y et al
2007/01/01
-
備考：
-
参照：
- No.： 872
-
文献情報：
Kanetsuna Y et al. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes. Am. J. Physiol. Renal Physiol. 2006 Dec;291(6):F1315-22
Kanetsuna Y et al
2006/01/01
-
備考：
-
参照：
- No.： 873
-
文献情報：
Gurley SB et al. Impact of genetic background on nephropathy in diabetic mice. Am. J. Physiol. Renal Physiol. 2006 Jan;290(1):F214-22
Gurley SB et al
2006/01/01
-
備考：
-
参照：
- No.： 874
-
文献情報：
Yang T et al. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am. J. Physiol. Renal Physiol. 2005 Jun;288(6):F1125-32
Yang T et al
2005/01/01
-
備考：
-
参照：
- No.： 875
-
文献情報：
Kralisch S et al. The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease. Eur. J. Endocrinol. 2019 Aug;181(2):151-159
Kralisch S et al
2019/01/01
-
備考：
-
参照：
- No.： 876
-
文献情報：
Wen Y et al. TNF-α in T lymphocytes attenuates renal injury and fibrosis during nephrotoxic nephritis. Am. J. Physiol. Renal Physiol. 2020 01;318(1):F107-F116
Wen Y et al
2020/01/01
-
備考：
-
参照：
- No.： 877
-
文献情報：
Lo CS et al. Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice. Sci Rep 2019 10;9(1):15765
Lo CS et al
2019/01/01
-
備考：
-
参照：
- No.： 878
-
文献情報：
Saleh MA et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J. Clin. Invest. 2015 Mar;125(3):1189-202
Saleh MA et al
2015/01/01
-
備考：
-
参照：
- No.： 879
-
文献情報：
Rubio-Navarro A et al. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J. Pathol. 2018 03;244(3):296-310
Rubio-Navarro A et al
2018/01/01
-
備考：
-
参照：
- No.： 880
-
文献情報：
Elmarakby AA et al. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats. Clin. Sci. 2013 Oct;125(7):349-59
Elmarakby AA et al
2013/01/01
-
備考：
-
参照：
- No.： 881
-
文献情報：
Heimlich JB et al. ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus. Acta Physiol (Oxf) 2015 Mar;213(3):722-30
Heimlich JB et al
2015/01/01
-
備考：
-
参照：
- No.： 882
-
文献情報：
Elmarakby AA et al. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011 Nov;301(5):R1307-17
Elmarakby AA et al
2011/01/01
-
備考：
-
参照：
- No.： 883
-
文献情報：
Cechova S et al. <i>MYH9</i> E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration. J. Am. Soc. Nephrol. 2018 01;29(1):155-167
Cechova S et al
2018/01/01
-
備考：
-
参照：
- No.： 884
-
文献情報：
Wang W et al. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 2014 Dec;15(4):384-95
Wang W et al
2014/01/01
-
備考：
-
参照：
- No.： 885
-
文献情報：
Koshikawa M et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 2005 Sep;16(9):2690-701
Koshikawa M et al
2005/01/01
-
備考：
-
参照：
- No.： 886
-
文献情報：
Mima A et al. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy. FASEB J. 2012 Jul;26(7):2963-74
Mima A et al
2012/01/01
-
備考：
-
参照：
- No.： 887
-
文献情報：
Li XQ et al. Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage. Sci Rep 2016 05;6:26854
Li XQ et al
2016/01/01
-
備考：
-
参照：
- No.： 888
-
文献情報：
Tesch GH et al. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007 Jun;12(3):261-6
Tesch GH et al
2007/01/01
-
備考：
-
参照：
- No.： 889
-
文献情報：
Awad AS et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2006 Apr;290(4):F828-37
Awad AS et al
2006/01/01
-
備考：
-
参照：
- No.： 890
-
文献情報：
Kolavennu V et al. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2008 Mar;57(3):714-23
Kolavennu V et al
2008/01/01
-
備考：
-
参照：
- No.： 891
-
文献情報：
Cohen MP et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int. 2005 Oct;68(4):1554-61
Cohen MP et al
2005/01/01
-
備考：
-
参照：
- No.： 892
-
文献情報：
Sugaru E et al. Enhanced effect of combined treatment with SMP-534 (antifibrotic agent) and losartan in diabetic nephropathy. Am. J. Nephrol. 2006;26(1):50-8
Sugaru E et al
2006/01/01
-
備考：
-
参照：
- No.： 893
-
文献情報：
Sugaru E et al. Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice. Nephron Exp. Nephrol. 2007;105(2):e45-52
Sugaru E et al
2007/01/01
-
備考：
-
参照：
- No.： 894
-
文献情報：
Quigley JE et al. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension. Clin. Exp. Pharmacol. Physiol. 2009 Jul;36(7):724-8
Quigley JE et al
2009/01/01
-
備考：
-
参照：
- No.： 895
-
文献情報：
Cohen MP et al. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am. J. Physiol. Renal Physiol. 2007 Feb;292(2):F789-95
Cohen MP et al
2007/01/01
-
備考：
-
参照：
- No.： 896
-
文献情報：
Sugaru E et al. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice. Am. J. Physiol. Renal Physiol. 2006 Apr;290(4):F813-20
Sugaru E et al
2006/01/01
-
備考：
-
参照：
- No.： 897
-
文献情報：
Soto-Gutierrez A et al. Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric. Transplantation 2007 Jan;83(2):129-37
Soto-Gutierrez A et al
2007/01/01
-
備考：
-
参照：